0001702924 WRAP TECHNOLOGIES, INC.
false --12-31 FY 2021 5,000,000 5,000,000 0.0001 0.0001 0 0 0 0
150,000,000 150,000,000 0.0001 0.0001 40,851,945 40,851,945
37,554,162 37,554,162 6.00 3.00 5.00 6.00 6.50 6.50 8.125 0 0 0 3 1
20 0 0 0 68 0 0 2 2 3 3 3 3 3 4 18 3,168 720 3 3 2
00017029242021-01-012021-12-31 iso4217:USD 00017029242021-06-30
xbrli:shares 00017029242022-03-09 thunderdome:item
00017029242021-12-31 00017029242020-12-31 iso4217:USDxbrli:shares
00017029242020-01-012020-12-31
0001702924us-gaap:CommonStockMember2019-12-31
0001702924us-gaap:AdditionalPaidInCapitalMember2019-12-31
0001702924us-gaap:RetainedEarningsMember2019-12-31
00017029242019-12-31
0001702924us-gaap:CommonStockMember2020-01-012020-12-31
0001702924us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31
0001702924wrap:WarrantsAt300PerShareMember2020-12-31
0001702924wrap:WarrantsAt300PerShareMemberus-gaap:CommonStockMember2020-01-012020-12-31
0001702924wrap:WarrantsAt300PerShareMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31
0001702924wrap:WarrantsAt300PerShareMember2020-01-012020-12-31
0001702924wrap:WarrantsAt500PerShareMember2020-12-31
0001702924wrap:WarrantsAt500PerShareMemberus-gaap:CommonStockMember2020-01-012020-12-31
0001702924wrap:WarrantsAt500PerShareMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31
0001702924wrap:WarrantsAt500PerShareMember2020-01-012020-12-31
0001702924wrap:WarrantsAt600PerShareMember2020-12-31
0001702924wrap:WarrantsAt600PerShareMemberus-gaap:CommonStockMember2020-01-012020-12-31
0001702924wrap:WarrantsAt600PerShareMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31
0001702924wrap:WarrantsAt600PerShareMember2020-01-012020-12-31
0001702924wrap:WarrantsAt650PerShareMember2020-12-31
0001702924wrap:WarrantsAt650PerShareMemberus-gaap:CommonStockMember2020-01-012020-12-31
0001702924wrap:WarrantsAt650PerShareMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31
0001702924wrap:WarrantsAt650PerShareMember2020-01-012020-12-31
0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-31
0001702924us-gaap:RetainedEarningsMember2020-01-012020-12-31
0001702924us-gaap:CommonStockMember2020-12-31
0001702924us-gaap:AdditionalPaidInCapitalMember2020-12-31
0001702924us-gaap:RetainedEarningsMember2020-12-31
0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31
0001702924wrap:WarrantsAt650PerShareMember2021-12-31
0001702924wrap:WarrantsAt650PerShareMemberus-gaap:CommonStockMember2021-01-012021-12-31
0001702924wrap:WarrantsAt650PerShareMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-31
0001702924wrap:WarrantsAt650PerShareMember2021-01-012021-12-31
0001702924wrap:WarrantsAt8125PerShareMember2021-12-31
0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:CommonStockMember2021-01-012021-12-31
0001702924wrap:WarrantsAt8125PerShareMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-31
0001702924wrap:WarrantsAt8125PerShareMember2021-01-012021-12-31
0001702924us-gaap:CommonStockMember2021-01-012021-12-31
0001702924us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-31
0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-31
0001702924us-gaap:RetainedEarningsMember2021-01-012021-12-31
0001702924us-gaap:CommonStockMember2021-12-31
0001702924us-gaap:AdditionalPaidInCapitalMember2021-12-31
0001702924us-gaap:RetainedEarningsMember2021-12-31
0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31
0001702924wrap:PatentsAndTrademarksMember2021-01-012021-12-31
0001702924wrap:PatentsAndTrademarksMember2020-01-012020-12-31
0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2021-01-012021-12-31
0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2020-01-012020-12-31
xbrli:pure utr:Y 0001702924srt:MinimumMember2021-01-012021-12-31
0001702924srt:MaximumMember2021-01-012021-12-31
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-31
0001702924us-gaap:ShippingAndHandlingMember2021-01-012021-12-31
0001702924us-gaap:ShippingAndHandlingMember2020-01-012020-12-31
0001702924wrap:VirtualRealityTrainingMember2021-12-31
0001702924wrap:ExtendedProductWarrantiesMember2021-12-31
0001702924wrap:VirtualRealityTrainingMember2020-12-31
0001702924wrap:ExtendedProductWarrantiesMember2020-12-31
0001702924wrap:NsenaIncMember2020-12-142020-12-14
0001702924wrap:NsenaIncMemberwrap:ShorttermNotePayableMember2020-12-142020-12-14
0001702924wrap:NsenaIncMemberwrap:NotePayaleOnMarch152021Member2020-12-142020-12-14
0001702924wrap:NsenaIncMemberwrap:NotePaybleOnJune152021Member2020-12-142020-12-14
0001702924wrap:NsenaIncMemberwrap:NotePayableOnSeptember152021Member2020-12-142020-12-14
0001702924wrap:NsenaIncMember2020-12-14
0001702924wrap:NsenaIncMember2021-01-012021-06-30
0001702924wrap:NsenaIncMember2021-07-012021-09-30
00017029242020-12-14
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-14
0001702924us-gaap:CustomerContractsMember2020-12-14
0001702924us-gaap:TradeNamesMember2020-12-14
0001702924us-gaap:NoncompeteAgreementsMember2020-12-14
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-142020-12-14
0001702924us-gaap:CustomerContractsMember2020-12-142020-12-14
0001702924us-gaap:TradeNamesMember2020-12-142020-12-14
0001702924us-gaap:NoncompeteAgreementsMember2020-12-142020-12-14
0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2021-12-31
0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2021-01-012021-12-31
0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2021-12-31
0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2021-01-012021-12-31
0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2021-12-31
0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2021-01-012021-12-31
0001702924us-gaap:FairValueInputsLevel1Member2021-12-31
0001702924us-gaap:FairValueInputsLevel1Member2021-01-012021-12-31
0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2020-12-31
0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2020-01-012020-12-31
0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2020-12-31
0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2020-01-012020-12-31
0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2020-12-31
0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2020-01-012020-12-31
0001702924us-gaap:FairValueInputsLevel1Member2020-12-31
0001702924us-gaap:FairValueInputsLevel1Member2020-01-012020-12-31
0001702924wrap:ProductLineExitCostsMember2021-01-012021-12-31
0001702924wrap:RawMaterialsAndScrapPartsMember2020-01-012020-12-31
0001702924wrap:ProductionAndLabEquipmentMember2021-12-31
0001702924wrap:ProductionAndLabEquipmentMember2020-12-31
0001702924wrap:ToolingMember2021-12-31
0001702924wrap:ToolingMember2020-12-31
0001702924us-gaap:ComputerEquipmentMember2021-12-31
0001702924us-gaap:ComputerEquipmentMember2020-12-31
0001702924us-gaap:FurnitureAndFixturesMember2021-12-31
0001702924us-gaap:FurnitureAndFixturesMember2020-12-31
00017029242021-04-012021-06-30
0001702924us-gaap:PatentsMember2021-12-31
0001702924us-gaap:PatentsMember2020-12-31
0001702924us-gaap:TrademarksMember2021-12-31
0001702924us-gaap:TrademarksMember2020-12-31
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-31
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2020-12-31
0001702924us-gaap:OtherIntangibleAssetsMember2021-12-31
0001702924us-gaap:OtherIntangibleAssetsMember2020-12-31
0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2021-04-012021-06-30
0001702924wrap:SyzygyLicensingLLCMember2021-12-31
0001702924wrap:SyzygyLicensingLLCMember2020-12-31
0001702924wrap:V3CapitalPartnersLLCMember2020-12-31
0001702924wrap:CommissionsPayableMember2021-12-31
0001702924wrap:CommissionsPayableMember2020-12-31
0001702924wrap:ImprovedOfficeAndWarehouseInTempeArizonaMember2021-01-012021-12-31
0001702924wrap:ImprovedOfficeAndWarehouseInTempeArizonaMember2020-01-012020-12-31
0001702924wrap:PaycheckProtectionProgramCaresActMember2020-05-012020-05-01
0001702924wrap:PaycheckProtectionProgramCaresActMember2020-05-01
0001702924wrap:PaycheckProtectionProgramCaresActMember2021-12-31
0001702924wrap:PaycheckProtectionProgramCaresActMember2021-01-012021-12-31
0001702924wrap:June2020FollowonPublicOfferingMember2020-06-02
0001702924wrap:WarrantsIssuedWithJune2019FollowonOfferingMember2020-06-02
0001702924wrap:June2020FollowonPublicOfferingMember2020-06-022020-06-02
0001702924wrap:PurchaseWarrantsMember2019-12-31
0001702924wrap:PurchaseWarrantsMember2020-01-012020-12-31
0001702924wrap:PurchaseWarrantsMember2020-12-31
0001702924wrap:PurchaseWarrantsMember2021-01-012021-12-31
0001702924wrap:PurchaseWarrantsMember2021-12-31
0001702924srt:OfficerMember2020-01-012020-12-31
0001702924wrap:PurchaseWarrantsExpiringJune182021Member2021-12-31
0001702924wrap:The2017StockIncentivePlanMember2017-03-31
0001702924wrap:The2017StockIncentivePlanMember2019-05-012019-05-31
0001702924wrap:The2017StockIncentivePlanMember2020-06-012020-06-30
0001702924wrap:The2017StockIncentivePlanMember2020-06-30
0001702924wrap:The2017StockIncentivePlanMember2021-06-012021-06-30
0001702924wrap:The2017StockIncentivePlanMember2021-12-31
00017029242019-01-012019-12-31
0001702924us-gaap:EmployeeStockOptionMember2021-01-012021-12-31
0001702924us-gaap:EmployeeStockOptionMember2020-01-012020-12-31
0001702924wrap:ExercisePriceRangeOneMember2021-01-012021-12-31
0001702924wrap:ExercisePriceRangeOneMember2021-12-31
0001702924wrap:ExercisePriceRangeTwoMember2021-01-012021-12-31
0001702924wrap:ExercisePriceRangeTwoMember2021-12-31
0001702924wrap:ExercisePriceRangeThreeMember2021-01-012021-12-31
0001702924wrap:ExercisePriceRangeThreeMember2021-12-31
0001702924wrap:ExercisePriceRangeFourMember2021-01-012021-12-31
0001702924wrap:ExercisePriceRangeFourMember2021-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMemberwrap:OfficersAndEmployeesMember2019-01-012019-01-31
0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberwrap:The2017StockIncentivePlanMember2019-08-012019-09-30
0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMemberwrap:OfficersAndDirectorsMember2020-01-012020-01-31
0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberwrap:The2017StockIncentivePlanMember2020-04-012020-04-30
0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMembersrt:OfficerMember2020-04-012020-04-30
0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberwrap:The2017StockIncentivePlanMember2020-07-012020-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberwrap:The2017StockIncentivePlanMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-07-012020-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberwrap:The2017StockIncentivePlanMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-07-012020-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2019-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-31
0001702924wrap:ServicebasedRsuMember2020-01-012020-12-31
0001702924wrap:PerformancebasedRsuMember2020-01-012020-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2020-12-31
0001702924wrap:ServicebasedRsuMember2021-01-012021-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-31
0001702924us-gaap:RestrictedStockUnitsRSUMember2021-12-31
0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-31
0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-31
0001702924us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-31
0001702924us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-31
0001702924us-gaap:EmployeeStockOptionMember2021-12-31
0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2016-09-30
0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2021-01-012021-12-31
0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2020-01-012020-12-31
0001702924wrap:FutureComponentDeliveriesAndContractServicesMember2021-12-31
0001702924wrap:MrElwoodNorrisMember2021-01-012021-12-31
0001702924wrap:MrElwoodNorrisMember2020-01-012020-12-31
0001702924wrap:MrElwoodNorrisMember2021-07-012021-12-31
0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2021-07-012021-12-31
0001702924wrap:V3CapitalPartnersLLCMember2020-01-012020-12-31
0001702924wrap:BonusForAssistanceInAFinancingMemberwrap:V3CapitalPartnersLLCMember2020-01-012020-07-31
0001702924us-gaap:DomesticCountryMember2021-12-31
0001702924us-gaap:StateAndLocalJurisdictionMember2021-12-31
0001702924us-gaap:DomesticCountryMember2020-12-31
0001702924us-gaap:StateAndLocalJurisdictionMember2020-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2021-01-012021-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2021-01-012021-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2021-01-012021-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2021-01-012021-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2021-01-012021-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2021-01-012021-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2020-01-012020-12-31
0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2020-01-012020-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2020-01-012020-12-31
0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2020-01-012020-12-31
0001702924srt:AmericasMember2021-01-012021-12-31
0001702924srt:AmericasMember2020-01-012020-12-31
0001702924wrap:EuropeMiddleEastAndAfricaMember2021-01-012021-12-31
0001702924wrap:EuropeMiddleEastAndAfricaMember2020-01-012020-12-31
0001702924srt:AsiaPacificMember2021-01-012021-12-31
0001702924srt:AsiaPacificMember2020-01-012020-12-31
0001702924wrap:ImprovedOfficeAndWarehouseInTempeArizonaMemberus-gaap:SubsequentEventMember2022-01-012022-01-31
0001702924wrap:ImprovedOfficeAndWarehouseInTempeArizonaMemberus-gaap:SubsequentEventMember2022-01-31
UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2021
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT
|
Commission File Number: 000-55838

Wrap Technologies, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
98-0551945
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification Number)
|
1817 W 4th Street
Tempe, Arizona
85281
(Address of principal executive offices) (Zip Code)
(800) 583-2652
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
None
Title of each
class
|
Trading
Symbol(s)
|
Name of each exchange on
which registered
|
Common Stock, par value $0.0001 per share
|
WRAP
|
Nasdaq Capital Market
|
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No
☒
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the Exchange
Act. Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such
files).
☒ Yes ☐ No
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the
definitions of “accelerated filer,” “large accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large Accelerated Filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
Emerging growth company ☒
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant has filed a report on
and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the
registered public accounting firm that prepared or issued its audit
report. ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The aggregate market value of the registrant’s common stock held by
non-affiliates of the registrant on June 30, 2021 (the last
business day of the registrant’s most recently completed second
fiscal quarter) was $206,057,335 based on the closing price as
reported on the Nasdaq Capital Market (“Nasdaq”). Shares of
the registrant’s common stock held by each officer and director and
each person known to the registrant to own 10% or more of the
outstanding voting power of the registrant have been excluded in
that such persons may be deemed to be affiliates. This
determination of affiliate status is not a determination for other
purposes.
Indicate the number of shares outstanding of each of the
registrant’s classes of common stock, as of the latest
practicable date: 40,939,371 shares of common stock, par value
$0.0001 per share, as of March 9, 2022.
Documents Incorporated by Reference
The registrant incorporates information required by Part III (Items
10, 11, 12, 13, and 14) of this report by reference to portions of
the registrant’s definitive proxy statement with respect to its
2022 Annual Meeting of Stockholders to be filed with the Securities
and Exchange Commission within 120 days after the close of the
fiscal year ended December 31, 2021, pursuant to Regulation
14A.
TABLE
OF CONTENTS
PART
I
FORWARD-LOOKING STATEMENTS
In addition to historical information, this Annual Report on
form 10-K (the “Annual Report”) contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 and the Company desires to
take advantage of the “safe harbor” provisions
thereof. Therefore, the Company is including this statement for the
express purpose of availing itself of the protections of such safe
harbor with respect to all of such forward-looking statements. The
forward-looking statements in this report reflect the
Company’s current views with respect to future events and
financial performance. These forward-looking statements are subject
to certain risks and uncertainties, including those discussed
herein, that could cause actual results to differ materially from
historical results or those anticipated. In this report, the
words “anticipates,” “believes,”
“expects,” “intends,” “future” and similar
expressions identify forward-looking statements. Readers are
cautioned to consider the specific risk factors described below and
not to place undue reliance on the forward-looking statements
contained herein, which speak only as of the date hereof. The
Company undertakes no obligation to publicly revise these
forward-looking statements to reflect events or circumstances that
may arise after the date hereof.
For purposes of this Annual Report, the terms “we,”
“us,” “our” “Wrap” and the
“Company” refer to Wrap Technologies, Inc. and its
consolidated subsidiary.
Use of Market and Industry Data
This Annual Report includes market and industry data that we have
obtained from third party sources, including industry publications,
as well as industry data prepared by our management on the basis of
its knowledge of and experience in the industries in which we
operate (including our management’s estimates and assumptions
relating to such industries based on that knowledge). Management
has developed its knowledge of such industries through its
experience and participation in these industries. While our
management believes the third-party sources referred to in this
Annual Report are reliable, neither we nor our management have
independently verified any of the data from such sources referred
to in this Annual Report or ascertained the underlying economic
assumptions relied upon by such sources. Furthermore, references in
this Annual Report to any publications, reports, surveys or
articles prepared by third parties should not be construed as
depicting the complete findings of the entire publication, report,
survey or article. The information in any such publication, report,
survey or article is not incorporated by reference in this Annual
Report.
Forecasts and other forward-looking information obtained from these
sources involve risks and uncertainties and are subject to change
based on various factors, including those discussed in sections
entitled “Forward-Looking Statements,” “Item 1A. Risk Factors” and
“Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in this Annual Report.
TRADEMARKS, TRADE NAMES AND SERVICE MARKS
BolaWrap and Wrap are registered trademarks in the U.S. and certain
other jurisdictions. They, along with our other common law
trademarks, service marks or trade names appearing in this Annual
Report are the property of the Company. Other trademarks, service
marks or trade names appearing in this Annual Report are the
property of their owners. We do not intend our use or display of
other companies’ trade names or trademarks to imply a relationship
with, or endorsement or sponsorship of us by, any other companies.
We have omitted the ® and ™ designations, as applicable, for the
trademarks used in this Annual Report.
ITEM 1. BUSINESS
Overview
We are a global public safety technology and services company
delivering modern policing solutions to law enforcement and
security personnel. We began sales of our first public safety
product, the BolaWrap 100 remote restraint device, in late 2018. In
October 2021 we released a new generation product, the BolaWrap
150. The BolaWrap 150 is electronically deployed and is more
robust, smaller, lighter and simpler to deploy than the BolaWrap
100 that is being phased out.
 |
 |
 |
BolaWrap 150 Remote Restraint Device |
|
BolaWrap 150 Remote Restraint Device and Cassette |
|
|
|
|
|
|
As an alternative to more traditional means of restraint and
detainment, BolaWrap represents a breakthrough in the development
of a less-lethal tool on the low end of the applied force
continuum. As communities continue to ask for more compassionate
and safe policing practices, BolaWrap is rapidly gaining worldwide
awareness and recognition through media exposure, trade show
participation, product demonstrations and word of mouth.
The immediate addressable domestic market for our solutions
consists of approximately 900,000 full-time sworn law enforcement
officers at over 15,300 federal, state and local law enforcement
agencies in the United States. We are also exploring other domestic
markets, including military and private security. Our international
focus is on countries with the largest police forces. The 100
largest international police agencies are estimated to have over
12.1 million law enforcement personnel. According to 360iResearch,
a market research firm, we participate in a segment of the
non-lethal products global market expected to grow to $16.1 billion
by 2027.
We focus our efforts on the following products, services and
solutions:
BolaWrap Remote Restraint Device – is a hand-held remote
restraint device that discharges an eight-foot bola style Kevlar
tether to entangle an individual at a range of 10-25 feet. BolaWrap
assists law enforcement to safely and effectively control
encounters early in the use of force continuum without resorting to
painful force options.
Wrap Reality – is a law enforcement training system
utilizing immersive computer graphics virtual reality with
proprietary software-enabled content. It allows up to two
participants to enter a simulated training environment
simultaneously, and customized weapons controllers enable trainees
to engage in strategic decision making along the force
continuum.
In addition to the United States law enforcement market, we have
shipped our restraint products to 51 countries. We have established
an active distributor network with 12 domestic distributors
representing 49 states and one dealer representing Puerto Rico. We
have distribution agreements with 47 international distributors
covering 54 countries. We focus significant sales, training and
business development efforts to support our distribution
network.
We focus significant resources on research and development
innovations and continue to enhance our products and plan to
introduce new products. We believe we have established a strong
branding and market presence globally and have established
significant competitive advantages in our markets.
Industry Background
The market for use-of-force related products and devices includes
law enforcement agencies, correctional facilities, military
agencies, private security guard companies and retail consumers. We
believe law enforcement officials are the opinion leaders regarding
market acceptance of new public safety products. We are focused on
the law enforcement agency segment of the market for our BolaWrap
remote restraint solution and the Wrap Reality virtual reality
system.
A number of well-publicized national events, such as the death of
George Floyd, the protesting thereafter, the Capitol riots and
other publicized encounters and events throughout 2020 and 2021,
have highlighted some of the challenges of modern policing and
emphasized the need for more hands-off, less-lethal engagements and
new approaches for more extensive officer training. Police reform
and reorganization of police departments have now become a topic
with heightened community focus and public engagement. We believe
these events are garnering additional government funding and
community support for new law enforcement solutions and more
focused training. In conversations with industry leading
organizations such as the Major City Chiefs Association
("MCCA"), International Association of Chiefs of Police
("IACP"), and others, police reform is a priority and area
of focus in the Biden-Harris administration.
Currently, law enforcement agencies authorize a continuum of force
options ranging from verbal commands to lethal force. Studies have
concluded that most police officers never deploy lethal force in
the course of their careers. Although a majority of law enforcement
officers around the world are armed with firearms, only a small
percentage will actually ever use them. Officers, however, use
less-lethal force on a regular basis. Traditional tactics such as
using a control hold, baton, club, or combat to control a suspect
may result not only in a risk of injury to the suspect, but also a
risk that the officer will be injured. Other force options
including chemical spray, impact munitions and CEWs, not only risk
injury, but are often controversial. Each weapon available to law
enforcement has distinct advantages and disadvantages, and we
believe law enforcement agencies require a variety of different
tools for different situations.
We believe BolaWrap is a necessary tool to meet modern policing
requirements when individuals do not respond to verbal commands. At
the same time, the public is demanding less-lethal policing. This
is even more apparent in police interactions with persons in crisis
and the mentally ill. According to a report by The State of Mental
Health in America, 2018, published by The Mental Health America an
estimated 40 million adults in the U.S. suffer from mental health
issues. And, in a 2015 report on The Role of Mental Illness in
Fatal Law Enforcement Encounters, the Treatment Advocacy Center:
Office of Research & Public Affairs, 7.9 million individuals
have severe mental illness that affect their thinking and behavior.
Amounting to somewhat fewer than four in every 100 adults in
America, individuals with severe mental illness generate no less
than one in ten calls for police service and occupy at least one in
five prison and jail beds in the U.S. An estimated one in three
individuals transported to hospital emergency rooms in psychiatric
crisis are taken there by police. BolaWrap enables officers to more
safely and humanely take subjects into custody without injury to
get them the help they need. BolaWrap restraint of individuals at a
distance may offer reduced frequency of deployment of other control
techniques, including CEWs, especially in encounters with the
mentally ill.
Litigation and insurance costs involving use of force for law
enforcement agencies can be significant, with settlements in the
millions of dollars for many departments. Reducing the frequency of
need for other use of force tools and the number of injuries and
fatalities caused by law enforcement officers may reduce the number
of legal cases filed against agencies for excessive use of force,
wrongful death and injury.
We believe BolaWrap increases goodwill between public safety
agencies and their communities. Community relations considerations
can be particularly important at a time when almost any interaction
with public safety officers can be recorded and scrutinized by the
media and the public.
The industry response to BolaWrap confirms the need to fill a gap
between verbal commands and pain inducing compliance tools. During
2021 dozens of agency released body or dash camera videos from
actual police uses which demonstrated the utility of BolaWrap to
safely detain persons often for transport for medical help. Our
goal is to equip every public safety officer with the BolaWrap
remote restraint solution.
Markets
We participate in the global non-lethal market that, according to
the January 2022 report by 360iResearch, was estimated to be $8.3
billion in 2020, $9 billion in 2021 and expected to grow to $16.1
billion in 2027. The following segments are our target markets:
Domestic and International Law Enforcement
Federal, state and local law enforcement agencies in the United
States currently represent the primary target market for our
products and services. According to the FBI’s Criminal Justice
Information Services Division in 2018 there were over 800,000 local
and state full-time law enforcement officers in the U.S. In October
2019, the U.S. Department of Justice reported that based on 2016
data, there were over 100,000 full-time federal officers primarily
providing police protection, and over 15,300 general purpose law
enforcement agencies in the U.S.
Federal officers include over 37,000 customs and border patrol
officers. We believe our product line can be an effective tool to
safely assist in detention of individuals subject to the agency’s
jurisdiction. The BolaWrap offers an additional tool for frontline
agents to de-escalate encounters while effecting agent
responsibilities.
Additionally, we have estimated an addressable international market
of over 12.1 million police officers in the 100 largest police
forces gathered from individual country statistics outside the U.S.
We delivered our first international order in 2018 and in 2019
entered into agreements with our first international distributors.
Through December 31, 2021, we have delivered BolaWrap products to
51 countries, with international revenues during 2021 representing
60% of total revenues. We currently anticipate that sales
attributable to international markets will continue to represent
significant sales in the fiscal year ending December 31, 2022. Our
belief is based on the fact that sales of our products within the
U.S. to larger agencies are characterized by longer sales cycles
compared to international sales, where purchase decisions are
largely centralized at the national level.
Correctional Facilities
In 2005, the United States Bureau of Justice statistics (“Census of
State and Federal Correctional Facilities, 2005,” U.S. Department
of Justice, Bureau of Justice Statistics, published October 2008)
estimated that there were 295,000 correctional officers in over
1,800 federal and state correctional facilities in the United
States, therefore representing a large potential market for our
products and services.
Private Security Firms and Guard Services
According to 2019 Bureau of Labor Statistics estimates
(“Occupational Employment Statistics,” United States Department of
Labor), there were approximately 1.1 million privately employed
security guards in the U.S. They represent a broad range of
individuals, including those employed by investigation and security
services, hospitals, schools, local government, and others. We
believe that some security personnel armed with the BolaWrap could
be effective to de-escalate some encounters without eliminating
other devices available today. Providing guards with the BolaWrap
may reduce the potential liability of private security companies
and personnel in such encounters.
In most countries private security personnel outnumbers police
officers. Research produced and reported by The Guardian suggests
there were over 20 million private security workers worldwide in
2017 and that global spending on private security was anticipated
to exceed $240 billion in 2020. Just the ten largest target
countries outside the U.S. had approximately 17 million security
workers in 2017.
Although there are use cases in private security, correctional
facilities and in military policing, we are currently targeting our
products and services for law enforcement. We do not currently plan
a consumer version of the device.
Virtual Reality Training Market
According to a 2019 report published by Allied Market Research, the
virtual training and simulation market size was valued at $204.41
billion in 2019 and is projected to grow to $601.85 billion by
2027. We believe virtual reality and simulation will expand in many
nascent industries including law enforcement. Although a relatively
small segment today, law enforcement and military are important
segments of this market and the rise in awareness regarding virtual
training and simulation drives market growth. Technology
innovations now allow virtual reality to bring real world
situations into the virtual space in a 360-degree immersion.
Wrap Products and Services
BolaWrap Remote Restraint
The BolaWrap 100 was our first remote restraint product, with the
BolaWrap 150 (collectively with the BolaWrap 100, the
"BolaWrap") released in October 2021. The BolaWrap 150 is
electronically deployed and is more robust, smaller, lighter and
simpler to deploy than the BolaWrap 100 that is being phased out.
BolaWrap is a hand-held remote restraint device that discharges an
eight-foot Kevlar tether to entangle an individual at a range of
10-25 feet. Inspired by law enforcement professionals, the device
allows law enforcement to safely and effectively control encounters
on the low end of the applied-force continuum.

The BolaWrap functions by wrapping an individual’s arms and/or
legs, impeding a subject from fleeing a scene, rapidly approaching
an officer, or inducing harm to themselves or others. This device
enables officers to safely and humanely help take subjects into
custody without injury in order to get them the help they need.
The small, light, but rugged BolaWrap is designed to provide remote
restraint while other use of force continuum options remain open.
The design of the device ensures a wide device-effectiveness zone;
it will impede a subject’s movement when deployed at the arms or
legs. A guiding laser ensures accurate placement of the Kevlar
tether, mitigating the risk of injury to subject and officer by
quickly ending an encounter. Quick ejection and rapid replacement
of BolaWrap cassettes allows one device to be reused in a single
encounter or in multiple encounters.
There are limited effective options for remote engagement, so when
verbal commands are ignored, law enforcement is faced with either
going “hands on” or escalating to potentially injurious less-lethal
forces or a firearm. The BolaWrap has shown to be effective in
restraining individuals, hindering the flight ability and reducing
the ability to fight, allowing effective officer action. We believe
our tool is essential to meet modern policing requirements in
working with subjects who are incapable of responding to verbal
commands. With increased public attention paid to mental illness
and implicit bias, there has also been increased agency demand for
an effective non-lethal tool that does not rely on pain compliance.
We believe our device minimizes the need to employ other uses of
force, including hand-to-hand combat and other less-lethal
weapons.
The BolaWrap does not rely on pain to gain compliance or
electricity-enabled neuromuscular incapacitation for effectiveness.
The wrapping effect is intended to impede flight while not inducing
uncontrolled falls or injury. There is no issue of recovery time,
as is the case with CEW, impact munitions or chemical devices.
Other less-lethal weapons relying on “pain compliance” have been
shown to have an adverse effect, sometimes causing an incident to
escalate into one causing injury to both subjects and officers.
We spend significant resources training law enforcement on the safe
and effective use of the BolaWrap in conjunction with de-escalation
and apprehension techniques. However, like any restraining action,
injuries may result from the use of BolaWrap or as a consequence of
its use. Our training includes primary use cases that fall into the
three broad categories routinely encountered by law enforcement and
security personnel:
|
●
|
To remotely restrain and limit the mobility of an individual who is
experiencing a mental health crisis, narcotics-induced psychosis,
or other crisis condition rendering them incapable of responding to
law enforcement’s verbal commands but that presents a danger to law
enforcement, the public or themselves if not restrained;
|
|
●
|
To remotely restrain and limit the mobility of an individual
attempting to evade arrest or questioning, as well as individuals
ignoring verbal commands from law enforcement. These individuals
are commonly referred to as passively resistant or non-compliant;
and
|
|
●
|
To assist in subduing individuals actively resisting arrest by
limiting mobility, possibly making other engagement options less
risky to officers and less injurious to individuals.
|
Law enforcement encounters with the mentally ill or those suffering
a mental health crisis present a difficult challenge, often
generating public controversy and costly consequences. According to
the Treatment Advocacy Center: Office of Research & Public
Affairs in a 2015 report on The Role of Mental Illness in Fatal Law
Enforcement Encounters, one in ten police encounters involve the
mentally ill and a minimum of one in four fatal police encounters
involve the mentally ill.
Reports from dozens of field deployments by law enforcement
agencies during 2020 and 2021, on stationary as well as moving
targets, have been encouraging and we expect additional use data in
2022. A field deployment is generally considered ‘successful’ by
law enforcement agencies if compliance is achieved, and no
additional force is required after the BolaWrap is exposed or used.
Agencies have reported achieving compliance by utilizing the
BolaWrap in the following ways:
|
●
|
By pointing the BolaWrap’s line dot laser at the suspect in
conjunction with verbal commands
|
|
●
|
Via the sound emitted by the BolaWrap upon deployment
|
|
●
|
Through the impact and/or restraint of the Kevlar cord around the
suspect
|
|
●
|
When used in conjunction with other less-lethal tools
|
We request that all agencies fill out a Use of Device Report when
the BolaWrap is used during an encounter in the field. However, not
all field deployments are reported to us by law enforcement
agencies, as many consider the deployment of the BolaWrap to be low
level that does not constitute a reportable use of force. Some
deployments to date have been captured on bodycam and shared with
the public. Others were reported by the agency or the media but
were not captured on bodycam. As more agencies adopt the BolaWrap
onto their duty belts, we believe we will continue to see an
increase in the rate of field deployments, which we anticipate will
contribute to further adoption of the device by law enforcement
worldwide.
BolaWrap 150
We announced a new generation BolaWrap 150 device in October 2021
and discontinued production of the legacy product, the BolaWrap
100. The BolaWrap 100 used removable cartridges, and we plan to
continue to provide cartridges to customers as long as they are
available; however, we have no plans to produce new cartridges. The
BolaWrap 150 employs cassettes that are custom to the device and
not interchangeable between models.
Since the October announcement of the BolaWrap 150, we have been
developing a more automated supply chain in the production, quality
control, and testing lines necessary to support the volume of
production anticipated for the BolaWrap 150. We continue to make
product improvements based on internal testing and field
experience.
We believe the improved, fully electronic BolaWrap 150 offers
important benefits, including:
|
●
|
Modern electronic deployment
|
|
●
|
Smaller size and less weight
|
|
●
|
Reduced production costs
|
|
●
|
LED status indicator for ease of operation
|
|
●
|
Long laser battery life
|
|
●
|
LED target illumination to improve accuracy
|
|
●
|
Hardened plastic for increased durability
|
|
●
|
Enhanced water resistance for harsh environments
|
The BolaWrap 150 employs two micro-gas generators to individually
expel each entangling projectile. Micro-gas generators are micro
explosive parts used in a variety of industrial products, including
automobile airbags.
We are unable to predict the market acceptance of the BolaWrap 150
product or the level of future sales. We believe we can grow orders
and shipments during 2022. We plan to extend the product line with
additional models and features in the future. However, there can be
no assurance of the timing or quantity of orders or sales in future
periods. See “Risk Factors” included below in this Annual Report
for additional information regarding risks and uncertainties
associated with our business.
Wrap Reality
During 2019, we partnered with an independent technology company to
scope and configure a virtual reality system with training
scenarios. We demonstrated the virtual reality system and training
scenarios during two large trade shows in October and November
2019. In December 2020 we acquired NSENA Inc. (“NSENA”), a
developer and provider of a law enforcement training system
employing immersive computer graphics virtual reality with
proprietary software-enabled content. The NSENA system leveraged
high-quality enterprise head-mounted devices ("HMDs") and a
high-GPU gaming personal computer to power proprietary software. We
have rebranded the system, software and business as Wrap Reality
Virtual Training, and believe our content library containing over
35 training scenarios is one of the largest available targeting law
enforcement. Wrap Reality’s scenarios were developed by and for
police officers, and cover a wide array of skills and scenarios
including de-escalation, conflict resolution, and all levels of
use-of-force.
Wrap Reality Virtual Training takes advantage of the most advanced
virtual reality hardware available. The Wrap Reality system allows
up to two participants to enter the simulated training environment
simultaneously, and customized weapons controllers enable trainees
to engage in strategic decision making along the force
continuum.
In August 2021, we announced the development of a new expanded Wrap
Reality Virtual Training platform powered by, and developed
through, a collaboration with Amazon Web Services ("AWS")
using AWS GovCloud (US). The new platform combines our advanced law
enforcement simulator with secure cloud services to automatically
track training progress and provide the ability to replay recorded
training sessions. By embedding AWS storage services, we offer a
fully-integrated training and training record management solution
targeting agencies of all sizes. We believe these agencies have
limited choices to meet the growing public safety training demands.
This next generation platform is in beta testing and we expect to
formally release the new platform by mid-2022.
While we are marketing and selling the Wrap Reality Virtual
Training system, we continue to upgrade existing scenarios and
develop de-escalation techniques into new scenarios. We also seek
to enhance the Wrap Reality experience through continued software
and platform innovation. The expanded platform developed with AWS
is expected to enhance the scope of our offering to law enforcement
customers.
Selling, Marketing and Training
Our sales, marketing and training organizations work together
closely to drive revenue growth by enhancing market awareness of
our solutions, generating leads, building a strong sales pipeline
and cultivating customer and distributor relationships.
Sales
Law enforcement agencies represent our primary target market. In
this market, we expect that the decision to purchase BolaWrap
product and accessories will normally be made by a group of people
including the agency head, his/her training staff, and use of force
and weapons experts. The decision sometimes involves political
decision-makers, such as city council members and various
committees. Although we expect the decision-making process for a
remote restraint device will be less complicated than for other
less-lethal products such as CEWs, the process may take as little
as a few weeks or as long as a year or more partially due to
budgeting reasons and other distractions of agencies. For instance,
during the summer of 2020, the U.S. had a significant number of
protests in many major cities, which took agency time away from
proactive planning actions.
We utilize demonstrations as a primary sales step with
demonstrations scheduled from the over 12,000 law enforcement leads
created by our marketing activities since 2018. Demonstrations are
generally followed by sales activities or delivery of product for
test and evaluation and training with appropriate selected
agencies. Some of these deliveries are paid sales and some are
issued as an incentive, with the goal and expectation of larger
future sales of devices and cartridges/cassettes. We have
demonstrated our products to more than 1,000 agencies and are
achieving significant brand awareness among law enforcement. We and
our distributors seek, when possible, to convert demonstration and
training deliveries to sales or after a trial period to have the
devices returned for use as further demonstration or training
devices. We consider training as an integral element of our sales
and marketing approach and believe that departments that have
trained instructors to be knowledgeable about our product will be
more likely to purchase devices. We provide our product training as
a service to agencies; however, training may be fee-based in the
future.
Initial sales in 2018 and early 2019 were made by our executive and
sales employees. In June 2019, we implemented a channel
distribution strategy in which we sell our products to existing
independent regional police equipment distributors who then sell to
local law enforcement agencies. We are focusing our internal sales,
sales support and business development resources on building
relationships with large agencies and actively supporting
distributors. Our sales force is currently comprised of 19
professionals. This team includes sales and business development
personnel primarily in the field working directly with agencies,
distributors and their customers and persons providing sales
support including supporting demonstration and training
contractors. In addition to full-time sales, sales support and
business development personnel from time to time we utilize
part-time consultants with law enforcement or government agency
expertise to support our sales and marketing activities. Our 12
domestic distributors have an estimated 120 sales representatives
that represent BolaWrap primarily to smaller agencies.
We currently have distribution agreements with 12 domestic
distributors representing 49 states and one dealer representing
Puerto Rico. These nonexclusive and cancelable agreements provide
certain territorial rights to distributors but allow us to sell
direct to certain agencies under certain terms.
We have distribution agreements with 47 international distributors
covering 54 countries. These agreements are generally exclusive,
require minimum performance and allow us to sell direct to
customers subject to certain compensation. We focus significant
sales and business development efforts to support our international
distributors.
While management is focused on sales of Wrap Reality virtual
reality systems, we are training our sales, distribution,
demonstration, training and other staff and our distributors on our
virtual reality training product to build awareness and grow sales.
We are also seeking to partner with other organizations to enhance
our virtual reality sales, marketing and technology. In 2021 we
collaborated with the National Tactical Officers Association
("NTOA") to assist in creating virtual reality training
scenarios responsive to the needs of their 40,000 members from
specialties that include patrol, Tactical Emergency Medical
Support ("TEMS"), crisis negotiations, canine,
corrections, sniper, protective operations, explosives, command,
tactical dispatchers, behavioral sciences and others. We work with
other experts in law enforcement as part of our goal of making our
virtual reality scenarios compliant with industry standards of
engagement.
Marketing
Prospective customers learn about Wrap solutions through a variety
of ways, including targeted social media, paid advertising, media,
press releases, web site searches, sales calls and public
relations. We have distributed agency body and dash camera videos
demonstrating effective use of BolaWrap in a variety of policing
encounters.
When a lead is generated through our marketing activities and
qualified, we connect them with a sales representative and/or a
distributor to discuss their needs and the solutions in which they
are interested. We track our marketing and sales activities to
provide immediate preview into activities, leads, quotes and
pipeline opportunities. We believe we are developing a strong
pipeline of opportunities for Wrap solutions.
Our marketing staff also engages with local, state and federal
agencies and personnel both directly and through professional firms
that advocate less-lethal engagements and increased education and
training.
We work with risk management organizations serving law enforcement
to educate on the benefits of BolaWrap remote restraint to reduce
incidents and costs of escalation. In December 2021 the Arizona
Municipal Risk Retention Pool (AMRRP) Board of Trustees voted
funding to assist its 60 rural police agencies to procure BolaWrap
devices for active-duty police officers. We are working with other
similar entities to increase awareness of the BolaWrap
solution.
We actively promote our brands and believe the Wrap and BolaWrap
tradenames are becoming increasingly known world-wide as the
pioneer and leader in remote restraint. We participate in a variety
of domestic and international trade shows and conferences, both
directly and with our distributors. We expect our marketing efforts
will also continue to benefit from significant free media
coverage.
We intend to increase the use of our trademarks throughout our
product distribution chain and believe growing brand awareness will
assist in expanding our business. We believe our reputation as a
pioneer in the new category of remote restraint, strong training
and product support provide us competitive advantages.
Demonstration, Training and Support
The Company maintains a demonstration and training department as a
part of its sales and marketing activities and does not charge for
product demonstrations or training. Training is not a condition or
requirement of sale as many sales are made through distributors to
their end customers. The Company conducts local and regional
in-person, webinar and on-line demonstrations and use of force and
de-escalation training to support law enforcement agencies with no
purchase requirement. Such training may occur before or after
initial or subsequent purchase or field deployment of the Company’s
products. The Company believes that law enforcement trainers and
officers that have seen demonstrations or have been trained about
its products are more supportive of their departments purchase and
deployment of product.
Most law enforcement and corrections agencies will not purchase new
use of force devices until a training program is in place to
certify officers in their proper use. Generally, they also must
adapt any new tools to their use of force policies and clear use
with any relevant committees or review boards. We have developed
and offer robust training and class materials that certify law
enforcement officers and trainers as BolaWrap Instructors in the
use and limitations of the BolaWrap solution.
Recognizing the need to provide robust training and sales support
we launched the Wrap “Train the Trainer” program in October 2018.
The program is designed such that our Master BolaWrap Instructors
train local BolaWrap Instructors at local agencies who then train
line officers in accordance with an agency’s policies.
BolaWrap Master Instructors are considered independent contractors
and are required to have law enforcement training experience and be
effective communicators. In order to be certified as a Master
Instructor, candidates must complete a two-day Master Instructor
school at our Tempe training facility, observe a Train the Trainer
course and then be observed teaching a Train the Trainer Course. We
have engaged 81 Master Instructors, residing in 30 states that have
completed the two-day course allowing them to conduct Instructor
Certification Training. In addition, we have nine Master
Instructors who have been designated Senior Master Instructors
qualified to assist with teaching and certifying other
Master Instructors. Of these Senior Master Instructors, six
also comprise our Training Advisory Board.
BolaWrap Instructors are generally sworn law enforcement officers,
typically department trainers, defensive tactic instructors or SWAT
officers. To be certified as a BolaWrap Instructor, individuals
must attend a five-hour BolaWrap Instructor certification course,
pass a written exam and show proficiency in deploying and using the
BolaWrap. We also assist Instructors on lessons learned and best
practices for teaching line officers in the use of BolaWrap. The
nature and extent of line officer training is at each agency’s
discretion. Instructor certification is effective for two years
after which it requires renewal.
We employ a cloud-based software system, the Wrap Learning
Management System, to schedule and organize training events,
registration and training records. This software also hosts a
Resource Library that distributors, purchasers and other interested
parties are highly encouraged to utilize to educate themselves on
BolaWrap use.
We have assembled a team of five experienced and well-known
trainers from different regions across the U.S. that form the Wrap
Training Academy Advisory Board. The Wrap Training Academy Advisory
Board provides guidance to maintain a high-quality training program
for Wrap products.
Since launching our ‘Train the Trainer’ program in October 2018, we
now have at least one individual at over 1,000 U.S. police
departments that has received formal training and over 3,000
officers are currently certified BolaWrap instructors
qualified and certified to train line officers. We encourage
training prior to use of the BolaWrap by individual departments but
the nature and extent of training, if any, is at the discretion of
each individual agency.
We also have two experienced trainers that install, demonstrate and
provide training on our Wrap Reality platform and modules.
We believe our professional training and sales support team and
systems provide both a competitive advantage and a barrier to new
competition. The nature of modern policing requires that equipment
and services be supported and that line officers have access to
training and procedures to properly perform their duties and
minimize the policing risks. We believe we have positioned our
training and support teams to respond to agencies of all sizes.
Our Strategy
Our product and training solutions continue to gain worldwide
awareness and recognition through media exposure, product
demonstrations, and word of mouth as a result of positive responses
and increased acceptance of our solutions. We believe we have a
strong global brand, technology and product foundation, which we
continue to expand to serve new markets and customers for greater
business growth. We believe we have strong market opportunities for
our product solutions throughout the world in the law enforcement,
defense, public safety and security sectors as a result of
increasing threats by non-compliant individuals and the demand for
less-lethal policing. We believe our training and virtual reality
platform are positioned in rapid growth markets worldwide.
Our commercialization strategy focuses on the immediate addressable
domestic market of approximately 900,000 full-time sworn officers
in over 15,300 federal, state and local law enforcement agencies,
and the 12.1 million plus police officers in the 100 largest police
forces internationally. Our goal is to realize the potential of our
entire suite of technology solutions targeting law enforcement and
security personnel worldwide.
In 2022 we intend to continue operating with financial discipline
in order to create value for our stockholders. We intend to
continue the pursuit of domestic and international business
opportunities with our network of well-established distributors and
grow our revenues. We plan to develop improved and new products to
our portfolio including products for use by security and related
personnel. We also seek business initiatives and opportunities
including acquisitions and collaborations that may be complementary
to existing product and service offerings through our sales
network.
Manufacturing and Suppliers
Manufacturing
We believe maintaining scalable assembly capabilities is essential
to the performance of our products and the growth of our business.
Our assembly processes involve unique systems and materials. We
contract with third-party suppliers to produce various parts,
components and subassemblies. We established initial startup
production in a Las Vegas facility in 2018. In October 2019, we
completed a move and started production at our new facility in
Tempe, Arizona. This facility now includes our corporate
administration, sales, training, engineering, manufacturing and
warehousing. In our Tempe facility, we complete the final assembly,
test and ship our products. We have refined our internal processes
to improve how we design, test, and qualify products. We continue
to implement rigorous manufacturing and quality processes to track
production and field issues. We implement design and component
changes periodically to reduce our product costs and improve
product reliability and manufacturability.
Suppliers
We minimize inventories and maximize the efficiency of our supply
chain by having a number of components and sub-assemblies produced
by outside suppliers. In particular, a single supplier is currently
the sole manufacturer of the BolaWrap 150 battery assembly and
another single supplier is the sole manufacturer of the propulsion
component for BolaWrap 150 cassettes. Other parts are sole sourced
from other suppliers. We believe we have developed strong
relationships with our key suppliers. Our ability to meet customer
demand depends, in part, on our ability to obtain timely and
adequate delivery of components for our products. Our global supply
chain has been subject to component shortages, increased lead
times, cost fluctuations, and logistics constraints. We expect
these supply chain challenges to continue throughout 2022. Supplier
shortages, quality issues and logistic delays affect our production
schedules and could in turn have a material adverse effect on our
financial condition, results of operation and cash flows.
Backlog
At December 31, 2021, we had backlog of approximately $268 thousand
expected to be delivered in the first quarter of 2022. The amount
of backlog at any point in time is dependent upon order timing,
scheduled delivery dates to our customers and product lead times.
Most orders are shipped shortly after order and backlog is
typically associated with larger international orders. Because of
our history of shipping shortly after order, at this time we do not
believe backlog at any period end is predictive of future order
volume or revenues beyond the reported amount. Distributor and
customer orders for future deliveries are generally subject to
modification, rescheduling or in some instances, cancellation in
the normal course of business.
Warranties
We warrant our products to be free from defects in materials and
workmanship for a period up to one year from the date of purchase.
The warranty will be generally a limited warranty, and in some
instances impose certain shipping costs on the customer. Some
jurisdictions require two-year or other warranty periods and we
seek to comply with local or distributor requirements regarding
warranties. We expect in most cases it will be more economical and
effective to replace the defective device rather than repair.
Competition
We target the BolaWrap product as a new solution for law
enforcement and not as a replacement for other devices currently in
use. However, we do compete with other use of force products for
budget dollar allocations. Law enforcement agencies may also
determine that we are an alternative to other solutions despite
such positioning.
Other use of force devices, including conducted electrical weapons
(“CEWs”), pepper spray, batons, and impact weapons may
compete with the BolaWrap product indirectly. Many law enforcement
and corrections personnel consider such less-lethal weapons to be
distinct tools, each best-suited to a particular set of
circumstances. Consistent with this tool kit approach, purchasing
any given tool does not preclude the purchase of one or several
more. In other cases, budgetary considerations and limited space on
officers’ belts dictate that only a limited number of devices will
be purchased and carried. We believe the BolaWrap’s unique remote
restraint use, effectiveness, and low possibility of injury will
enable it to compete effectively against other alternatives.
There are a number of competitors offering virtual reality
simulators for law enforcement to compete with Wrap Reality. We
also compete against established video-based simulators. There are
other virtual reality providers and developers focused on other
applications that may in the future elect to develop and compete in
the law enforcement training space.
Many of our present and potential future competitors have, or may
have, substantially greater resources to devote to compete in the
law enforcement market and to further technological and new product
developments. Also, these competitors or others may introduce
products with features and performance competitive to our
product.
Government Regulation
Globally, we are subject to numerous domestic, federal, state and
local laws and regulations and the laws and regulations of global
jurisdictions relating to matters regarding shipments, customs,
import, export, safe working conditions, manufacturing practices,
environmental protection and disposal of hazardous or potentially
hazardous substances. In addition, we have to ensure compliance
with economic sanctions and/or restrictions on individuals,
corporations or countries, and other government regulations
affecting trade that may apply to our international cross border
business activities. We may incur significant costs to comply with
such laws and regulations now or in the future.
The BolaWrap 100 and the BolaWrap 150 are each classified as a
“firearm” by the U.S. Bureau of Alcohol, Tobacco, Firearms and
Explosives (“ATF”), and are subject to federal
firearms-related regulations. We hold two Federal Firearms
Manufacturing Licenses that expire in 2022 through 2023. The
BolaWrap 150, and the related BolaWrap 150 cassette, are also
regulated as exempt special explosive devices by the ATF which
requires adherence to explosive manufacturing and handling
regulations. We hold one explosives manufacturing license and one
explosives import license, both expiring in 2024.
ATF regulations are enforced by surveillance and inspection. If the
ATF finds a violation, it can institute a wide range of enforcement
actions, ranging from public warnings to more severe sanctions such
as fines, penalties, suspension or withdrawal of regulatory
approvals, product recalls, seizure of products, operating
restrictions or total shutdown of production, and criminal
prosecution.
Many states also have regulations restricting the sale and use of
certain firearms and explosives and may determine their own
classification and restrictions irrespective of ATF regulation. In
most cases, the law enforcement and corrections market are subject
to different ATF and state regulations or exemptions than the
private citizen market, and we do not expect additional state
restrictions or approvals for sales to law enforcement. Where
different regulations exist, we expect that the regulations
affecting the private citizen market may also apply to the private
security markets, except as the applicable regulations otherwise
specifically provide.
Our BolaWrap cartridges, cassettes, and lithium-ion battery packs
are generally considered dangerous goods for shipment regulation.
The shipping of dangerous goods, whether via air or ground, falls
under the jurisdiction of many state, federal and international
agencies. The quality of the packaging that protects a product is
critical in determining whether it will arrive at its destination
in a satisfactory condition. Many of the regulations for
transporting dangerous goods in the United States are
determined by international rules formulated under the auspices of
the United Nations.
The International Civic Aviation Organization ("ICAO") is
the United Nations organization that develops regulations
(“Technical Instructions”) for the safe transport
of dangerous goods by air. If shipment is by air, compliance
with the rules established by the International Air Transport
Association ("IATA") is required. The IATA is a trade
association made up of airlines and air cargo couriers that
publishes annual editions of the IATA Dangerous Goods
Regulations. These regulations interpret and add to the ICAO
Technical Instructions to reflect industry practices. When we
ship dangerous goods, we follow strict and stringent
guidelines.
We are subject to a variety of government laws and regulations that
apply to companies engaged in international operations, including,
among others, the Foreign Corrupt Practices Act, U.S. Department of
Commerce export controls, local government regulations and
procurement policies and practices (including regulations relating
to import-export control, investments, exchange controls and
repatriation of earnings). The BolaWrap 100 and the BolaWrap 150
devices are also considered a crime control product by the U.S.
government. Accordingly, the export of our devices is regulated
under export administration regulations. As a result, we must
obtain export licenses from the Department of Commerce for all
shipments outside the U.S. We do not expect the need to obtain
these licenses will cause a material delay in our foreign
shipments. Export regulations also prohibit the further shipment of
our products from foreign markets in which we hold a valid export
license to markets in which we do not hold an export license for
our products. We are seeking export classification of our virtual
reality training product but do not currently believe export
licenses will be required. International destination regulations,
which may affect our products and services, and sale thereof, are
numerous and often unclear. We work with our international
distributors, agents and advisors who are familiar with the
applicable import regulations in each of our targeted international
markets.
Our products are produced to comply with standard product safety
requirements for sale in the U.S. and similar requirements for sale
in international markets. We expect to meet the electrical and
other regulatory requirements for any electronic systems or
components we sell throughout the world. As part of our
manufacturing operations, we are subject to various federal, state,
local and non-U.S. laws and regulations relating to environmental
protection, including the discharge, treatment, storage, disposal
and remediation of hazardous substances and wastes. We continually
assess our compliance status and management of environmental
matters to ensure our operations are in substantial compliance with
all applicable environmental laws and regulations.
Our Wrap Reality training software services offer agencies the
option for us to store certain training records and related
information. We are committed to complying with, and helping our
customers comply with, data protection laws globally. We monitor
guidance from industry and regulatory bodies, meet with our
supplier partners and update our product features and contractual
commitments when necessary to meet new or evolving privacy legal
requirements. We maintain a privacy policy that describes how we
collect, uses and disclose information, and what choices
organizations and users have.
Intellectual Property Rights and Proprietary Information
We intend to vigorously protect our intellectual property assets
including issued patents, pending patents, trademarks, copyrights,
trade craft, contractual obligations and trade secrets such as
know-how. Our policy is to enter into confidentiality and
nondisclosure agreements with key employees and consultants or
third party to whom any of our proprietary information is
disclosed. These agreements prohibit the disclosure of confidential
information to others, both during and subsequent to employment or
the duration of the working relationship. These agreements may not
prevent disclosure of confidential information or provide adequate
remedies for any breach. We rely on copyrights, trade secrets and
other proprietary rights to protect the content of our training
services including the Wrap Reality VR training software and
content.
In addition to such factors such as innovation, technological
expertise, and experienced personnel, we believe strong product
offerings that are continually upgraded and enhanced will keep us
competitive, and we seek patent and other intellectual property
protection on important technological improvements that we make.
Prior to the filing and granting of patents, our policy is to
disclose key features to patent counsel and maintain these features
as trade secrets prior to product introduction. Patent applications
may not result in issued patents covering all important claims and
could be denied in their entirety.
We currently have thirteen issued U.S. patents related to the
BolaWrap technology and fifteen additional U.S. patents pending. In
September 2018, we commenced filing our first foreign patent
applications targeting the European Union (38 countries) and 17
other countries, of which six have issued to date. During 2021 we
filed additional foreign patent applications and we have reserved
rights to file additional foreign patents. The failure to obtain
patent protection or the loss of patent protection on our existing
and future technologies or the circumvention of our patents by
competitors could have a material adverse effect on our ability to
compete successfully.
We have been granted trade name protection for “BolaWrap” and
“Wrap” in multiple countries and expect to employ a combination of
registered and common law trade names, trademarks and service marks
in our business. We rely on a variety of intellectual property
protections for our products and technologies, including
contractual obligations, and we intend to pursue a policy of
vigorously enforcing such rights.
The law enforcement product and services industry is characterized
by frequent litigation regarding patent and other intellectual
property rights. Others, including academic institutions and
competitors, hold numerous patents in less-lethal and related
technologies. Although we are not aware of any existing patents
that would materially inhibit our ability to commercialize our
technology, others may assert claims in the future. Such claims,
with or without merit, may have a material adverse effect on our
financial condition, results of operations or cash flows.
Research and Development
Our research and development initiatives are led by our internal
personnel and make use of specialized consultants when necessary.
These initiatives include basic research, mechanical engineering
design and testing. Future development projects will focus on new
versions of the BolaWrap technology and new public safety
technologies.
For the fiscal years ended December 31, 2021 and 2020, we spent
approximately $6.2 million and $2.8 million, respectively, on
company-sponsored research and development. Future levels of
research and development expenditures will vary depending on the
timing of further new product development and the availability of
funds to carry on additional research and development on currently
owned technologies or in other areas. During 2022 in addition to
continued development and enhancement of our remote restraint
products we expect to incur additional costs improving our training
systems including enhancing our Wrap Reality simulator and related
content.
Related Party License and Royalties
We are obligated to pay royalties pursuant to an exclusive Amended
and Restated Intellectual Property License Agreement, dated as of
September 30, 2016, with Syzygy Licensing, LLC (“Syzygy”), a
private technology invention, consulting and licensing company
owned and controlled by Elwood G. Norris, a former officer and
current stockholder of the Company, and James A. Barnes, an officer
and stockholder of the Company. Syzygy has no ongoing operations,
and does not engage in any manufacturing, production or other
related activities.
The agreement provides for the payment of royalties of 4% of
revenue from products employing the licensed device technology up
to the earlier to occur of (i) the payment by the Company of an
aggregate of $1.0 million in royalties, or (ii) September 30, 2026.
All development and patent costs have been paid by us and patent
applications and the technology related to the BolaWrap 100 and the
BolaWrap 150 have been assigned to the Company, subject to the
royalty obligation.
As a part of our acquisition of NSENA in December 2020, we agreed
to pay additional earn-out consideration equal to 10% of net
revenues (or a lesser amount equal to 50% of direct profit) from
specific identified prospects that become revenue customers before
September 30, 2021, but only on amounts collected between
consummation of the acquisition and June 30, 2022. No royalties
were earned or are payable under the agreement.
Seasonality
We do not expect to experience any significant seasonality trends.
However, seasonality trends may occur in the future.
Financial Information about Customer Concentration and
Geographic Areas
Financial information regarding customer concentration and
geographic areas in which we operate is contained in Note 16, Major
Customers and Related Information to our consolidated financial
statements.
Human Capital
Executive Officers
The current executive officers of Wrap Technologies, Inc. and their
ages and business experience are set forth below.
LW Varner, Jr., age 71, joined the Company as Interim
Chief Executive Officer in January 2022. Mr. Varner will
serve as Interim Chief Executive Officer under the terms of a
Consulting Agreement dated January 24, 2022, by and between the
Company and LWV Consulting, LLC. Mr. Varner has significant
experience as a corporate executive and director in transition and
turnaround situations. From June 2020 through November 2021, Mr.
Varner was the Chief Executive Officer and a director of Select
Interior Concepts, a publicly traded company focused on the
building product space. Prior to that, from July 2012 to May 2018,
he was Chief Executive Officer of United Subcontractors, led a
transformation of the business through organic growth and strategic
transactions that resulted in USI achieving double digit EBITDA
margins and an eventual sale, creating significant value for
shareholders. From 2004 to 2012, Mr. Varner served as the President
and Chief Executive Officer of Aquilex Corporation, a leading
provider of specialty services to the energy sector. Under his
leadership, the company grew revenues by fivefold and achieved
record earnings. Prior to joining in 2004, Mr. Varner served as
President for several global businesses in various industries
orchestrating their growth in new markets through expansion of
service and product offerings. He is a graduate of The Citadel in
Charleston, South Carolina, and has served on various
philanthropic, industry and community boards. He has also served as
a director of Bartlett Holdings, Aquilex Inc., USI and The Identity
Group, and currently serves on the Board of Directors of Acousti
Engineering, a portfolio company of Ardian, a global private equity
firm.
Glenn Hickman, age 34, was appointed as the Company’s
Chief Operating Officer (“COO”) on July 1, 2021. Prior to
his appointment, since March 2021, Mr. Hickman served as a
consultant to the Company. From 2014 to 2019, Mr. Hickman served as
Vice President of Research and Development for Axon Enterprises
(formerly TASER International). At Axon, Hickman led the launch of
six hardware products, all connected to an ecosystem of cloud
software and mobile apps. He created engineering and supply chain
processes and grew the engineering team from 35 to 70. Hickman was
responsible for establishing Axon’s first manufacturing line in
Shenzhen, China, and an optics engineering team in Finland. Mr.
Hickman graduated with distinction from Stanford University,
receiving his Bachelor and Master of Science in Mechanical
Engineering, and his MBA with honors from Northwestern University’s
Kellogg School of Management with a double major in Strategy and
Marketing.
James A. Barnes age 67, cofounded the Company with
Messrs. Elwood Norris and Scot Cohen in March 2016, and currently
serves as Chief Financial Officer, Secretary and Treasurer. He
served as Manager until the Company’s incorporation in March 2017
when he was appointed President and Chief Financial Officer. He
served as a member of the Company’s Board of Directors from March
2017 to November 2018. In January 2018 he was appointed to the
additional positions of Secretary and Treasurer and resigned as
President. He has served as the President of Sunrise Capital, Inc.,
a private venture capital and financial and regulatory consulting
firm, since 1984. He was Chief Financial Officer of Parametric
Sound Corporation (now Turtle Beach Corporation) from 2010 to
February 2015, and from February 2015 to February 2017 served as
Vice President Administration at Turtle Beach Corporation. Since
1999, he has been Manager of Syzygy Licensing LLC, a private
technology invention and licensing company he owns with Mr. Elwood
Norris. He previously practiced as a certified public accountant
and management consultant with Ernst & Ernst, Touche Ross &
Co., and as a principal in J. McDonald & Co. Ltd., Phoenix,
Arizona. He graduated from the University of Nebraska with a
Bachelor of Arts Degree in Business Administration in 1976 and is a
certified public accountant (status: inactive).
Pending his planned retirement, Mr. Barnes will continue to serve
as Chief Financial Officer, Treasurer and Secretary of the Company
until the earlier of his retirement or the naming of his
replacement by the Company. In this regard, the Board of Directors
has commenced a formal search to identify a highly qualified
candidate to serve in the capacity of Chief Financial Officer.
Executive officers serve at the discretion of the board of
directors.
Employees
We employ 68 full-time employees with 47 in the United States and
three located in the United Kingdom. In addition to our three
executive officers, we had 19 persons engaged in sales, marketing,
sales support and training, 21 in production, 15 in research and
development and 10 in administration. In addition, we engage
consultants from time to time to provide additional sales,
marketing, training and research and development services, and
anticipate engaging consultants going forward to supplement our
full- and part-time personnel.
We are dedicated to preserving operational excellence and remaining
an employer of choice. We provide and maintain a work environment
that is designed to attract, develop and retain top talent through
offering our employees an engaging work experience that contributes
to their career development. We recognize that our success is based
on the collective talents and dedication of those we employ, and we
are highly invested in their success.
Available Information
As a public company, we are required to file our annual reports on
Form 10-K, quarterly reports on Form 10-Q, current reports on Form
8-K, proxy statements on Schedule 14A and other information
(including any amendments) with the Securities and Exchange
Commission (the “SEC”). The SEC maintains an Internet site
that contains reports, proxy and information statements, and other
information regarding issuers that file electronically with the
SEC. You can find our SEC filings at the SEC’s website at
www.sec.gov.
Our Internet address is www.wrap.com. Information
contained on our website is not part of this Annual Report. Our SEC
filings (including any amendments) are also made available free of
charge on www.wrap.com, as soon as
reasonably practicable after we electronically file such material
with, or furnish it to, the SEC.
ITEM 1A. RISK
FACTORS
An investment in our Company involves a high degree of risk. In
addition to the other information included in this Annual Report,
you should carefully consider the following risk factors in
evaluating an investment in our Company. You should consider these
matters in conjunction with the other information included or
incorporated by reference in this Annual Report. If any of the
following risks actually occurs, our business, reputation,
financial condition, results of operations, revenue, and future
prospects could be negatively impacted. In that event, the market
price of our Common Stock could decline, and you could lose part or
all of your investment.
Risk Factors Relating to
Our Business and Industry
We have a history of operating losses, expect additional
losses and may not achieve or sustain profitability.
We have a history of operating losses and expect to incur
additional losses until we achieve sufficient revenue and resulting
margins to offset our operating costs. Our net loss for the
years ended December 31, 2021 and 2020 was $24.4 million and $12.6
million, respectively. Our ability to achieve future profitability
is dependent on a variety of factors, many of which are outside of
our control. Failure to achieve profitability or sustain
profitability, if achieved, may require us to raise additional
financing, which could have a material negative impact on the
market value of our Common Stock.
The continued spread of COVID-19 and uncertain market
conditions may adversely affect our business, financial condition
and results of operations.
We are monitoring the impact of the COVID-19 pandemic, which has
caused significant uncertainty and disruption to global financial
markets and supply chains, beginning in early calendar year 2020.
The Company's business, operating results, and financial condition
could continue to be adversely affected due to the COVID-19
pandemic. The significance of the operational and financial impact
of the COVID-19 pandemic will depend on how long and widespread the
uncertainty and disruption continue. The extent to which the
COVID-19 pandemic continues to impact our financial conditions and
results of operations, or those of our third-party suppliers, will
depend on future developments, which are highly uncertain and
cannot be predicted with confidence at this time, including the
duration of the outbreak, new information which may emerge
concerning the severity of COVID-19 and the actions being taken to
contain COVID-19 or treat its impact, among others. Uncertainty
surrounds the duration and broader impact of the COVID-19 pandemic
and therefore, the effects it will have on our financial results
and operations. If economic or market conditions in key global
markets deteriorate, we may experience material adverse effects on
our business, financial condition and results from operations.
Factors deriving from the domestic and international response to
the COVID-19 pandemic that may negatively impact sales and gross
margin in the future include but are not limited to: limitations on
the ability of our suppliers to meet delivery requirements and
commitments; limitations on the ability of employees to perform
their work due to illness caused by the pandemic or local, state or
federal orders requiring employees to remain at home; limitations
on the ability of carriers to deliver products to customers;
limitations on the ability of our customers to conduct their
business and purchase our products and services; and limitations on
the ability of our customers to pay us on a timely basis.
Substantially all of our employees are located in the U.S. In
addition to our employees, we rely on (i) distributors, agents and
third-party logistics providers in connection with product sales
and distribution and (ii) raw material and component suppliers in
the U.S., Canada, Europe and Asia. If we, or any of these
third-party partners encounter any disruptions to our or their
respective operations or facilities, or if we or any of these
third-party partners were to shut down for any reason, including by
pandemic, fire, natural disaster, such as a hurricane, tornado or
severe storm, power outage, systems failure, labor dispute, or
other unforeseen disruption, then we or they may be prevented or
delayed from effectively operating our or their business,
respectively. Any losses or damages we incur could have a material
adverse effect on our financial results and our ability to conduct
business as expected.
We may need additional capital to execute our business plan,
and raising additional capital, if possible, by issuing additional
equity securities may cause dilution to existing stockholders. In
addition, raising additional capital by issuing additional debt
instruments may restrict our operations.
Although we believe we have adequate financial resources to fund
our operations and capital needs for at least the next twelve
months, and that we may be able to generate funds from product
sales during that time, existing working capital may not be
sufficient to achieve profitable operations due to product
introduction costs, operating losses and other factors. Principal
factors affecting the availability of internally generated funds
include:
|
●
|
failure of product sales and services to meet planned
projections;
|
|
●
|
government spending levels impacting sales of our products;
|
|
●
|
working capital requirements to support business growth;
|
|
●
|
our ability to integrate acquisitions;
|
|
●
|
our ability to control spending;
|
|
●
|
our ability to collect accounts receivable; and
|
|
●
|
acceptance of our products and services in planned markets.
|
In the event we are required to raise additional capital through
the issuance of equity or convertible debt securities, the
percentage ownership of our stockholders could be diluted
significantly, and such newly issued securities may have rights,
preferences or privileges senior to those of our existing
stockholders. In addition, the issuance of any equity securities
could be at a discount to the market price.
If we incur debt financing, the payment of principal and interest
on such indebtedness may limit funds available for our business
activities, and we could be subject to covenants that restrict our
ability to operate our business and make distributions to our
stockholders. These restrictive covenants may include
limitations on additional borrowing and specific restrictions on
the use of our assets, as well as prohibitions on our ability to
create liens, pay dividends, redeem stock or make investments.
There is no assurance that any equity or debt financing transaction
will be available on acceptable terms, if at all.
We expect to be dependent on sales of our BolaWrap product
line for the foreseeable future, and if this product is not widely
accepted, our growth prospects will be diminished.
We expect to depend on sales of the BolaWrap product line and
related cassettes for the foreseeable future. A lack of demand for
this product, or its failure to achieve broader market acceptance,
would significantly harm our growth prospects, operating results
and financial condition. To execute our business plan successfully,
we will need to execute on the following objectives, either on our
own or with strategic collaborators:
|
●
|
Grow our commercialization of the BolaWrap product, and develop
additional future products and accessories for
commercialization;
|
|
●
|
Maintain required regulatory approvals for our products in global
market locations;
|
|
●
|
Expand and, as required, enforce our intellectual property
portfolio for the BolaWrap product and other future products;
|
|
●
|
Maintain sales, distribution and marketing capabilities, and/or
enter into strategic partnering arrangements to access such
capabilities; and
|
|
●
|
Grow market acceptance for the BolaWrap product line and/or other
future products.
|
We may experience difficulties in integrating and
transitioning from the BolaWrap 100 to the BolaWrap
150.
The success of our new generation product, the BolaWrap 150,
depends on a number of factors including, but not limited to,
timely and successful product development, market acceptance, the
Company’s ability to manage the risks associated with new product
production ramp-up issues and supply chain challenges, the
effective management of purchase commitments and inventory levels
in line with anticipated product demand, the availability of
products in appropriate quantities and costs to meet anticipated
demand, and the risk that new products may have quality or other
defects or deficiencies in the early stages of introduction.
We face risks commercializing our virtual reality training
platform and may be unsuccessful in growing revenues.
We do not have extensive experience with virtual reality training,
and are relying on new hires and consultants with expertise in the
field. We continue to invest substantial funds in developing and
commercializing this product line which is highly competitive. The
commercial launch of the Wrap Reality Virtual Training product is
in the early stages. Our ability to commercialize this product line
may be influenced by many factors, including:
|
●
|
our ability to develop new products and new content;
|
|
●
|
our ability to successfully integrate our virtual reality product
with our custom AWS solution into a viable platform acceptable to
customers;
|
|
●
|
our ability to obtain, set up and service new customers;
|
|
●
|
our ability to achieve and maintain market acceptance;
|
|
●
|
the impact of competition; and
|
|
●
|
our ability to attract and retain talent.
|
We are materially dependent on the acceptance of our product
by the law enforcement market. If law enforcement agencies do not
purchase our product or we do not meet their expectations, our
revenue will be adversely affected and we may not be able to expand
into other markets, or otherwise continue as a going
concern.
A substantial number of law enforcement agencies may not purchase
our remote restraint product. In addition, if our product is not
widely accepted by the law enforcement market or we do not meet
their expectations, we may not be able to expand sales of our
product into other markets. Law enforcement agencies may be
influenced by claims or perceptions that our product is not
effective or may be used in an abusive manner. Our reputation could
be damaged if we do not meet customer expectations for performance,
value and quality. Sales of our product to agencies may be delayed
or limited by such claims or perceptions or to any negative
publicity or damage to our reputation.
We may incur significant and unpredictable warranty costs as
our products are introduced and produced.
We warrant our products to be free from defects in materials and
workmanship for a period of up to one year from the date of
purchase. We may incur substantial and unpredictable warranty costs
from post-production product or component failures. Future warranty
costs could further adversely affect our financial position,
results of operations and business prospects.
We could incur charges for excess or obsolete inventory and
incur production costs for improvements or model
changes.
While we strive to effectively manage our inventory, rapidly
changing technology, and uneven customer demand may result in short
product cycles and the value of our inventory may be adversely
affected by changes in technology that affect our ability to sell
the products in our inventory. If we do not effectively forecast
and manage our inventory, we may need to write off inventory as
excess or obsolete, which in turn can adversely affect cost of
sales and gross profit.
We have experienced, and may in the future experience, improvement
and model changes and unusual production costs associated with
implementing production for our products. We currently have no
reserve for slow moving or obsolete inventory but may incur future
charges for obsolete or excess inventory.
Our international operations could be harmed by factors
including natural disasters, fluctuations in currency exchange
rates, and changes in regulations that govern international
transactions.
We sell our products worldwide and have exported to multiple
countries. We expect exports to continue to be a significant part
of our future business. The risks inherent in international trade
may reduce our international sales or impede growth and harm our
business and the businesses of our customers and our suppliers.
These risks include, among other things:
|
●
|
Changes in tariff regulations;
|
|
●
|
Foreign currency exchange rate fluctuations;
|
|
●
|
Establishing and maintaining relationships with local distributors,
agents and dealers;
|
|
●
|
Lengthy shipping times and accounts receivable payment cycles;
|
|
●
|
Import and export control and licensing requirements;
|
|
●
|
Compliance with a variety of U.S. laws, including the Foreign
Corrupt Practices Act, by us or key subcontractors or agents;
|
|
●
|
Compliance with a variety of foreign laws and regulations,
including unexpected changes in taxation and regulatory
requirements;
|
|
●
|
Greater difficulty in safeguarding intellectual property abroad
than in the U.S.; and
|
|
●
|
Difficulty in staffing and managing geographically diverse
operations.
|
These and other risks may preclude or curtail international sales
or increase the relative price of our products compared to those
manufactured in other countries, reducing the demand for our
products. Failure to comply with U.S. and international
governmental laws and regulations applicable to international
business, such as the Foreign Corrupt Practices Act or U.S. export
control regulations, could have an adverse impact on our business
with the U.S. and international governments.
Global economic weakness and uncertainty, including
geopolitical conflict, could adversely affect our revenues, gross
margins and expenses.
Our business may be impacted by global economic conditions, which
have been in recent years, and continue to be, volatile.
Geopolitical conflict, such as the recent conflict in Ukraine, and
related international economic sanctions and their impact may
exacerbate this volatility. Specifically, our revenues and gross
margins depend significantly on global economic conditions and the
demand by foreign governments and agencies for the BolaWrap in many
of our target markets. Economic weakness and uncertainty in these
markets have resulted, and may result in the future, in decreased
revenue attributable to these markets, gross margin, earnings or
growth rates, and difficulty managing inventory levels. Sustained
uncertainty about global economic conditions and geopolitical
events may adversely affect demand for the BolaWrap and could cause
demand to differ materially from our expectations as foreign
governments and agencies curtail or delay spending. Economic
weakness and uncertainty also make it more difficult for us to make
accurate forecasts of revenues, gross margins and expenses.
We anticipate that a significant portion of our revenue in
the short-term will be generated from international sales, which
may adversely affect our ability to timely collect accounts
receivable.
During the year ended December 31, 2021, we generated approximately
60% of our revenue from international sales. Due principally to the
longer sales cycle, logistic delays and regulatory issues
associated with domestic sales versus international sales, we
currently anticipate that a significant portion of our sales in the
year ended December 31, 2022 will be generated from international
orders. In the event we are unable to timely collect account
receivables associated with international sales, or timing of such
international sales are delayed, our financial condition could be
adversely and materially affected.
If we are unable to manage our projected growth, our growth
prospects may be limited, and our future profitability may be
adversely affected.
We intend to continue to expand our sales, marketing and training
programs and our manufacturing capability. Rapid expansion may
strain our managerial, financial and other resources. If we are
unable to manage our growth, our business, operating results and
financial condition could be adversely affected. Our systems,
procedures, controls and management resources also may not be
adequate to support our future operations. We will need to
continually improve our operational, financial and other internal
systems to manage our growth effectively, and any failure to do so
may lead to inefficiencies and redundancies, and result in reduced
growth prospects and profitability.
We may face personal injury and other liability claims that
harm our reputation and adversely affect our sales and financial
condition.
Our product is intended to be used in confrontations that could
result in injury to those involved, whether or not involving our
product. Our product may cause or be associated with such injuries.
A person injured in a confrontation or otherwise in connection with
the use of our product may bring legal action against us to recover
damages on the basis of theories including personal injury,
wrongful death, negligent design, dangerous product or inadequate
warning. We may also be subject to lawsuits involving allegations
of misuse of our product. If successful, personal injury, misuse
and other claims could have a material adverse effect on our
operating results and financial condition. Although we carry
product liability insurance, significant litigation could also
result in a diversion of management’s attention and resources,
negative publicity and an award of monetary damages in excess of
our insurance coverage.
The nature of our business may result in undesirable press
coverage or other negative publicity.
Our solutions are used to assist law enforcement and first
responders in volatile encounters. Even when our device works as
intended, incidents can lead to injury, loss of life and other
negative outcomes, and such events are likely to receive negative
publicity. If our product fails to help de-escalate an encounter,
related adverse outcomes may receive negative media attention. At
times, body or dash camera images or other images of use of our
product may become a matter of public record due to legal or other
obligations (for example, as a result of public-records requests or
subpoenas to provide information or to testify in court), and we
may receive negative media attention as a result.
We may be subject to criticism and unflattering media coverage
regarding the effectiveness of our remote restraint solutions and
the cost of our solutions to our customers, or the appropriateness
of use on persons in crisis or the mentally ill. Such negative
publicity could have an adverse impact on new sales, which would
adversely impact our financial results and future prospects.
Our future success is dependent on our ability to expand
sales through distributors, and our inability to grow our sales
force or maintain distributors would negatively affect our
sales.
Our distribution strategy is to pursue sales through multiple
channels with an emphasis on independent distributors, domestically
and internationally. Our inability to recruit and retain sales
personnel and maintain and add police equipment distributors who
can successfully sell our products could adversely affect our
sales. If we do not competitively price our products, meet the
requirements of any future distributors or end-users, provide
adequate marketing support, or comply with the terms of any
distribution arrangements, such distributors may fail to
aggressively market our product or may terminate their
relationships with us. These developments would likely have a
material adverse effect on our sales. Our reliance on the sales of
our products by distributors also makes it more difficult to
predict our revenue, cash flow and operating results.
We expect to expend significant resources to generate sales
due to our lengthy sales cycle, and such efforts may not result in
sales or revenue.
Generally, law enforcement agencies consider a wide range of issues
before committing to purchase a product, including product
benefits, training costs, the cost to use our product in addition
to, or in place of, other use of force products, product
reliability and budget constraints. The length of our sales cycle
may range from 30 days to a year or more. We may incur
substantial selling costs and expend significant effort in
connection with the evaluation of our product by potential
customers before they place an order, if they place an order at
all. If these potential customers do not purchase our product, we
will have expended significant resources without corresponding
revenue.
Most of our intended end-users are subject to budgetary and
political constraints that may delay or prevent sales.
Most of our and our distributors intended end-user customers are
government agencies. These agencies often do not set their own
budgets and therefore have little control over the amount of money
they can spend. In addition, these agencies experience political
pressure that may dictate the manner in which they spend money. As
a result, even if an agency wants to acquire our product, it may be
unable to purchase our product due to budgetary or political
constraints. Some government agency orders may also be canceled or
substantially delayed due to budgetary, political or other
scheduling delays, which frequently occur in connection with the
acquisition of products by such agencies.
Our dependence on third-party suppliers for key components of
our product make us vulnerable to price increases and supply
shortages that could delay shipment of our products and reduce our
sales or margins.
We depend on certain domestic and foreign suppliers for the
delivery of components used in the assembly of our product. Our
reliance on third-party suppliers creates risks related to our
potential inability to obtain an adequate supply of components or
sub-assemblies and reduced control over pricing and timing of
delivery of components and subassemblies. Specifically, we depend
on suppliers of sub-assemblies, electronic components, injection
molded plastic parts, and other miscellaneous custom parts for our
product, some from sole source suppliers. We are subject to the
risk of shortages and long lead times in the supply of these
components and the risk that our suppliers discontinue or modify
components used in our products. In addition, the lead times
associated with certain components are lengthy and preclude rapid
changes in quantities. Delays in our suppliers’ abilities,
especially any sole suppliers, to provide us with necessary
materials and components may delay production or may require us to
seek alternative supply sources. Any delay in receiving supplies
could impair our ability to deliver products to our customers and,
accordingly, could have a material adverse effect on our business,
results of operations and financial condition.
We have recently experienced, and in the future are likely to
experience, disruption of the supply of some of our parts,
components and assemblies that we obtain from suppliers. For
example, the rapid increase in global demand as the COVID-19
pandemic wanes has caused, and is expected to continue to cause,
significant stress on global supply chains. As economies around the
world have reopened, sharp increases in demand have created
significant disruptions to the global supply chain, which have
affected our ability to source and receive certain goods on a
timely basis and at anticipated costs. Increases in input costs and
freight due to price inflation and global supply chain disruptions
may adversely affect our financial performance.
We do not have any long-term supply agreements with any suppliers.
We actively monitor and mitigate supply chain risk, but there
can be no assurance that our mitigation plans will be effective to
prevent disruptions that may arise from shortages of materials that
we use in the production of our products. Any interruption of
supply for any material components of our products could
significantly delay production and shipment of our products and
have a material adverse effect on our revenue, profitability and
financial condition.
We may not be able to successfully integrate acquisitions in
the future, and we may not be able to realize, revenue enhancements
or other synergies from such acquisitions.
On December 14, 2020, we acquired substantially all of the virtual
reality system assets and business of NSENA. Our ability to
successfully implement our business plan and achieve targeted
financial results and other benefits including, among other things,
greater market presence and development, and enhancements to our
product portfolio and customer base, is dependent on our ability to
successfully identify, consummate and integrate acquisitions we may
acquire in the future. We may not realize the intended benefits of
the acquisition of other businesses in the future as rapidly as, or
to the extent, anticipated by our management. There can be no
assurance that we will be able to successfully integrate any other
acquired businesses, products or technologies without substantial
expense, delay or other operational or financial problems.
Acquisitions involve a number of risks, some or all which could
have a material adverse effect on our acquired businesses, products
or technologies. Furthermore, there can be no assurance that any
acquired business, product, or technology will be profitable or
achieve anticipated revenues and income. Our failure to manage our
acquisition and integration strategy successfully could have a
material adverse effect on our business, results of operations and
financial condition. The process of integrating an acquired
business involves risks, including but not limited to:
|
●
|
Demands on management related to changes in the size and possible
locations of our businesses and employees;
|
|
●
|
Diversion of management's attention from the management of daily
operations;
|
|
●
|
Difficulties in the assimilation of different corporate cultures,
employees and business practices;
|
|
●
|
Retaining the loyalty and business of the employees or customers of
acquired businesses;
|
|
●
|
Retaining employees that may be vital to the integration of
acquired businesses or to the future prospects of the combined
businesses;
|
|
●
|
Difficulties and unanticipated expense related to the integration
of departments, information technology systems, including
accounting systems, technologies, books and records, and
procedures, and maintaining uniform standards, such as internal
accounting controls, procedures, and policies;
|
|
●
|
Costs and expense associated with any undisclosed or potential
liabilities; and
|
|
●
|
The use of more cash or other financial resources on integration
and implementation activities than we expect.
|
Failure to successfully integrate any acquired business in the
future may result in reduced levels of revenue, earnings, or
operating efficiency than might have been achieved if we had not
acquired such businesses.
In addition, the acquisition of any future businesses could result
in additional debt and related interest expense, contingent
liabilities, and amortization expense related to intangible assets,
as well as the issuance of our Common Stock, which could have a
material adverse effect on our financial condition, operating
results, and cash flow.
Government regulation of our products may adversely affect
sales.
Our BolaWrap device is classified as a firearm and the BolaWrap 150
is also classified as an exempt special explosive device. Both
firearms and explosive devices are regulated by the U.S. Bureau of
Alcohol, Tobacco, Firearms and Explosives (“ATF”) involving
substantial regulatory compliance. ATF regulations are enforced by
surveillance and inspection. If ATF finds a violation, it can
institute a wide range of enforcement actions, ranging from public
warnings to more severe sanctions such as fines, penalties,
suspension or withdrawal of regulatory approvals, product recalls,
seizure of products, operating restrictions or total shutdown of
production, and criminal prosecution. Any such actions could have a
material adverse impact on our operations.
Our device may face state restrictions, especially regarding sales
to security agencies. Our product sales may be significantly
affected by federal, state and local regulation. Failure to comply
with regulations could also result in the imposition of fines,
penalties and other actions that could adversely impact our
financial position, cash flows and operating results.
Our product is also controlled by the U.S. Department of Commerce
(“DOC”) for exports directly from the United States.
Consequently, we need to obtain export licenses from the DOC for
the export of our products from the United States. Compliance with
or changes in U.S. export regulations could significantly and
adversely affect any future international sales.
The shipment of some of our components and our products involve
conformity to regulations governing the transport of “dangerous
goods”. Failure to comply with shipping regulations could result in
the imposition of fines, penalties and other actions that could
adversely impact our financial position, cash flows and operating
results.
Certain foreign jurisdictions may restrict the importation or sale
of our products, limiting our international sales
opportunities.
Our products, including the BolaWrap 100 and BolaWrap 150,
have limited issued patents or other intellectual property
protection. If we are unable to protect our intellectual property,
we may lose a competitive advantage or incur substantial litigation
costs to protect our rights.
Our future success depends in part upon our proprietary technology.
We currently own thirteen issued U.S. patents related to BolaWrap
technology, and have fifteen U.S. patents pending. We have filed
foreign patent applications in the European Union (up to 38
countries) and 17 other countries and reserved our rights to file
additional foreign patents. Our protective measures taken thus far,
including our issued patents, pending patents, issued and pending
trademarks and trade secret laws, may prove inadequate to protect
our proprietary rights. There can be no assurance we will be
granted any patent rights from pending patents. The scope of any
possible patent rights may not prevent others from developing and
selling competing products. The validity and breadth of claims
covered in any possible patents involve complex legal and factual
questions, and the resolution of such claims may be highly
uncertain, lengthy, and expensive. In addition, any patents, if
granted, may be held invalid upon challenge, or others may claim
rights in or ownership of our patents.
Our competitive position will be seriously damaged if our
products are found to infringe on the intellectual property rights
of others.
Other companies and our competitors may currently own or obtain
patents or other proprietary rights that might prevent, limit or
interfere with our ability to make, use or sell our products. Any
intellectual property infringement claims made against us, with or
without merit, could be costly and time-consuming to defend and
divert our management’s attention from our business. In the event
of a successful claim of infringement against us and our failure or
inability to license the infringed technology, our business and
operating results could be adversely affected. Any litigation or
claims, whether or not valid, could result in substantial costs and
diversion of our resources. An adverse result from intellectual
property litigation could force us to do one or more of the
following:
|
●
|
Cease selling, incorporating or using products or services that
incorporate the challenged intellectual property;
|
|
●
|
Obtain a license from the holder of the infringed intellectual
property right, which license may not be available on reasonable
terms, if at all; and
|
|
●
|
Redesign products or services that incorporate the disputed
technology.
|
If we are forced to take any of the foregoing actions, we could
face substantial costs and shipment delays and our business could
be materially harmed. Although we carry general liability
insurance, our insurance may not cover potential claims of this
type or be adequate to indemnify us for all liability that may be
imposed.
In addition, it is possible that our distributors and customers may
seek indemnity from us in the event that our products are found or
alleged to infringe the intellectual property rights of others. Any
such claim for indemnity could result in substantial expense to us
that could harm our operating results.
Competition in the law enforcement market could reduce our
sales, make our products obsolete or inferior and prevent us from
achieving profitability.
The law enforcement market is highly competitive. We face
competition from numerous larger, better capitalized, more
experienced and more widely known companies that make restraint
devices, less-lethal weapons and other law enforcement products.
One or more of our competitors may have developed or may succeed in
developing technologies and products that are more effective than
any of ours, rendering our technology and products obsolete or
noncompetitive. Increased competition could result in reduced
sales, greater pricing pressure, lower gross margins, and prevent
us from achieving profitability.
Foreign currency fluctuations may reduce our competitiveness
and sales in international markets.
The relative change in currency values creates fluctuations in
product pricing for future potential international customers. These
changes in international end-user costs may result in lost orders
and reduce the competitiveness of our products in certain
international markets. These changes may also negatively affect the
financial condition of some international customers and reduce or
eliminate their future orders of our products.
Our business is dependent on the continued services of
certain executives and key employees.
Our business and operations are substantially dependent upon the
experience and continued service of certain executives and certain
key sales and research employees. We have no employment agreements
or post-employment agreements to have access to important
institutional knowledge should any key person resign or be
dismissed. The loss of one or several key employees could have a
material adverse effect upon our business, financial condition,
results of operations and cash flows.
We are also dependent on our ability to retain and motivate high
quality personnel, especially sales and skilled engineering
personnel. Competition for such personnel is intense, and we may
not be able to attract, assimilate or retain other highly qualified
managerial, sales and technical personnel in the future. The
inability to attract and retain the necessary managerial, sales and
technical personnel could cause our business, operating results or
financial condition to suffer.
We have experienced recent changes in management. These
changes have the potential to disrupt our business, and any such
disruption could adversely affect our operations, product
development, growth, financial condition or results from
operations.
We had significant changes in management in the past three years,
most recently in January 2022 when LW Varner, Jr. was appointed to
serve as interim Chief Executive Officer pursuant to a consulting
agreement following the departure of Thomas P. Smith as the
Company’s Chief Executive Officer. Also in January 2022, the
Company entered into a consulting agreement with Lawrence Hirsh to
provide certain services to Mr. Varner and the Company with respect
to finance and related matters. The Board of Directors have
commenced a search to identify a permanent Chief Executive
Officer.
In addition, the Board of Directors has commenced a formal search
to identify a highly qualified candidate to serve in the capacity
of Chief Financial Officer upon the earlier of the retirement of
James A. Barnes, the Company’s current Chief Financial Officer, or
the Board of Directors’ naming of his replacement.
Executive leadership transitions can be inherently difficult to
manage, may cause significant and costly disruption to our
business, might lead to additional departures of existing
personnel, and could have a material adverse effect on our
business, operating results, financial condition and internal
controls over financial reporting.
Risk Factors Relating to
Our Financial Statements and Operating Results
We cannot predict our future operating results. Our quarterly
and annual results will likely be subject to fluctuations caused by
many factors, any of which could result in our failure to achieve
our expectations.
We currently expect that the BolaWrap product will be the primary
source of our revenue in the foreseeable future. We expect our
revenue to vary significantly due to a number of factors. Many of
these factors are beyond our control. Any one or more of these
factors, including those listed below, could cause us to fail to
achieve our revenue expectations. These factors include, among
others:
|
●
|
Our ability to develop and supply product to customers;
|
|
●
|
Market acceptance of, and changes in demand for, our products;
|
|
●
|
Gains or losses of significant customers, distributors or strategic
relationships;
|
|
●
|
Unpredictable volume and timing of customer orders;
|
|
●
|
The availability, pricing and timeliness of delivery of components
for our products;
|
|
●
|
Fluctuations in the availability of manufacturing capacity or
manufacturing yields and related manufacturing costs;
|
|
●
|
Timing of new technological advances, product announcements or
introductions by us and by our competitors;
|
|
●
|
Unpredictable warranty costs associated with our products;
|
|
●
|
Budgetary cycles and order delays by customers or production delays
by us or our suppliers;
|
|
●
|
Regulatory changes affecting the marketability of our products;
|
|
●
|
Logistics challenges of obtaining supplies and components and
shipping products resulting from the pandemic;
|
|
●
|
General economic conditions that could affect the timing of
customer orders and capital spending and result in order
cancellations or rescheduling; and
|
|
●
|
General political conditions in this country and in various other
parts of the world that could affect spending for the products that
we intend to offer.
|
Some or all of these factors could adversely affect demand for our
products and, therefore, adversely affect our future operating
results. As a result of these and other factors, we believe that
period-to-period comparisons of our operating results may not be
meaningful in the near term, and accordingly you should not rely
upon our performance in a particular period as indicative of our
performance in any future period.
Our expense may vary from period to period, which could
affect quarterly results and our stock price.
If we incur additional expense in a quarter in which we do not
experience increased revenue, our results of operations will be
adversely affected, and we may incur larger losses than anticipated
for that quarter. Factors that could cause our expense to fluctuate
from period to period include:
|
●
|
The timing and extent of our research and development efforts;
|
|
●
|
Investments and costs of maintaining or protecting our intellectual
property;
|
|
●
|
Marketing and sales efforts to promote our products and
technologies; and
|
|
●
|
The timing of personnel and consultant hiring.
|
Most of our operating expenses are relatively fixed in the short
term. We may be unable to rapidly adjust spending to compensate for
any unexpected sales shortfalls, which could harm our quarterly
operating results and our stock price. We do not have the ability
to predict future operating results with any certainty.
Our disclosure controls and procedures may not prevent or
detect all acts of fraud.
Our disclosure controls and procedures are designed to reasonably
assure that information required to be disclosed in reports filed
or submitted under the Securities Exchange Act is accumulated and
communicated to management and is recorded, processed, summarized
and reported within the time periods specified in the SEC’s rules
and forms. Our management expects that our disclosure controls and
procedures and internal controls and procedures, no matter how well
conceived and operated, can provide only reasonable, not absolute,
assurance that the objectives of the control system are met.
Because of the inherent limitations in all control systems, they
cannot provide absolute assurance that all control issues and
instances of fraud, if any, within our company have been prevented
or detected. These inherent limitations include the realities that
judgments in decision-making can be faulty, and that breakdowns can
occur because of a simple error or mistake. Additionally, controls
can be circumvented by the individual acts of some persons, by
collusion of two or more people, or by an unauthorized override of
the controls. The design of any system of controls also is based in
part upon certain assumptions about the likelihood of future
events, and we cannot assure that any design will succeed in
achieving its stated goals under all potential future conditions.
Accordingly, because of the inherent limitations in a
cost-effective control system, misstatements due to error or fraud
may occur and not be detected.
Failure to maintain an effective system of internal control
over financial reporting could harm stockholder and business
confidence in our financial reporting, our ability to obtain
financing and other aspects of our business.
Maintaining an effective system of internal control over financial
reporting is necessary for us to provide reliable financial
reports. Section 404 of the Sarbanes-Oxley Act of 2002
("Sarbanes-Oxley Act") and the related rules and regulations
promulgated by the SEC require us to include in our Form 10-K a
report by management regarding the effectiveness of our internal
control over financial reporting. The report includes, among other
things, an assessment of the effectiveness of our internal control
over financial reporting as of the end of the respective fiscal
year, including a statement as to whether or not our internal
control over financial reporting is effective. This assessment must
include disclosure of any material weaknesses in our internal
control over financial reporting identified by management. While
our management has concluded that our internal control over
financial reporting was effective as of December 31, 2021, it is
possible that material weaknesses will be identified in the future.
In addition, components of our internal control over financial
reporting may require improvement from time to time. If management
is unable to assert that our internal control over financial
reporting is effective in any future period, investors may lose
confidence in the accuracy and completeness of our financial
reports, which could have an adverse effect on the Company’s stock
price.
Risk Factors Relating to
Our Common Stock
Our stock price is volatile and may continue to be volatile
or may decline regardless of our operating performance, resulting
in substantial losses for investors.
The market price of our Common Stock has fluctuated significant to
date and in the future may fluctuate significantly in response to
numerous factors, many of which are beyond our control, including
the factors listed below and other factors described in this “Risk
Factors” section:
|
●
|
Actual or anticipated fluctuations in our operating results;
|
|
●
|
Failure of securities analysts to initiate or maintain coverage of
our Company, changes in financial estimates by any securities
analysts who follow our Company, or our failure to meet these
estimates or the expectations of investors;
|
|
●
|
Rating changes by any securities analysts who follow our
Company;
|
|
●
|
Changes in the availability of federal funding to support local law
enforcement efforts, or local budgets;
|
|
●
|
Announcements by us of significant technical innovations,
acquisitions, strategic partnerships, joint ventures or capital
commitments;
|
|
●
|
Changes in operating performance and stock market valuations of
other security product companies generally;
|
|
●
|
Price and volume fluctuations in the overall stock market,
including as a result of trends in the economy as a whole;
|
|
●
|
Announcements of merger or acquisition transactions;
|
|
●
|
Changes in our board of directors or management;
|
|
●
|
Sales of large blocks of our Common Stock, including sales by our
executive officers, directors and significant stockholders;
|
|
●
|
Lawsuits threatened or filed against us;
|
|
●
|
Short sales, hedging and other derivative transactions involving
our capital stock;
|
|
●
|
General economic conditions in the United States and abroad;
and
|
|
●
|
Other events or factors, including those resulting from war,
incidents of terrorism or responses to these events.
|
In addition, stock markets have experienced extreme price and
volume fluctuations that have affected and continue to affect the
market prices of equity securities of many security and technology
companies. Stock prices of many security and technology companies
have fluctuated in a manner unrelated or disproportionate to the
operating performance of those companies.
We are and, in the future, may be subject to securities
litigation, which may be expensive and could divert management
attention.
Our share price is volatile, and in the past companies that have
experienced volatility in the market price of their stock have been
subject to securities class action litigation. For instance, in
September 2020 a putative class action lawsuit and in November 2020
a shareholder derivative lawsuit were filed against us and certain
of our directors and officers. Our motion to dismiss the putative
class action lawsuit was successful in December 2021.
Lawsuits of this nature divert financial and management resources
that would otherwise be used to benefit our operations. Although we
deny the material allegations in the lawsuits and intend to defend
ourselves vigorously, defending the lawsuits may result in
substantial costs. Any lawsuit to which we or our directors or
officers are a party, with or without merit, may result in an
unfavorable judgment. We also may decide to settle lawsuits on
unfavorable terms. Any such negative outcome could result in
payments of substantial damages or fines, damage to our reputation
or adverse changes to our offerings or business practices. Any of
these results could adversely affect our business.
In addition, we may be the target of securities-related litigation
in the future. Such litigation may divert our management’s
attention and resources, result in substantial costs, and have an
adverse effect on our business, results of operations and financial
condition. We maintain director and officer insurance that we
regard as reasonably adequate to protect us from potential claims;
however, we cannot assure you that it will. Further, if we are
subject to future litigation, the costs of insurance may increase,
and the availability of coverage may decrease. As a result, we may
not be able to maintain our current levels of insurance at a
reasonable cost, or at all, which might make it more difficult to
attract qualified candidates to serve as executive officers or
directors of the Company.
Sales of a substantial number of shares of our Common Stock
may adversely affect the market price of our Common
Stock.
Sales or distributions of a substantial number of shares of our
Common Stock in the public market, or the perception that such
sales could occur, could adversely affect the market price of our
Common Stock. Many of the outstanding shares of our Common Stock,
other than the shares held by executive officers and directors, are
eligible for immediate resale in the public market. Substantial
selling of our Common Stock could adversely affect the market price
of our Common Stock.
Our Common Stock could be delisted from the Nasdaq Stock
Market.
Nasdaq’s continued listing standards for our Common Stock require,
among other things, that (i) we maintain a closing bid price for
our Common Stock of at least $1.00, and (ii) we maintain: (A)
stockholders’ equity of $2.5 million; (B) market value of listed
securities of $35 million; or (C) net income from continuing
operations of $500,000 in the most recently completed fiscal year
or in two of the last three most recently completed fiscal years.
Any failures to satisfy any continued listing requirements could
lead to the receipt of a deficiency notice from Nasdaq and
ultimately to a delisting from trading of our Common Stock. If our
Common Stock were delisted from Nasdaq, among other things, this
could result in a number of negative implications, including
reduced liquidity in our Common Stock as a result of the loss of
market efficiencies associated with Nasdaq and the loss of federal
preemption of state securities laws as well as the potential loss
of confidence by suppliers, customers and employees, institutional
investor interest, fewer business development opportunities,
greater difficulty in obtaining financing and possible breaches of
certain contractual obligations.
Our officers and directors are among our largest stockholders
and may have certain personal interests that may affect the
Company.
Management and certain directors owned approximately 34% of our
Common Stock at December 31, 2021. As a result, our management
and certain directors, acting individually or as a group, has the
potential ability to exert influence on the outcome of issues
requiring approval by our stockholders. This concentration of
ownership may have effects such as delaying or preventing a change
in control of the Company that may be favored by other stockholders
or preventing transactions in which stockholders might otherwise
recover a premium for their shares over current market prices.
We may issue additional shares of Common Stock in the future.
The issuance of additional shares of Common Stock may reduce the
value of your Common Stock.
We may issue additional shares of Common Stock without further
action by our stockholders. Moreover, the economic and voting
interests of each stockholder will be diluted as a result of any
such issuances. Although the number of shares of Common Stock that
stockholders presently own will not decrease, such shares will
represent a smaller percentage of the total shares that will be
outstanding after the issuance of additional shares. The
issuance of additional shares of Common Stock may cause the market
price of our Common Stock to decline.
Sales of shares of Common Stock issuable upon the exercise of
any future options or warrants may lower the price of our Common
Stock.
At December 31, 2021, we had warrants, options and restricted stock
units outstanding on 5.6 million shares of our Common Stock. The
issuance of shares of Common Stock issuable upon the exercise of
options or warrants or issuance from restricted stock units could
cause substantial dilution to existing holders of our Common Stock,
and the sale of those shares in the market could cause the market
price of our Common Stock to decline. The potential dilution from
the issuance of these shares could negatively affect the terms on
which we are able to obtain equity financing.
We may issue preferred stock in the future, and the terms of
the preferred stock may reduce the value of your Common
Stock.
We are authorized to issue up to 5.0 million shares of preferred
stock in one or more series. Our Board of Directors may determine
the terms of future preferred stock offerings without further
action by our stockholders. If we issue preferred stock, it could
affect your rights or reduce the value of your Common Stock. In
particular, specific rights granted to future holders of preferred
stock could be used to restrict our ability to merge with or sell
our assets to a third party. Preferred stock terms may include
voting rights, preferences as to dividends and liquidation,
conversion and redemption rights and sinking fund provisions.
We incur substantial costs as a result of being a public
company.
As a public company, we incur significant levels of legal,
accounting, insurance, exchange listing fees and other expenses
that we did not incur as a private company. We are subject to the
reporting requirements of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), the Sarbanes-Oxley Act, the
Dodd-Frank Act, the listing requirements of the Nasdaq Capital
Market and other applicable securities rules and regulations.
Compliance with these rules and regulations increases our legal and
financial compliance costs, makes some activities more difficult,
time-consuming or costly and increases demand on our systems and
resources as compared to when we operated as a private company. The
Exchange Act requires, among other things, that we file annual,
quarterly and current reports with respect to our business and
operating results. The Sarbanes-Oxley Act requires, among other
things, that we maintain effective disclosure controls and
procedures and internal control over financial reporting. In order
to maintain and, if required, improve our disclosure controls and
procedures and internal control over financial reporting to meet
this standard, significant resources and management oversight may
be required. As a result, management’s attention may be diverted
from other business concerns, which could adversely affect our
business and operating results. We may need to hire more corporate
employees in the future or engage outside consultants to comply
with these requirements, which would increase our costs and
expenses.
In addition, changing laws, regulations and standards relating to
corporate governance and public disclosure are creating uncertainty
for public companies, increasing legal and financial compliance
costs and making some activities more time-consuming. These laws,
regulations and standards are subject to varying interpretations,
in many cases due to their lack of specificity, and, as a result,
their application in practice may evolve over time as new guidance
is provided by regulatory and governing bodies. This could result
in continuing uncertainty regarding compliance matters and higher
costs necessitated by ongoing revisions to disclosure and
governance practices. We intend to invest resources to comply with
evolving laws, regulations and standards, and this investment may
result in increased general and administrative expense and a
diversion of management’s time and attention from
revenue-generating activities to compliance activities. If our
efforts to comply with new laws, regulations and standards differ
from the activities intended by regulatory or governing bodies due
to ambiguities related to their application and practice,
regulatory authorities may initiate legal proceedings against us
and our business may be adversely affected.
As a result of disclosure of information in this report and in the
filings that we are required to make as a public company, our
business, operating results and financial condition have become
more visible, which has resulted in, and may in the future result
in threatened or actual litigation, including by competitors and
other third parties. If any such claims are successful, our
business, operating results and financial condition could be
adversely affected, and even if the claims do not result in
litigation or are resolved in our favor, these claims, and the time
and resources necessary to resolve them, could divert the resources
of our management and adversely affect our business, operating
results and financial condition.
The payment of dividends will be at the discretion of our
Board of Directors.
We have never declared dividends on our Common Stock, and currently
do not anticipate that we will do so in the foreseeable future. The
declaration and amount of future dividends, if any, will be
determined by our Board of Directors and will depend on our
financial condition, earnings, capital requirements, financial
covenants, regulatory constraints, industry practice and other
factors our Board of Directors deems relevant.
ITEM 1B. UNRESOLVED STAFF
COMMENTS
None.
ITEM 2.
PROPERTIES
Our executive offices, sales, training, assembly and warehouse
facilities are located at 1817 West 4th Street, Tempe, Arizona. The
lease of 11,256 square feet commenced in June 2019 and expires July
2022. The aggregate monthly payments are currently $8,120,
increasing 3% for June and July 2022 during the lease term, plus
other certain costs and charges as specified in the lease
agreement, including the Company’s proportionate share of the
building operating expense and real estate taxes. In January 2022
we renewed this lease for three years with aggregate payments of
$9,905 commencing August 2022, increasing 4% annually through the
term ending July 31, 2025.
Beginning in October 2017, we commenced reimbursing former officer,
stockholder and consultant, Mr. Elwood Norris, $1,500 per month on
a month-to-month basis for laboratory facility costs.
We from time to time rent executive space on a month-to-month basis
for remotely located employees. We currently have three Wrap
Reality employees located in a 186 square foot space in Buffalo,
New York on a month-to-month rental agreement, which payments are
currently $1,750 per month.
ITEM 3. LEGAL
PROCEEDINGS
Securities Litigation
On November 15, 2021, the Hon. Dolly M. Gee of the United States
District Court for the Central District of California (the
“Court”) granted the motion to dismiss filed by the Company,
David Norris (“Norris”), James A. Barnes (“Barnes”),
Thomas Smith (“Smith”), Mike Rothans (“Rothans”) and
Marc Thomas (“Thomas”) (collectively, “Defendants”)
in the action captioned In re Wrap Technologies, Inc.
Securities Exchange Act Litigation (the “Securities
Action”). The Court granted Defendants’ motion on the
grounds that the complaint failed to identify any statement by
Defendants that was either false or made with scienter.
Concurrently, the Court granted Plaintiff leave to file a second
amended complaint on or before December 6, 2021, noting that a
failure to file a second amended complaint by that date would
result in dismissal of the Securities Action with
prejudice. On December 20, 2021, following Plaintiff’s failure
to file a second amended complaint, the Court dismissed the
Securities Action with prejudice.
Shareholder Derivative Litigation
On November 13, 2020, Naresh Rammohan filed a shareholder
derivative action in the United States District Court for the
Central District of California against Smith, Barnes, Rothans,
Thomas, and Norris, as well as directors Messrs. Scot Cohen,
Patrick Kinsella, Michael Parris, and Wayne Walker, alleging unjust
enrichment, breach of fiduciary duty, waste of corporate assets,
and contribution claims under the Securities Exchange Act of 1934,
docketed as Case No. 2:20-cv-10444-DMG-PVCx (the “Rammohan
Complaint”). The Company is named as a nominal defendant.
On January 20, 2021, Ray Westerman filed a second derivative
complaint in the same court against the same parties, alleging
breach of fiduciary duty and contribution claims under the
Securities Exchange Act of 1934, docketed as Case No.
2:21-cv-00550-DMG-PVCx (the “Westerman Complaint”). On
January 22, 2021, Jesse Lowe filed a third derivative complaint in
the same court against the same parties, alleging breach of
fiduciary duty and asserting various claims under the Securities
Exchange Act of 1934, docketed as Case No. 2:21-cv-00597-DMG-PVCx
(the “Lowe Complaint”).
On January 27, 2021, Judge Gee entered an order to show cause why
the derivative actions should not be consolidated and stayed
pending the resolution of the Securities Action, given the
“apparent substantial overlap” between the cases. On February 16,
2021, Judge Gee issued an order consolidating the derivative
actions under the caption In re Wrap Technologies, Inc.
Shareholder Derivative Litigation, Case No.
2:20-10444-DMG-PVCx, (the “Derivative Action”), and stayed
the Derivative Action at least until the resolution of the
Securities Action, which has been dismissed with
prejudice. The Company believes that the Derivative Action is
without merit and will vigorously defend against the claims raised
therein.
Other Legal Proceeding Information
We may become subject to other legal proceedings, as well as
demands and claims that arise in the normal course of our business,
including claims of alleged infringement of third-party patents and
other intellectual property rights, breach of contract, employment
law violations, and other matters and matters involving requests
for information from us or our customers under federal or state
law. Such claims, even if not meritorious, could result in the
expenditure of significant financial and management resources. We
make a provision for a liability relating to legal matters when it
is both probable that a liability has been incurred and the amount
of the loss can be reasonably estimated. These provisions are
reviewed and adjusted to include the impacts of negotiations,
estimated settlements, legal rulings, advice of legal counsel, and
other information and events pertaining to a particular matter. At
December 31, 2021 we had no provision for liability under existing
litigation.
An unfavorable outcome on any litigation matters could require
payment of substantial damages, or, in connection with any
intellectual property infringement claims, could require us to pay
ongoing royalty payments or could prevent us from selling certain
of our products. As a result, a settlement of, or an unfavorable
outcome on, any of the matters referenced above or other litigation
matters or legal proceedings could have a material adverse effect
on our business, operating results, financial condition and cash
flows.
ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.
PART
II
ITEM
5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES
Our Common Stock is listed on the Nasdaq Capital Market under the
symbol “WRAP”.
Holders
At March 9, 2022 there were 40,939,371 shares of Common
Stock outstanding and approximately 25 stockholders of
record.
Equity Compensation Plan Information
On March 31, 2017, the Company adopted, and the stockholders
approved, the 2017 Stock Incentive Plan (as amended from time to
time, the “Plan”). The Plan reserved 2.0 million shares of
our Common Stock for issuance as one of four types of equity
incentive awards: (i) stock options, (ii) shares of Common Stock,
(iii) restricted stock awards, and (iv) restricted stock units. The
Plan permits the qualification of awards under the plan as
“performance-based compensation” within the meaning of
Section 162(m) of the Internal Revenue Code.
In May 2019, stockholders ratified an increase in the Plan
authorizing an additional 2,100,000 shares of Common Stock; in June
2020, stockholders ratified an increase in the Plan authorizing an
additional of 1,900,000 shares of Common Stock; and in June 2021,
stockholders ratified an increase in the Plan authorizing an
additional 1,500,000 shares of Common Stock, for a total of
7,500,000 shares reserved for issuance under the Plan as of the
date of this Report. At December 31, 2021, there were 1,380,816
shares of Common Stock available for grant under the Plan.
The following table sets forth information as of December 31, 2021,
with respect to compensation plans (including individual
compensation arrangements) under which our equity securities are
authorized for issuance, aggregated as follows:
Plan Category
|
|
Number of securities to be
issued upon exercise of
outstanding options, warrants and rights
|
|
|
Weighted-average exercise
price of outstanding
options, warrants and rights
|
|
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities reflected in column (a))
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity compensation plans approved by security holders
|
|
|
4,205,186 |
|
|
$ |
5.32 |
|
|
|
1,380,816 |
|
Equity compensation plans not approved by security holders
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Total
|
|
|
4,205,186 |
|
|
$ |
5.32 |
|
|
|
1,380,816 |
|
Recent Sales of Unregistered Securities
No unregistered securities were issued during the fiscal year that
were not previously reported in a Quarterly Report on Form
10-Q or Current Report on Form 8-K.
Transfer Agent
Our Transfer Agent and Registrar for our Common Stock is Colonial
Stock Transfer, located at 66 Exchange Place, Suite 100, Salt Lake
City, Utah 84111.
Issuer Purchases of Equity Securities
Not applicable.
ITEM
6. SELECTED FINANCIAL DATA
Information requested by this Item is not included, as we are
electing to take advantage of scaled disclosure requirements
available to Smaller Reporting Companies.
ITEM 7. MANAGEMENT'S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The discussion and analysis set forth below should be read in
conjunction with the information presented in other sections of
this Annual Report, including “Item 1. Business,”
“Item 1A. Risk Factors,” and “Item 8. Financial
Statements and Supplementary Data.” The following discussion
may contain forward-looking statements that reflect our plans,
estimates and beliefs. Words such as “expects,”
“anticipates,” “intends,” “plans,”
“believes,” “seeks,” “estimates” and
similar expressions or variations of such words are intended to
identify forward-looking statements but are not the only means of
identifying forward-looking statements. Our actual results could
differ materially from those discussed in these forward-looking
statements.
Overview
We are a global public safety technology and services company
organized in March 2016 delivering modern policing solutions to law
enforcement and security personnel. We began sales of our first
public safety product, the BolaWrap 100 remote restraint device, in
late 2018. In October 2021 we released a new generation product,
the BolaWrap 150. The BolaWrap 150 is electronically deployed and
is more robust, smaller, lighter and simpler to deploy than the
BolaWrap 100 that is being phased out.
The immediate addressable domestic market for our solutions
consists of approximately 900,000 full-time sworn law enforcement
officers at over 15,300 federal, state and local law enforcement
agencies, and over 12 million police officers in over 100
countries. We are also exploring other domestic markets, including
military and private security. Our international focus is on
countries with the largest police forces. The 100 largest
international police agencies are estimated to have over 12.1
million law enforcement personnel. According to 360iResearch, a
market research consulting firm, we participate in a segment of the
non-lethal products global market expected to grow to $16.1 billion
by 2027.
We focus our efforts on the following products and services:
BolaWrap Remote Restraint Device – is a hand-held remote
restraint device that discharges an eight-foot bola style Kevlar
tether to entangle an individual at a range of 10-25 feet. BolaWrap
assists law enforcement to safely and effectively control
encounters early in the use of force continuum without resorting to
painful force options.
Wrap Reality – is a law enforcement training system
employing immersive computer graphics virtual reality ("VR")
with proprietary software-enabled content. It allows up to two
participants to enter a simulated training environment
simultaneously, and customized weapons controllers enable trainees
to engage in strategic decision making along the force
continuum.
In addition to the United States law enforcement market, we have
shipped our restraint products to 51 countries. We have established
an active distributor network with 12 domestic distributors
representing 49 states and one dealer representing Puerto Rico. We
have distribution agreements with 47 international distributors
covering 54 countries. We focus significant sales, training and
business development efforts to support our distribution
network.
We focus significant resources on research and development
innovations and continue to enhance our products and plan to
introduce new products. We believe we have established a strong
branding and market presence globally and have established
significant competitive advantages in our markets.
Recent Developments
During the year ended December 31, 2021 we accomplished the
following:
|
●
|
Received an aggregate of $12.0 million in proceeds from the
exercise of 1,815,012 warrants.
|
|
●
|
Received an aggregate of $1.7 million in proceeds from the exercise
of 915,404 stock options.
|
|
●
|
Shipped BolaWrap products to 15 new countries, with BolaWrap
products now being used in 51 countries.
|
|
●
|
Granted three new U.S. patents, and filed 16 new U.S. patent
applications.
|
|
●
|
Expanded the geographic scope of our international patent and
trademark applications, which now cover up to 38 countries in
Europe, and 17 other countries.
|
|
●
|
Earned the ISO 9001:2015 Certification for our Quality Management
System, a demonstration of our commitment to excellence in
providing quality products and services.
|
|
●
|
Extended our pilot program with the Los Angeles Police Department
for one year, positioning the deployment of the BolaWrap 150
planned in the first quarter of 2022.
|
|
●
|
Announced the first 50 reported field uses of the BolaWrap
tabulated from police agencies, with the BolaWrap effectively
assisting in taking a suspect into custody without excessive force,
and thereby facilitating a successful outcome, in more than 80% of
the reported field uses.
|
|
●
|
Increased our focus on sustainability by becoming a participant of
the United Nations Global Compact, the largest corporate
citizenship and sustainability initiative, and publishing our
initial Environmental, Social and Governance ("ESG")
letter.
|
|
●
|
Announced a collaboration with Amazon Web Services ("AWS")
to deliver the Wrap Reality Virtual Training platform, and the
capability to keep and maintain training records, to law
enforcement, built on AWS GovCloud (US).
|
|
●
|
Upgraded the Wrap Reality Virtual Training platform and began
offering a subscription-based service model while beta testing the
platform developed with AWS.
|
|
●
|
Unveiled the next generation BolaWrap 150 remote restraint device
featuring electronic deployment, and is more robust, smaller,
lighter and simpler to deploy than the BolaWrap 100.
|
|
●
|
Received a favorable non-firearm classification of the BolaWrap 150
from the Royal Canadian Mounted Police ("RCMP").
|
|
●
|
Obtained the first risk pool funding to support agency purchases of
BolaWrap from the Arizona Municipal Risk Retention Pool
("AMRRP").
|
|
●
|
Increased revenue to $7.7 million, an increase of 96% over revenue
in 2020.
|
Management Restructuring
On January 24, 2022, the Board of Directors approved and initiated
a leadership transition plan to support the next phase of its
corporate strategy, which is focused on diversifying the Company’s
suite of products, offerings and services. The transition and
corporate strategy included the resignation of President, CEO and
director Thomas P. Smith; appointment of LW Varner, Jr. as a
consultant and Interim CEO; appointment of Lawrence Hirsh as a
financial consultant; announcement of the planned retirement of
CFO, Secretary and Treasurer James A. Barnes expected upon
appointment of a successor; appointment of director Wayne Walker as
Chairman of the Board; and acceptance of the resignation of
directors Patrick Kinsella and Jeffrey Kukowski. The Board of
Directors announced they are conducting a formal process to
identify highly qualified candidates for the CEO and CFO roles and
also announced that directors Scot Cohen and Kim Sentovich were
appointed as a Special Transition Committee of the Board of
Directors to support and oversee the interim management team which
in addition to Mr. Varner and Mr. Hirsh includes Chief Operating
Officer Glenn Hickman (the "Management Transition").
Pursuant to a Cooperation Agreement between the Company and Elwood
G. Norris, a former officer of the Company and current shareholder,
dated March 4, 2021, Mr. Norris may have certain rights to nominate
a replacement board candidate as a result of Mr. Kukowski’s
resignation.
Business Outlook and Challenges
Our products and solutions continue to gain worldwide awareness and
recognition through social media, media exposure, trade shows,
product demonstrations and word of mouth as a result of positive
responses from agencies and early adoption and deployment success.
We believe Wrap is gaining traction as a recognized global brand,
with innovative technology and an initial product foundation
achieved through aggressive marketing and public relations. We
believe that we have strong market opportunities for our remote
restraint solution throughout the world in the law enforcement and
security sectors as a result of increasing demands for less lethal
policing and increasing threats posed by non-compliant
subjects.
During the year ended December 31, 2021, the Company received an
increased number of field reports of successful BolaWrap usage from
law enforcement agencies. Many agencies consider BolaWrap as a very
low level, or non-reportable, use of force option and, accordingly,
many uses are not reported to us. Others are considered evidence
and are also not shared. Some law enforcement agencies have shared
bodycam footage of their field uses, some of which we are allowed
to use in our marketing activities. We believe increased reports of
avoiding escalation will help grow revenues in the future.
Revenues for the year ended December 31, 2021 increased 96% over
the prior year, and we continue to expand our business, both
domestically and internationally, through direct and distributor
sales. We have a robust and growing pipeline of market
opportunities for our restraint product offering and training
services within the law enforcement, military and homeland security
business sectors domestically and internationally. Social trends
demanding more compassionate and safe policing practices are
expected to continue to drive our global business. We are pursuing
large business prospects internationally and also pursuing business
with large police agencies in the U.S. It is difficult to
anticipate how long it will take to close these opportunities, or
if they will ultimately come to fruition especially given the
uncertainty of COVID-19 and social unrest, as discussed below.
To support our increased sales and distribution activities, we have
developed and offer robust training and class materials that
certify law enforcement officers and trainers as BolaWrap
instructors in the use and limitations of the BolaWrap, in
conjunction with modern policing tactics for de-escalation of
encounters. We believe law enforcement trainers and officers that
have seen demonstrations or have been trained about our products
are more supportive of their department’s purchase and deployment
of our products. Over 1,000 agencies have received BolaWrap
training, with over 3,000 training officers at those agencies
actively certified as BolaWrap instructors, qualified to train the
rest of their departments. The number of agencies and training
officers has doubled compared to the year ended December 31,
2021.
With the acquisition of NSENA in December 2020, and the rebranding
of the NSENA business as Wrap Reality, we have continued to market
our virtual reality system while working to integrate previous
scenarios into a robust platform, employing BolaWrap and additional
de-escalation techniques into new Wrap Reality scenarios. In August
2021 we announced the development of a new expanded Wrap Reality
Virtual Training platform powered by, and developed through, a
collaboration with AWS using AWS GovCloud (US). The new platform
combines our advanced law enforcement simulator with secure cloud
services to automatically track training progress and provide the
ability to replay recorded training sessions. We plan to increase
marketing activities for our virtual reality solution as our
platform enhancements are introduced to market.
At December 31, 2021 we had backlog of approximately $268 thousand
expected to be delivered in the first quarter of 2022. We had
deferred revenue of $265 thousand expected to be recognized
generally over the next five years. Distributor and customer orders
for future deliveries are generally subject to modification,
rescheduling or in some instances, cancellation, in the normal
course of business.
During the second quarter of 2021, we began to wind down our
production line for the BolaWrap 100 product line and in the third
quarter completed a shift to a new production process for the next
generation BolaWrap 150 product, which required new tooling, new
production equipment and processes, and additional licensing. We
recorded $747 thousand of product line exit costs related to this
change in production activities in the second quarter.
Since inception in March 2016, we have generated significant losses
from operations and anticipate that we will continue to generate
significant losses from operations for the foreseeable future. We
believe that we have adequate financial resources to sustain our
operations for the next year.
We expect that we will need to continue to innovate new
applications for our public safety technology, develop new products
and technologies to meet diverse customer requirements and identify
and develop new markets for our products.
We have experienced recent changes in management. Changes in
management and other key personnel have the potential to disrupt
our business, and any such disruption could adversely affect our
operations, programs, growth, financial condition or results of
operations. In addition, new members of management may have
different perspectives regarding product development and
opportunities for our business, which may cause us to focus on new
business opportunities or reduce or change emphasis on our existing
products and business.
Impact of COVID-19 and Social Unrest on our Business
We continue to face significant challenges in operating and growing
our business related to the global impact of the novel coronavirus
(“COVID-19”). COVID-19 impact includes continued travel
restrictions, quarantines, “stay-at-home” and
“shelter-in-place” orders, shutdowns and slowdowns of certain
businesses around the world and impacts on supply chains and
logistics. The COVID-19 pandemic has resulted in a substantial
curtailment of business activities worldwide and is causing
weakened economic conditions, both in the United States and many
countries abroad. As part of intensifying efforts to contain the
spread of COVID-19, many companies and state, local and foreign
governments continue to impose restrictions, including
shelter-in-place orders and travel bans. While some of these
companies and jurisdictions have started to relax such
restrictions, in some cases, the restrictions are put back in place
after having been lifted. These factors negatively impacted our
operations and results of operations for 2020 and 2021. We expect
that the evolving COVID-19 pandemic, associated travel restrictions
and social distancing requirements, especially internationally, may
continue to have an adverse impact on our results of operations.
While the ultimate economic impact of the COVID-19 pandemic is
highly uncertain, we expect that our business and results of
operations, including our revenues, earnings and cash flows from
operations, will be adversely impacted during 2022, including as a
result of:
|
●
|
Delays in our ability to travel and train, especially
internationally;
|
|
●
|
Greater funding challenges for our customer base, which may
adversely affect timing of anticipated contracts and new customer
sales;
|
|
●
|
Disruption to our supply chain caused by distribution and other
logistical issues, which may further delay our ability to deliver
product to customers during and beyond 2022; and
|
|
●
|
Potential decrease in productivity of our employees or those of our
customers or suppliers due to travel bans or restrictions,
work-from-home or shelter-in-place policies and orders.
|
We also may be adversely affected by continued social unrest,
protests against police and movements such as “Defund the Police”.
These events may directly or indirectly affect police agency
budgets and funding available to current and potential customers.
Participants in these events may also attempt to create the
perception that our solutions are contributing to the perceived
problems or ineffective as a solution, which may adversely affect
us, our business and results of operations, including our revenues,
earnings and cash flows from operations.
It is currently not possible to predict the magnitude or duration
of the COVID-19 pandemic’s impact on our business or the future
impact of the recent, ongoing and possible future unrest. The
extent to which these events impact our business will depend on
numerous evolving factors that we may not be able to control or
accurately predict, including without limitation:
|
●
|
the duration and scope of the challenges created by the COVID-19
pandemic or by ongoing social unrest;
|
|
●
|
governmental, business and individuals’ actions that have been
and continue to be taken in response to these events;
|
|
●
|
the impact of the COVID-19 pandemic and social unrest on economic
activity and actions taken in response;
|
|
●
|
the effect on our customers and demand for our products and
services;
|
|
●
|
our ability to continue to sell and deliver our products and
services, including as a result of travel restrictions, logistic
and supply chain challenges, people working from home, or
restrictions on access to our potential customers;
|
|
●
|
the ability of our customers to pay for our products and
services;
|
|
●
|
any closures of our facilities and the facilities of our customers
and suppliers; and
|
|
●
|
the degree to which our employees or those of our customers or
suppliers become ill with COVID-19.
|
Critical Accounting Policies and Estimates
The preparation of financial statements in accordance with
accounting principles generally accepted in the United States
(“U.S. GAAP”) requires us to make estimates and judgments
that affect the reported amounts of assets, liabilities, revenue
and expense, and related disclosure of contingent assets and
liabilities. We evaluate our estimates, on an on-going basis,
including those estimates related to recognition and measurement of
contingencies and accrued expense. We base our estimates on
historical experience and on various other assumptions we believe
to be reasonable under the circumstances. Actual results may differ
from these estimates under different assumptions or conditions.
As part of the process of preparing our financial statements, we
are required to estimate our provision for income taxes.
Significant management judgment is required in determining our
provision for income taxes, deferred tax assets and liabilities,
tax contingencies, unrecognized tax benefits, and any required
valuation allowance, including taking into consideration the
probability of the tax contingencies being incurred. Management
assesses this probability based upon information provided by its
tax advisers, its legal advisers and similar tax cases. If later
our assessment of the probability of these tax contingencies
changes, our accrual for such tax uncertainties may increase or
decrease. Our effective tax rate for annual and interim reporting
periods could be impacted if uncertain tax positions that are not
recognized are settled at an amount which differs from our
estimates.
Some of our accounting policies require higher degrees of judgment
than others in their application. These include share-based
compensation and contingencies and areas such as revenue
recognition, allowance for doubtful accounts, valuation of
inventory and intangible assets, estimates of product line exit
costs, warranty liabilities and impairments.
Revenue Recognition. We sell our products to customers
including law enforcement agencies, domestic distributors and
international distributors and revenue from such transactions is
recognized in the periods that products are shipped (free on board
(“FOB”) shipping point) or received by customers (FOB
destination), when the fee is fixed or determinable and when
collection of resulting receivables is reasonably assured. We
identify customer performance obligations, determine the
transaction price, allocate the transaction price to the
performance obligations and recognize revenue as we satisfy the
performance obligations. Our primary performance obligations are
products/accessories and virtual reality software licensing or
sale. Our customers do not have the right to return product unless
the product is found to be defective.
Periodically, certain customers request bill and hold transactions
for future delivery as scheduled and designated by them. In such
cases, revenue is not recognized until after control, title and
risk of ownership has transferred which is generally when the
customer has requested such transaction under normal billing and
payment terms and has been notified that the product (i) has been
completed according to customer specifications, (ii) has passed
quality control inspections, and (iii) has been tagged and packed
for shipment, separated from other inventory and ready for physical
transfer to the customer. The value associated with custodial
storage services is deemed immaterial in the context of such
contracts and in total, and accordingly, none of the transaction
price is allocated to such service.
Share-Based Compensation. We follow the fair value
recognition provisions issued by the Financial Accounting Standards
Board (“FASB”) in Accounting Standards Codification
(“ASC”) Topic 718, Stock Compensation (“ASC 718”) and
we adopted Accounting Standards Update (“ASU”) 2018-07 for
share-based transactions with non-employees. Share-based
compensation expense recognized during 2020 and 2019 includes stock
option and restricted stock unit compensation expense. The grant
date fair value of stock options is determined using the
Black-Scholes option-pricing model. The grant date is the date at
which an employer and employee or non-employee reach a mutual
understanding of the key terms and conditions of a share-based
payment award. The Black-Scholes option-pricing model requires
inputs including the market price of the Company’s Common Stock on
the date of grant, the term that the stock options are expected to
be outstanding, the implied stock volatilities of several
publicly-traded peers over the expected term of stock options,
risk-free interest rate and expected dividend. Each of these inputs
is subjective and generally requires significant judgment to
determine. The grant date fair value of restricted stock units is
based upon the market price of the Company’s Common Stock on the
date of the grant. We determine the amount of share-based
compensation expense based on awards that we ultimately expect to
vest and account for forfeitures as they occur. The fair value of
share-based compensation is amortized to compensation expense over
the vesting term.
Allowance for Doubtful Accounts. Our products are sold to
customers in many different markets and geographic locations. We
estimate our bad debt reserve on a case-by-case basis and the aging
of accounts due to a limited number of customers mostly government
agencies or well-established distributors. We base these estimates
on many factors including customer credit worthiness, past
transaction history with the customer, current economic industry
trends and changes in customer payment terms. Our judgments and
estimates regarding collectability of accounts receivable have an
impact on our financial statements.
Valuation of Inventory. Our inventory is comprised of raw
materials, assemblies and finished products. We must periodically
make judgments and estimates regarding the future utility and
carrying value of our inventory. The carrying value of our
inventory is periodically reviewed and impairments, if any, are
recognized when the expected future benefit from our inventory is
less than carrying value.
Valuation of Intangible Assets. Intangible assets consisted
of (a) capitalized legal fees and filing expense related to
obtaining patents and trademarks, (b) customer agreements,
tradenames, software, non-solicitation and non-compete agreements
acquired in business combinations and valued at fair value at the
acquisition date, and (c) the purchase cost of indefinite-lived
website domains. We must make judgments and estimates regarding the
future utility and carrying value of intangible assets. The
carrying values of such assets are periodically reviewed and
impairments, if any, are recognized when the expected future
benefit to be derived from an individual intangible asset is less
than carrying value. This generally could occur when certain assets
are no longer consistent with our business strategy and whose
expected future value has decreased.
Exit Expense. Our product line exit expense included
estimates of end of product life raw material write offs, costs of
noncancelable raw material purchase orders and retirement of
unamortized production tooling costs. We make these estimates based
on current production plans and these judgments and estimates have
an impact on our financial statements.
Accrued Expense. We establish a warranty reserve based on
anticipated warranty claims at the time product revenue is
recognized. This reserve requires us to make estimates regarding
the amount and costs of warranty repairs we expect to make over a
period of time. Factors affecting warranty reserve levels include
the number of units sold, anticipated cost of warranty repairs, and
anticipated rates of warranty claims. We have very limited history
to make such estimates and warranty estimates have an impact on our
financial statements. Warranty expense is recorded in cost of
revenues. We evaluate the adequacy of this reserve each reporting
period.
We use the recognition criteria of ASC 450-20, “Loss Contingencies”
to estimate the amount of bonuses when it becomes probable a bonus
liability will be incurred and we recognize expense ratably over
the service period. We accrue bonus expense each quarter based on
estimated year-end results, and then adjust the actual in the
fourth quarter based on our final results compared to targets.
Historically, our assumptions, judgments and estimates relative to
our critical accounting policies have not differed materially from
actual results. Other than the planned production change requiring
a new estimate of exit expense, there were no significant changes
or modification of our critical accounting policies and estimates
involving management valuation adjustments affecting our results
for the period ended December 31, 2021.
Recent Accounting Pronouncements
New pronouncements issued for future implementation are discussed
in Note 1 to our financial statements.
Segment and Related Information
The Company operates as a single segment. The Company’s chief
operating decision maker is its Chief Executive Officer, who
manages operations for purposes of allocating resources. Refer to
Note 16, Major Customers and Related Information, in our financial
statements for further discussion.
Operating Expense
Our operating expense includes (i) selling, general and
administrative expense, and (ii) research and development expense.
Research and development expense is comprised of the costs incurred
in performing research and development activities and developing
production on our behalf, including compensation and consulting,
design and prototype costs, contract services, patent costs and
other outside expense. The scope and magnitude of our future
research and development expense is difficult to predict at this
time and will depend on elections made regarding research projects,
staffing levels and outside consulting and contract costs. The
future level of selling, general and administrative expense will be
dependent on staffing levels, elections regarding expenditures on
sales, marketing and customer training, the use of outside
resources, public company and regulatory costs, and other factors,
some of which are outside of our control.
We expect our operating costs will increase as we expand product
distribution activities and expand our research and development,
production, distribution, training, service and administrative
functions in the near term. We may also incur substantial non-cash
stock-based compensation costs depending on future option and
restricted stock unit grants that are impacted by stock prices and
other valuation factors. Historical expenditures are not indicative
of future expenditures.
Results of Operations
Year Ended December 31, 2021 Compared to Year Ended December
31, 2020
The following table and narrative sets forth for the periods
indicated certain items of our condensed statement of operations,
expressed in thousands of dollars. The financial information and
the discussion below should be read in conjunction with the
financial statements and notes contained in this Report.
|
|
Year Ended December 31,
|
|
|
Change
|
|
|
|
2021
|
|
|
2020
|
|
|
|
$ |
|
|
%
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
$ |
7,381 |
|
|
$ |
3,868 |
|
|
$ |
3,513 |
|
|
|
91 |
% |
Other revenue
|
|
|
348 |
|
|
|
76 |
|
|
|
272 |
|
|
|
358 |
% |
Total revenues
|
|
|
7,729 |
|
|
|
3,944 |
|
|
|
3,785 |
|
|
|
96 |
% |
Cost of revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products and services
|
|
|
4,987 |
|
|
|
2,601 |
|
|
|
2,386 |
|
|
|
92 |
% |
Product line exit expense
|
|
|
747 |
|
|
|
- |
|
|
|
747 |
|
|
|
- |
|
Total cost of revenues
|
|
|
5,734 |
|
|
|
2,601 |
|
|
|
3,133 |
|
|
|
120 |
% |
Gross profit
|
|
|
1,995 |
|
|
|
1,343 |
|
|
|
652 |
|
|
|
49 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
20,276 |
|
|
|
11,631 |
|
|
|
8,645 |
|
|
|
74 |
% |
Research and development
|
|
|
6,214 |
|
|
|
2,789 |
|
|
|
3,425 |
|
|
|
123 |
% |
Total operating expenses
|
|
|
26,490 |
|
|
|
14,420 |
|
|
|
12,070 |
|
|
|
84 |
% |
Loss from operations
|
|
$ |
(24,495 |
) |
|
$ |
(13,077 |
) |
|
$ |
(11,418 |
) |
|
|
87 |
% |
Revenue
We reported revenue of $7.7 million for the year ended December 31,
2021 (“Fiscal 2021”) as compared to revenue of $3.9 million
for the year ended December 31, 2020 ("Fiscal 2020"), a 96%
increase over the prior year. We believe our sales during Fiscal
2021 were negatively impacted by the COVID-19 pandemic as we were
limited in our ability to make product demonstrations and conduct
training especially in our international markets. We also believe
some customers delayed purchase decisions during the last quarter
of Fiscal 2021 in anticipation of the introduction of our
second-generation product, the BolaWrap 150. As some areas of the
United States eased restrictions, during Fiscal 2021, we were able
to commence limited in-person demonstrations and training to
supplement our webinar capabilities.
We incurred product promotional costs of $924 thousand for Fiscal
2021, related primarily to the cost of demonstration and training
products and accessories delivered to law enforcement agencies that
were expensed as marketing costs, as compared to $747 thousand for
Fiscal 2020. We are responding to increased demand for training as
a result of expanded product and brand awareness and increased
successful field use by agencies.
We had $265 thousand of deferred revenue at December 31, 2021, of
which $172 thousand related to virtual reality training and $67
thousand related to extended warranties.
At December 31, 2021, we had backlog of $268 thousand expected to
be delivered in the next twelve months. Distributor and customer
orders for future deliveries are generally subject to modification,
rescheduling or in some instance’s cancellation in the normal
course of business.
The impact of the COVID-19 pandemic and geopolitical conflicts,
including the recent war in Ukraine, has created much uncertainty
in the global marketplace, with the COVID-19 pandemic continuing to
restrict our ability to travel internationally and, to a more
limited extent, domestically. These conditions are expected to
continue at least through the first quarter of 2022. We are
therefore unable to predict at this time whether our sales will
continue to increase during fiscal year ending December 31, 2022 at
the same rate as the fiscal year ended December 31, 2021 due to
these uncertainties. Although no assurances can be given, we do
believe, however, that the challenges to substantially increasing
sales caused by COVID-19 will abate as the pandemic wanes,
especially given the number of BolaWrap trials currently ongoing
and the current environment where non-lethal options are being
widely considered by law enforcement domestically and
internationally. As a result, we believe that revenue during
the fiscal year 2022 will increase compared to the revenue recorded
during 2021, and this anticipated increase is likely to be
material, although no assurances can be given.
We have experienced recent changes in management. Changes in
management and other key personnel have the potential to disrupt
our business, and any such disruption could adversely affect our
revenue growth in future periods, especially in the near term as we
execute our Management Transition plan.
Gross Profit
Our cost of revenue for Fiscal 2021 was $5.7 million and included
$747 thousand of restructuring inventory charge. Excluding this
non-cash charge, the gross margin for Fiscal 2021 was 36%. Our cost
of revenue for Fiscal 2020 was $2.6 million resulting in a gross
margin of 34%. During the third quarter ended September 30, 2021,
we began production of our new generation BolaWrap 150 product with
different material inputs and manufacturing processes such that
historical margins may not be indicative of future margins. We have
limited warranty cost experience and estimated future warranty
costs can impact our gross margins.
Selling, General and
Administrative Expense
Selling, general and administrative (“SG&A”) expense
increased by $8.6 million during Fiscal 2021, when compared to
Fiscal 2020. The largest driver of this increase was related to an
increase of $2.6 million in share-based compensation, of which $1.5
million was for director compensation, and the remaining $1.1
million was related to incentive for management and employees.
We continue to invest in our marketing and promotion, which
augments the media attention we receive from external sources, such
as news broadcasts. During Fiscal 2021, we incurred increases of
$325 thousand related to public relations initiatives and $111
thousand related to digital marketing campaigns. Costs related to
advertising and promotional products remained flat from Fiscal
2020.
For Fiscal 2021, our public reporting expense increased by
$1.56 million. This includes $818 thousand in connection with
actions by a former executive officer/shareholder seeking changes
in the composition of our Board of Directors and candidates to
stand for election at the 2021 Annual Shareholders’ Meeting,
changes to the Executive Chairman position, and related matters.
There were no comparable costs in 2020. This matter was settled in
March 2021, and we do not expect additional costs.
Other SG&A expense increases included a $2.8 million increase
in cash compensation, recruiting and consultancy costs resulting
from our growth in personnel over the prior year. In addition, our
travel expense related to sales, demonstrations and training
increased by $523 thousand as a result of resumption of travel by
sales and training personnel. In the second and third quarters of
2020, we had virtually no travel due to the COVID-19 pandemic and
the various travel restrictions that were in place. Despite the
growth in 2021, we are still well below historical norms for our
travel expense but expect travel expense to increase as
international travel restrictions ease.
In 2022, we expect to monitor and control the amount of resources
we expend on the marketing and selling of our products, training
distributors and customers and administratively supporting our
operations to respond to increased opportunities, but amounts could
vary depending on sales levels, the impact of the COVID-19 pandemic
and other factors outside of our control. We expect increased
administrative costs due to costs associated with the Management
Transition but cannot estimate such costs at this time.
Research and Development
Expense
Research and development expense increased by $3.4 million for
Fiscal 2021, when compared to Fiscal 2020. We incurred a $518
thousand period over period increase in non-cash share-based
compensation expense allocated to research and development expense
as a result of new award grants and vesting timing. The increase in
costs during the Fiscal 2021 compared to the prior year included a
$758 thousand increase in cash compensation costs resulting from an
increase in headcount primarily associated with product
development. Outside consulting costs increased by $1.2 million and
prototype related costs increased by $570 thousand for Fiscal 2021,
primarily due to costs related to the new generation BolaWrap 150
product, initiatives to develop new products, and increased
development of virtual reality scenarios. We expect our research
and development costs to remain at current levels despite our plans
to increase personnel, as the increase in personnel costs is
expected to be offset by lower costs for outside resources due to
the substantial completion of BolaWrap 150 and a focus on
controlling spending on new research initiatives.
Net Loss
Loss from operations during Fiscal 2021 increased by $11.4 million
when compared to Fiscal 2020, resulting primarily from increased
share-based compensation and increased operating costs due to
increased personnel, marketing and selling, public company costs,
and supporting activities. We also incurred a one-time non-cash
product line exit expense of $747 thousand during the period that
we do not expect to recur.
Liquidity and Capital Resources
Overview
We have experienced net losses and negative cash flows from
operations since our inception. As of December 31, 2021, we had
cash and cash equivalents of $4.9 million, short-term investments
of $30 million, positive working capital of $38 million and had
sustained cumulative losses attributable to stockholders of $49.8
million. We believe that our cash on hand and short-term
investments will sustain our operations for at least the next
twelve months from the date of this Report.
During Fiscal 2021, we received $13.7 million of proceeds from the
exercise of previously issued stock purchase warrants and from the
exercise of stock options.
During Fiscal 2020, we received $11.7 million of net proceeds
resulting from the consummation of a registered offering of our
Common Stock in June 2020, $25.9 million of net proceeds from the
exercise of previously issued warrants and stock options and
obtained $414 thousand in proceeds from a loan issued under the
Paycheck Protection Act (the "PPP Loan") (See Note 10 to the
Consolidated Financial Statements of this Report).
Our primary source of liquidity to date has been funding from our
stockholders from the sale of equity securities and the exercise of
derivative securities, consisting of options and warrants. We
expect our primary source of future liquidity will be from the sale
of products, exercise of stock options and warrants and if required
from future equity or debt financings.
Capital Requirements
Due in part to the volatility caused by COVID-19, we do not have a
high degree of confidence in our estimates for our future liquidity
requirements or future capital needs, which will depend on, among
other things, capital required to grow product revenues and the
staffing and support requirements, as well as the timing and amount
of future revenue and product costs. We anticipate that demands for
operating and working capital may grow depending on decisions on
staffing, development, production, marketing, training and other
functions and based on other factors outside of our control. We
believe we have sufficient capital to sustain our operations for
the next twelve months.
Our future capital requirements, cash flows and results of
operations could be affected by, and will depend on, many factors,
some of which are currently unknown to us, including, among other
things:
|
●
|
The impact and effects of the global outbreak of the COVID-19
pandemic, and other potential pandemics or contagious diseases or
fear of such outbreaks, and geopolitical conflicts;
|
|
●
|
Decisions regarding staffing, development, production, marketing
and other functions;
|
|
●
|
The timing and extent of market acceptance of our products;
|
|
●
|
Costs, timing and outcome of planned production and required
customer and regulatory compliance of our products;
|
|
●
|
Costs of preparing, filing and prosecuting our patent applications
and defending any future intellectual property-related claims;
|
|
●
|
Costs and timing of additional product development;
|
|
●
|
Costs, timing and outcome of any future warranty claims or
litigation against us associated with any of our products;
|
|
●
|
Ability to collect accounts receivable; and
|
|
●
|
Timing and costs associated with any new financing.
|
Principal factors that could affect our ability to obtain cash from
external sources including from exercise of outstanding warrants
and options include:
|
●
|
Volatility in the capital markets; and
|
|
●
|
Market price and trading volume of our common stock.
|
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Cash Flow
Operating Activities
During Fiscal 2021, net cash used in operating activities was $18.2
million. The net loss of $24.4 million was decreased by
non-cash expense of $7.2 million, consisting primarily of
share-based compensation expense of $5.4 million, restructuring
inventory charges of $747 thousand, depreciation and amortization
expense of $478 thousand, and shares issued for services of $239
thousand. Other major component changes using operating cash
included an increase of $2.1 million in accounts receivable, and an
increase in prepaid expense of $109 thousand. A decrease in
inventories of $559 thousand, an increase in accounts payable and
accrued expense of $492 thousand, and an increase of $249
thousand in deferred revenue reduced the cash used in operating
activities.
During Fiscal 2020, net cash used in operating activities was $12.2
million. The net loss of $12.6 million was decreased by
non-cash expense of $2.1 million consisting primarily of
share-based compensation expense of $2.2 million less debt
forgiveness income of $417 thousand related to the PPP loan. Other
major component changes using operating cash included an increase
of $1.7 million in accounts receivable, an increase in inventories
of $343 thousand, a $342 thousand decrease in customer deposits and
a $508 thousand increase in prepaid expense and other current
assets. An increase of $825 thousand in accounts payable and an
increase of $493 thousand in accrued liabilities reduced the cash
used in operating activities.
Investing Activities
During Fiscal 2021, we used $55 million of cash to purchase
short-term investments and had proceeds from maturities of
short-term investments of $50 million.
During Fiscal 2020, we used $35 million of cash to purchase
short-term investments and we had proceeds from maturities of
short-term investments of $10 million.
We used $995 thousand and $249 thousand of cash for the purchase of
property and equipment during Fiscal 2021 and Fiscal 2020,
respectively. We invested $187 thousand and $129 thousand in
patents during Fiscal 2021 and Fiscal 2020, respectively. During
Fiscal 2020, we purchased $543 thousand of indefinite life
intangible assets and software and paid $210 thousand for the first
installment of the NSENA acquisition.
Financing Activities
During Fiscal 2021, we received $12 million from previously issued
stock purchase warrants, $1.7 million in proceeds from the exercise
of previously issued stock options and paid $275 thousand in debt
relating to the December 2020 acquisition of NSENA.
During Fiscal 2020, we received $11.7 million of net proceeds
resulting from a registered offering of our Common Stock in June
2020, $25.9 million of net proceeds from the exercise of previously
issued warrants and stock options and $414 thousand in proceeds
from a PPP Loan.
Contractual Obligations and Commitments
Pursuant to that certain exclusive Amended and Restated
Intellectual Property License Agreement dated September 30, 2016,
by and between the Company and Syzygy Licensing, LLC
(“Syzygy”), we are obligated to pay to Syzygy a 4% royalty
fee on future product sales up to an aggregate amount of $1.0
million in royalty payments or until September 30, 2026, whichever
occurs earlier.
In January 2022 we extended our facility lease for three years
through July 2025 and we are committed to aggregate lease payments
on the lease of $107 thousand in 2022, $121 thousand in 2023, $126
thousand in 2024 and $75 thousand in 2025.
At December 31, 2021 we were committed for approximately $1.5
million for future component deliveries and contract services that
are generally subject to modification or rescheduling in the normal
course of business.
On January 24, 2022, we announced a Management Transition plan and
entered into consulting agreements with LW Varner as our interim
CEO, and Lawrence Hirsch as our interim financial consultant.
Pursuant to the consulting agreements, unless earlier terminated,
we are obligated for aggregate consulting payments of $225 thousand
through April 17, 2022 and up to $75 thousand of share-based
compensation plus travel costs and expenses.
Effects of Inflation
We do not believe that inflation has had a material impact on our
business, revenue or operating results during the periods
presented.
Recent Accounting Pronouncements
There have been no recent accounting pronouncements or changes in
accounting pronouncements during the year ended December 31, 2021,
or subsequently thereto, that we believe are of potential
significance to our financial statements.
ITEM 7A. QUANTITATIVE AND
QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The Financial Statements of the Company required to be included in
this Item 8 are set forth in a separate section of this report
following Item 15 commencing on Page F-1.
ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
There have been no disagreements or any reportable events requiring
disclosure under Item 304(b) of Regulation S-K.
ITEM 9A. CONTROLS AND
PROCEDURES.
We are required to maintain disclosure controls and procedures
designed to ensure that material information related to us, is
recorded, processed, summarized and reported within the time
periods specified in the SEC rules and forms.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act) that are designed
to ensure that information required to be disclosed in our Exchange
Act reports is recorded, processed, summarized and reported within
the time periods specified in the SEC’s rules and forms. Our
disclosure controls and procedures are also designed to ensure that
information required to be disclosed in our Exchange Act reports is
accumulated and communicated to management, including our interim
Chief Executive Officer and Chief Financial Officer, to allow
timely decisions regarding required disclosures. In designing and
evaluating the disclosure controls and procedures, management
recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of
achieving the desired control objectives, and management is
required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures.
Our management, with the participation of our interim Chief
Executive Officer and Chief Financial Officer, evaluated the
effectiveness of our disclosure controls and procedures as of
December 31, 2021 and, based on this evaluation, our interim Chief
Executive Officer and Chief Financial Officer concluded that, as of
the end of the period covered by this report, our disclosure
controls and procedures were effective at the reasonable assurance
level.
Management’s Report on Internal Control Over Financial
Reporting
We are responsible for establishing and maintaining adequate
internal control over financial reporting (as defined in
Rule 13a-15(f) under the Exchange Act). Our internal control
over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes of GAAP.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Therefore, even those systems determined to be effective can
provide only reasonable assurance of achieving their control
objectives.
Management is responsible for establishing and maintaining adequate
internal control over financial reporting for the Company. With our
participation, an evaluation of the effectiveness of our internal
control over financial reporting was conducted as of December 31,
2021, based on the framework and criteria established in Internal
Control Integrated Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission. Based on this
evaluation, our interim Chief Executive Officer and Chief Financial
Officer concluded that our internal control over financial
reporting was effective as of December 31, 2021
This Annual Report does not include an attestation report of the
Company’s registered public accounting firm because the Company is
an “emerging growth company” under the JOBS Act. An attestation
report of the Company’s independent registered public accounting
firm regarding internal control over financial reporting is also
not required for smaller reporting companies.
Changes in Internal Controls
There have been no changes in our internal control over financial
reporting during the fiscal quarter ended December 31, 2021, that
have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting. Our process
for evaluating controls and procedures is continuous and
encompasses constant improvement of the design and effectiveness of
established controls and procedures and the remediation of any
deficiencies, which may be identified during this process.
ITEM 9B. OTHER
INFORMATION
None.
PART
III
Certain information required by this Part III is omitted from this
report and is incorporated by reference to our Definitive Proxy
Statement to be filed with the SEC in connection with the Annual
Meeting of Stockholders to be held in 2021 (the “Proxy
Statement”), which must be filed no later than 120 days after
the close of the fiscal year ended December 31, 2021, pursuant to
Regulation 14A.
ITEM 10. DIRECTORS, EXECUTIVE
OFFICERS AND CORPORATE GOVERNANCE.
The information required by this item will be incorporated by
reference from the Company’s definitive proxy statement, to be
filed with the SEC on or before April 30, 2022.
ITEM 11. EXECUTIVE
COMPENSATION.
The information required by this item will be incorporated by
reference from the Company’s definitive proxy statement, to be
filed with the SEC on or before April 30, 2022.
ITEM 12. SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS.
The information required by this item will be incorporated by
reference from the Company’s definitive proxy statement, to be
filed with the Securities and Exchange Commission on or before
April 30, 2022.
ITEM 13. CERTAIN RELATIONSHIPS
AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.
The information required by this item will be incorporated by
reference from the Company’s definitive proxy statement, to be
filed with the SEC on or before April 30, 2022.
ITEM 14. PRINCIPAL ACCOUNTING
FEES AND SERVICES.
The information required by this item will be incorporated by
reference from the Company’s definitive proxy statement, to be
filed with the SEC on or before April 30, 2022.
PART IV
ITEM 15. EXHIBITS AND FINANCIAL
STATEMENT SCHEDULES
Exhibit Number
|
Description
|
2.1
|
Stock Purchase Agreement, dated March 22, 2017, by and between Wrap
Technologies, LLC, Petro River Oil Corp., and Megawest Energy
Montana Corp. Incorporated by reference to Exhibit 2.1 to the
Registration Statement on Form S-1, filed on April 17, 2017.
|
2.2
|
Merger Agreement between Wrap Technologies, LLC and Megawest Energy
Montana Corp., dated March 30, 2017. Incorporated by reference to
Exhibit 2.2 to the Registration Statement on Form S-1, filed on
April 17, 2017.
|
3.1
|
Amended and Restated Certificate of Incorporation of the
Registrant. Incorporated by reference to Exhibit 3.1 to the
Registration Statement on Form S-1, filed on April 17, 2017.
|
3.2
|
Bylaws of the Registrant. Incorporated by reference to Exhibit 3.2
to the Registration Statement on Form S-1, filed on April 17,
2017.
|
4.1
|
Form of Common Stock Certificate. Incorporated by reference to
Exhibit 4.1 to Amendment No. 1 to the Registration Statement on
Form S-1, filed on May 30, 2017.
|
4.2
|
Form of Investor Warrant, dated October 30, 2018. Incorporated by
reference to Exhibit 4.1 to the Current Report on Form 8-K, filed
on November 5, 2018.
|
4.3
|
Form of Placement Agent Warrant, dated October 30, 2018.
Incorporated by reference to Exhibit 4.2 to the Current Report on
Form 8-K, filed on November 5, 2018.
|
4.4
|
Form of Investor Warrant, dated June 18, 2019. Incorporated by
reference to Exhibit 4.1 to the Current Report on Form 8-K, filed
on June 18, 2019.
|
4.5
|
Form of Offering Agent Warrant, dated June 18, 2019. Incorporated
by reference to Exhibit 4.1 to the Current Report on Form 8-K,
filed on June 18, 2019.
|
4.6
|
Form of Warrant Agreement. Incorporated by reference to Exhibit 4.2
to the Current Report on Form 8-K, filed on June 2, 2020.
|
10.1
|
Amended and Restated Intellectual Property License Agreement, dated
September 30, 2016, by and between Wrap Technologies, LLC and
Syzygy Licensing LLC. Incorporated by reference to Exhibit 10.1 to
the Registration Statement on Form S-1, filed on April 17,
2017.
|
10.2+
|
2017 Equity Compensation Plan. Incorporated by reference to Exhibit
10.2 to the Registration Statement on Form S-1, filed on April 17,
2017.
|
10.3
|
Form of Placement Agent Agreement, dated October 30, 2018.
Incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K, filed on November 5, 2018.
|
10.4
|
Form of Registration Rights Agreement, dated October 30, 2018.
Incorporated by reference to Exhibit 10.2 to the Current Report on
Form 8-K, filed on November 5, 2018.
|
10.5
|
Supplemental Engagement Letter by and between Wrap Technologies,
Inc. and Katalyst Securities LLC, dated June 7, 2019. Incorporated
by reference to Exhibit 10.1 to the Current Report on Form 8-K,
filed on June 13, 2019.
|
10.6
|
Engagement Letter by and between Wrap Technologies, Inc., Dinosaur
Financial Group, LLC and Katalyst Securities LLC, dated June 12 ,
2019. Incorporated by reference to Exhibit 10.2 to the Current
Report on Form 8-K, filed on June 18, 2019.
|
10.7
|
Amended 2017 Equity Compensation Plan. Incorporated by reference to
Exhibit 10.1 to the Registration Statement on Form S-8, filed on
June 24, 2019.
|
10.8
|
Industrial Real Estate Lease, dated May 10, 2019, by and between
Wrap Technologies, Inc. and JM Sky Harbor Properties LLC.
Incorporated by reference from Exhibit 10.1 to the Current Report
on Form 8-K, filed on June 6, 2019.
|
10.9
|
Promissory Note by and between Wrap Technologies, Inc. and Bank of
America, N.A. dated May 1, 2020. Incorporated by reference to
Exhibit 10.1 to the Current Report on Form 8-K, filed on May 5,
2020.
|
10.10
|
Consulting Agreement by and between the Company and V3, effective
April 1, 2020. Incorporated by reference to Exhibit 10.1 to the
Registration Statement on Form S-8, filed on May 29, 2020.
|
10.11
|
Amendment No. 2 to the Wrap Technologies, Inc. 2017 Equity
Compensation Plan. Incorporated by reference to Exhibit 10.1 to the
Registration Statement on Form S-8, filed on June 17, 2020.
|
10.12
|
Form of Subscription Agreement. Incorporated by reference to
Exhibit 10.1 to the Current Report on Form 8-K, filed on June 2,
2020.
|
10.13
|
Employment Agreement by and between Wrap Technologies, Inc., and
Marc T. Thomas, dated July 30, 2020. Incorporated by reference to
Exhibit 10.1 to the Current Report on Form 8-K, filed on July 31,
2020.
|
10.14
|
At-Will Employment, Confidential Information,
Non-Compete/Non-Solicitation, Invention Assignment, and Arbitration
Agreement, dated September 9, 2020 between the Company and Thomas
Smith. Incorporated by reference to Exhibit 10.1 to the Current
Report on Form 8-K, filed on September 14, 2020.
|
10.15
|
Asset Purchase Agreement between NSENA Inc. and Wrap Reality, Inc.
dated as of December 14, 2020. In accordance with the instructions
to Item 601(b)(2) of Regulation S-K, the schedules and exhibits to
the Asset Purchase Agreement are not filed
herewith. The Asset Purchase Agreement identifies
such schedules and exhibits, including the general nature of their
content. The Company undertakes to provide such
schedules and exhibits to the SEC upon request. Incorporated by
reference to Exhibit 2.1 to the Current Report on Form 8-K, filed
on September 14, 2020.
|
10.16
|
Form of At-Will Employment, Confidential Information, Non-Compete/
Non-Solicitation, Invention Assignment, and Arbitration Agreement
between the Key Employees and the Company dated December 14, 2020.
Incorporated by reference to Exhibit 2.2 to the Current Report on
Form 8-K, filed on September 14, 2020.
|
10.17
|
Cooperation Agreement by and between the Company and Elwood G.
Norris and certain of his affiliates dated March 4, 2021.
Incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K, filed on March 9, 2021.
|
10.18
|
Amendment No. 3 to the Wrap Technologies, Inc. 2017 Equity
Compensation Plan. Incorporated by reference to Exhibit 10.1 to the
Registration Statement on Form S-8, filed on November 5, 2021.
|
10.19 |
Separation Agreement between the Company and Mr. Smith, dated
January 24, 2022. Incorporated by reference to Exhibit 10.1
to the Current Report on Form 8-K, filed on January 26, 2022. |
10.20 |
Consulting Agreement between the Company and LWV Consulting, LLC,
dated January 24, 2022. Incorporated by reference to Exhibit
10.2 to the Current Report on Form 8-K, filed on January 26,
2022. |
10.21 |
Consulting Agreement between the Company and LRHIRSH, LLC, dated
January 24, 2022. Incorporated by reference to Exhibit 10.3 to the
Current Report on Form 8-K, filed on January 26, 2022. |
14.1
|
Code of Ethics of the Registrant Applicable to Directors, Officers
and Employees. Incorporated by reference to Exhibit 14.1 to the
Annual Report on Form 10-K, filed on March 4, 2021.
|
21.1
|
Subsidiaries of Wrap Technologies, Inc. Incorporated by reference
to Exhibit 21.1 to the Annual Report on Form 10-K, filed on March
4, 2021.
|
23.1
|
Consent of Independent Registered Public Accounting Firm -
Rosenberg Rich Baker Berman, P.A. *
|
31.1
|
Certification pursuant to Rule 13a-14(a) under the Securities
Exchange Act of 1934 *
|
31.2
|
Certification pursuant to Rule 13a-14(a) under the Securities
Exchange Act of 1934 *
|
32.1
|
Certifications pursuant to 18 U.S.C. Section 1350. This
certification is being furnished solely to accompany this Annual
Report on Form 10-K and is not being filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, and is not
to be incorporated by reference into any filing of the
Company.*
|
|
|
|
Extensible Business
Reporting Language (XBRL) Exhibits*
|
|
|
101.INS
|
Inline XBRL Instance Document - the instance document does not
appear in the Interactive Data File because its XBRL tags are
embedded within the Inline XBRL document
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL
Document and include in Exhibit 101)
|
* Filed concurrently herewith.
+ Management contract or compensatory plan or arrangement.
WRAP
TECHNOLOGIES, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Stockholders of Wrap Technologies, Inc.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Wrap
Technologies, Inc. (the “Company”) as of December 31, 2021, and
2020, and the related statements of operations and comprehensive
loss, stockholders’ equity, and cash flows for each of the years in
the two-year period ended December 31, 2021, and the related
notes (collectively referred to as the financial statements).
In our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of
December 31, 2021 and 2020, and the results of its operations and
its cash flows for each of the years in the two-year period ended
December 31, 2021, in conformity with accounting principles
generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting
Oversight Board (United States) (PCAOB) and are required to be
independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an
understanding of internal control over financial reporting, but not
for the purpose of expressing an opinion on the effectiveness of
the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis
for our opinion.
/s/ Rosenberg Rich Baker Berman, P.A.
|
|
|
We have served as the Company’s auditor since 2016.
|
|
|
Somerset, New Jersey
|
|
|
March 10, 2022
|
|
Wrap Technologies, Inc.
Consolidated Balance Sheets
(in thousands, except par value and share amounts)
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
4,937 |
|
|
$ |
16,647 |
|
Short-term investments
|
|
|
29,983 |
|
|
|
24,994 |
|
Accounts receivable, net
|
|
|
3,859 |
|
|
|
1,871 |
|
Inventories, net
|
|
|
1,566 |
|
|
|
2,655 |
|
Prepaid expenses and other current assets
|
|
|
868 |
|
|
|
760 |
|
Total current assets
|
|
|
41,213 |
|
|
|
46,927 |
|
Property and equipment, net
|
|
|
976 |
|
|
|
357 |
|
Operating lease right-of-use asset, net
|
|
|
51 |
|
|
|
139 |
|
Intangible assets, net
|
|
|
1,982 |
|
|
|
1,397 |
|
Other assets
|
|
|
9 |
|
|
|
13 |
|
Total assets
|
|
$ |
44,231 |
|
|
$ |
48,833 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
1,779 |
|
|
$ |
1,232 |
|
Accrued liabilities
|
|
|
824 |
|
|
|
721 |
|
Customer deposits
|
|
|
43 |
|
|
|
2 |
|
Deferred revenue- short term
|
|
|
155 |
|
|
|
16 |
|
Operating lease liability - short term
|
|
|
56 |
|
|
|
94 |
|
Business acquisition liability - short term
|
|
|
- |
|
|
|
275 |
|
Total current liabilities
|
|
|
2,857 |
|
|
|
2,340 |
|
|
|
|
|
|
|
|
|
|
Long-term liabilities:
|
|
|
|
|
|
|
|
|
Deferred revenue- long term
|
|
|
110 |
|
|
|
- |
|
Operating lease liability - long term
|
|
|
- |
|
|
|
56 |
|
Business acquisition liability - long term
|
|
|
- |
|
|
|
23 |
|
Total long-term liabilities
|
|
|
110 |
|
|
|
79 |
|
Total liabilities
|
|
|
2,967 |
|
|
|
2,419 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 13)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
Preferred stock - 5,000,000 authorized; par
value $0.0001 per share;
none issued
and outstanding
|
|
|
- |
|
|
|
- |
|
Common stock - 150,000,000 authorized;
par value $0.0001 per share;
40,851,945 and
37,554,162 shares issued
and outstanding each period, respectively
|
|
|
4 |
|
|
|
4 |
|
Additional paid-in capital
|
|
|
91,025 |
|
|
|
71,705 |
|
Accumulated deficit
|
|
|
(49,759 |
) |
|
|
(25,310 |
) |
Accumulated other comprehensive income (loss)
|
|
|
(6 |
) |
|
|
15 |
|
Total stockholders' equity
|
|
|
41,264 |
|
|
|
46,414 |
|
Total liabilities and stockholders' equity
|
|
$ |
44,231 |
|
|
$ |
48,833 |
|
See accompanying notes to consolidated financial statements.
Wrap
Technologies, Inc.
Consolidated Statements of Operations and Comprehensive
Loss
(in thousands, except share and per share amounts)
|
|
Year Ended December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Revenues:
|
|
|
|
|
|
|
|
|
Product sales
|
|
$ |
7,381 |
|
|
$ |
3,868 |
|
Other revenue
|
|
|
348 |
|
|
|
76 |
|
Total revenues
|
|
|
7,729 |
|
|
|
3,944 |
|
Cost of revenues
|
|
|
|
|
|
|
|
|
Products and services
|
|
|
4,987 |
|
|
|
2,601 |
|
Product line exit expense
|
|
|
747 |
|
|
|
- |
|
Total cost of revenues
|
|
|
5,734 |
|
|
|
2,601 |
|
Gross profit
|
|
|
1,995 |
|
|
|
1,343 |
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
20,276 |
|
|
|
11,631 |
|
Research and development
|
|
|
6,214 |
|
|
|
2,789 |
|
Total operating expenses
|
|
|
26,490 |
|
|
|
14,420 |
|
Loss from operations
|
|
|
(24,495 |
) |
|
|
(13,077 |
) |
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
Investment income
|
|
|
31 |
|
|
|
83 |
|
Debt forgiveness income
|
|
|
- |
|
|
|
417 |
|
Other
|
|
|
15 |
|
|
|
(3 |
) |
|
|
|
46 |
|
|
|
497 |
|
Net loss
|
|
$ |
(24,449 |
) |
|
$ |
(12,580 |
) |
|
|
|
|
|
|
|
|
|
Net loss per basic and diluted common share
|
|
$ |
(0.62 |
) |
|
$ |
(0.37 |
) |
Weighted average common shares used to compute net loss per basic
and diluted common share
|
|
|
39,281,620 |
|
|
|
33,846,338 |
|
|
|
|
|
|
|
|
|
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(24,449 |
) |
|
$ |
(12,580 |
) |
Net unrealized gain (loss) on short-term investments
|
|
|
(21 |
) |
|
|
15 |
|
Comprehensive loss
|
|
$ |
(24,470 |
) |
|
$ |
(12,565 |
) |
See accompanying notes to consolidated financial statements.
Wrap Technologies, Inc.
Consolidated Statements of Stockholders' Equity
(in thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
Other
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
|
|
|
|
Paid-In
|
|
|
Accumulated
|
|
|
Comprehensive
|
|
|
Stockholders'
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Income (Loss)
|
|
|
Equity
|
|
Balance at January 1, 2020
|
|
|
29,829,916 |
|
|
$ |
3 |
|
|
$ |
31,923 |
|
|
$ |
(12,730 |
) |
|
$ |
- |
|
|
$ |
19,196 |
|
Sale of Common Stock and warrants at $6.00 per share in public
offering, net of issuance costs
|
|
|
2,066,667 |
|
|
|
- |
|
|
|
11,667 |
|
|
|
- |
|
|
|
- |
|
|
|
11,667 |
|
Common shares issued upon exercise of warrants at $3.00 per share, net of issuance
costs
|
|
|
328,458 |
|
|
|
- |
|
|
|
961 |
|
|
|
- |
|
|
|
- |
|
|
|
961 |
|
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance
costs
|
|
|
3,890,839 |
|
|
|
1 |
|
|
|
18,718 |
|
|
|
- |
|
|
|
- |
|
|
|
18,719 |
|
Common shares issued upon exercise of warrants at $6.00 per share, net of issuance
costs
|
|
|
675,000 |
|
|
|
- |
|
|
|
3,848 |
|
|
|
- |
|
|
|
- |
|
|
|
3,848 |
|
Common shares issued upon exercise of warrants at $6.50 per share, net of issuance
costs
|
|
|
261,679 |
|
|
|
- |
|
|
|
1,646 |
|
|
|
- |
|
|
|
- |
|
|
|
1,646 |
|
Common shares issued upon exercise of stock options
|
|
|
371,000 |
|
|
|
- |
|
|
|
705 |
|
|
|
- |
|
|
|
- |
|
|
|
705 |
|
Common shares issued upon vesting of restricted stock units
|
|
|
130,603 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Share-based compensation expense
|
|
|
- |
|
|
|
- |
|
|
|
2,237 |
|
|
|
- |
|
|
|
- |
|
|
|
2,237 |
|
Net unrealized gain on short-term investments
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
15 |
|
|
|
15 |
|
Net loss for the period
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(12,580 |
) |
|
|
- |
|
|
|
(12,580 |
) |
Balance at December 31, 2020
|
|
|
37,554,162 |
|
|
$ |
4 |
|
|
$ |
71,705 |
|
|
$ |
(25,310 |
) |
|
$ |
15 |
|
|
$ |
46,414 |
|
Common shares issued upon exercise of warrants at $6.50 per share
|
|
|
1,661,320 |
|
|
|
- |
|
|
|
10,798 |
|
|
|
- |
|
|
|
- |
|
|
|
10,798 |
|
Common shares issued upon exercise of warrants at $8.125 per share
|
|
|
153,692 |
|
|
|
- |
|
|
|
1,249 |
|
|
|
- |
|
|
|
- |
|
|
|
1,249 |
|
Common shares issued upon exercise of stock options
|
|
|
915,404 |
|
|
|
- |
|
|
|
1,678 |
|
|
|
- |
|
|
|
- |
|
|
|
1,678 |
|
Common shares issued upon vesting of restricted stock units
|
|
|
524,491 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Common shares issued for services
|
|
|
42,876 |
|
|
|
- |
|
|
|
239 |
|
|
|
- |
|
|
|
- |
|
|
|
239 |
|
Share-based compensation expense
|
|
|
- |
|
|
|
- |
|
|
|
5,356 |
|
|
|
- |
|
|
|
- |
|
|
|
5,356 |
|
Net unrealized loss on short-term investments
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(21 |
) |
|
|
(21 |
) |
Net loss for the period
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(24,449 |
) |
|
|
- |
|
|
|
(24,449 |
) |
Balance at December 31, 2021
|
|
|
40,851,945 |
|
|
$ |
4 |
|
|
$ |
91,025 |
|
|
$ |
(49,759 |
) |
|
$ |
(6 |
) |
|
$ |
41,264 |
|
See accompanying notes to consolidated financial statements.
Wrap
Technologies, Inc.
Consolidated Statements of Cash Flows
(in thousands)
|
|
Year Ended December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(24,449 |
) |
|
$ |
(12,580 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
478 |
|
|
|
163 |
|
Share-based compensation
|
|
|
5,356 |
|
|
|
2,237 |
|
Common shares issued for services
|
|
|
239 |
|
|
|
- |
|
Product line exit expense
|
|
|
747 |
|
|
|
- |
|
Debt forgiveness income
|
|
|
- |
|
|
|
(417 |
) |
Gain on sale of assets
|
|
|
(27 |
) |
|
|
- |
|
Warranty provision
|
|
|
10 |
|
|
|
30 |
|
Inventory write-offs
|
|
|
- |
|
|
|
(68 |
) |
Software impairment charge
|
|
|
170 |
|
|
|
- |
|
Change in contingent liability
|
|
|
(23 |
) |
|
|
- |
|
Non-cash lease expense
|
|
|
88 |
|
|
|
122 |
|
Non-cash interest expense
|
|
|
- |
|
|
|
2 |
|
Provision for doubtful accounts
|
|
|
123 |
|
|
|
10 |
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(2,111 |
) |
|
|
(1,686 |
) |
Inventories
|
|
|
559 |
|
|
|
(343 |
) |
Prepaid expenses and other current assets
|
|
|
(109 |
) |
|
|
(508 |
) |
Accounts payable
|
|
|
546 |
|
|
|
825 |
|
Operating lease liability
|
|
|
(94 |
) |
|
|
(128 |
) |
Customer deposits
|
|
|
41 |
|
|
|
(342 |
) |
Accrued liabilities and other
|
|
|
(54 |
) |
|
|
493 |
|
Warranty settlement
|
|
|
38 |
|
|
|
4 |
|
Deferred revenue
|
|
|
249 |
|
|
|
(1 |
) |
Net cash used in operating activities
|
|
|
(18,223 |
) |
|
|
(12,187 |
) |
|
|
|
|
|
|
|
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
|
Purchase of short-term investments
|
|
|
(55,014 |
) |
|
|
(34,980 |
) |
Proceeds from maturities of short-term investments
|
|
|
50,005 |
|
|
|
10,000 |
|
Capital expenditures for property and equipment
|
|
|
(995 |
) |
|
|
(249 |
) |
Investment in patents and trademarks
|
|
|
(187 |
) |
|
|
(129 |
) |
Purchase of intangible assets
|
|
|
(750 |
) |
|
|
(543 |
) |
Business acquisition
|
|
|
- |
|
|
|
(210 |
) |
Proceeds from long-term deposits
|
|
|
4 |
|
|
|
- |
|
Net cash used in investing activities
|
|
|
(6,937 |
) |
|
|
(26,111 |
) |
|
|
|
|
|
|
|
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
|
Sale of common stock and warrants
|
|
|
- |
|
|
|
12,400 |
|
Offering costs paid on sale of common stock and warrants
|
|
|
- |
|
|
|
(733 |
) |
Proceeds from exercise of warrants
|
|
|
12,047 |
|
|
|
26,191 |
|
Offering costs paid on exercise of warrants
|
|
|
- |
|
|
|
(1,016 |
) |
Proceeds from exercise of stock options
|
|
|
1,678 |
|
|
|
705 |
|
Proceeds from bank note
|
|
|
- |
|
|
|
414 |
|
Repayment of debt
|
|
|
(275 |
) |
|
|
- |
|
Net cash provided by financing activities
|
|
|
13,450 |
|
|
|
37,961 |
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents
|
|
|
(11,710 |
) |
|
|
(337 |
) |
Cash and cash equivalents, beginning of period
|
|
|
16,647 |
|
|
|
16,984 |
|
Cash and cash equivalents, end of period
|
|
$ |
4,937 |
|
|
$ |
16,647 |
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosure of Non-Cash Investing
|
|
|
|
|
|
|
|
|
and Financing Activities:
|
|
|
|
|
|
|
|
|
Business acquisition liability
|
|
$ |
- |
|
|
$ |
298 |
|
Business acquisition cost in deferred revenue
|
|
$ |
- |
|
|
$ |
15 |
|
Change in unrealized gain on short-term investments
|
|
$ |
(21 |
) |
|
$ |
15 |
|
See accompanying notes to consolidated financial statements.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
1.
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Organization and Business
Description
Wrap Technologies, Inc., a Delaware corporation (the
“Company”, “we”, “us”, and “our”), is a
publicly traded company with our Common Stock, par value $0.0001
per share (“Common Stock”), listed on the Nasdaq Capital
Market (“Nasdaq”) under the trading symbol “WRAP”. The
Company is a developer and supplier of public safety products and
training services for law enforcement and security personnel. The
Company’s primary product is the BolaWrap® remote restraint device.
The principal markets for the Company’s proprietary products and
services are in North and South America, Europe, Middle East and
Asia.
Principles of
Consolidation
The Company has one wholly-owned subsidiary, Wrap Reality, Inc.
formed in December 2020 (see Note
3) that sells a virtual reality
training system primarily targeting law enforcement agencies. The
consolidated financial statements include the accounts of this
subsidiary after elimination of intercompany transactions and
accounts.
Basis of Presentation and
Use of Estimates
The accompanying financial statements have been prepared in
conformity with accounting principles generally accepted in the
United States of America (“U.S. GAAP”). The preparation of
financial statements in conformity with accounting principles
generally accepted in the United States of America requires
management to make estimates and assumptions (e.g., share-based
compensation valuation, allowance for doubtful accounts, valuation
of inventory and intangible assets, warranty reserve, accrued
costs, valuation allowance related to deferred tax assets and
recognition and measurement of contingencies) that affect the
reported amounts of assets and liabilities, and disclosure of
contingent assets and liabilities at the date of the financial
statements and affect the reported amounts of revenues and expenses
during the reporting period. Actual results could materially differ
from those estimates
.
Concentrations of
Risk
Credit Risk – Financial instruments that potentially subject
the Company to concentration of credit risk consisted primarily of
cash, cash equivalents, U.S. treasury bills and accounts receivable
from customers. The Company maintains its cash and cash equivalent
deposits at two domestic financial
institutions. The Company is exposed to credit risk in the event of
default by a financial institution to the extent that cash and cash
equivalents are in excess of the amount insured by the Federal
Deposit Insurance Corporation. The Company places its cash and cash
equivalents with high-credit quality financial institutions and are
managed within established guidelines to mitigate risks. To date,
the Company has not experienced any
losses on its cash and cash equivalents.
Concentrations of Accounts Receivable and Revenue – The
Company has a limited number of domestic and international
customers. The Company may
experience concentrations in both accounts receivable and revenue
due to the timing of sales and collections of related payments (see
Note 16).
Concentration of Suppliers – The Company assembles its
BolaWrap products in-house using components and subassemblies from
a limited number of suppliers and contract suppliers. In
particular, a single supplier is currently the sole manufacturer of
the BolaWrap battery assembly and another single supplier is the
sole manufacturer of the propulsion component for BolaWrap
cassettes. Other parts are sole sourced from other suppliers. If
supplier shortages or logistic delays occur, or quality problems
arise, production schedules could be significantly delayed or costs
significantly increased, which could in turn have a material
adverse effect on the Company’s financial condition, results of
operation and cash flows.
Impact of COVID-19 – In December 2019, a novel strain of coronavirus
(“COVID-19”) emerged
in China. In March 2020, the World
Health Organization declared the outbreak as a pandemic. The extent
to which the coronavirus impacts our operations will continue to
depend on future developments, which are highly uncertain and
cannot be predicted with confidence, including the duration of the
outbreak, new information which may
emerge concerning the severity of the coronavirus and the actions
to contain the coronavirus or treat its impact, among others. In
particular, the continued spread of the coronavirus globally and
emergence of new strains could adversely impact our operations,
including our manufacturing, logistics and supply chain. Our
operations could be negatively affected if employees are
quarantined as the result of exposure to a contagious illness.
Similarly, travel restrictions resulting from the rapid spread of
contagious illnesses may have a
material adverse effect on our business and results of
operations.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Cash and Cash
Equivalents
The Company considers all highly liquid investments purchased with
original maturities of three months
or less from the purchase date to be cash equivalents. Cash
equivalents consist primarily of amounts invested in Money Market
Funds and United States (“U.S.”) Treasury bills and are
stated at fair value.
Short-Term
Investments
The Company’s short-term investments consist of U.S. Treasury bills
with original maturities beyond three months at the date of purchase and
one year or less from the balance
sheet date. As of December 31,
2021, all of the Company’s short-term investments were
classified as available-for-sale and are carried at estimated fair
value with any unrealized gains and losses, unrelated to credit
loss factors, included in other comprehensive income in our
consolidated statements of stockholders’ equity.
We adopted Accounting Standards Codification
(“ASC”) Topic 326
issued by the Financial Accounting Standards Board
(“FASB”) effective January
1, 2020, and applied the credit loss guidance related to
short-term investments prospectively as we had no historical short-term investments. Because
we do not have any history of
losses for our short-term investments, our expected loss allowance
methodology is developed using published or estimated credit
default rates for similar investments and current and future
economic and market conditions. Any unrealized losses related
to credit loss factors are recorded through an allowance for credit
losses in other (expense) income, in our consolidated statements of
operations, rather than as a reduction to the amortized cost basis
in other comprehensive (loss) income, when a decline in fair value
has resulted from a credit loss. We determine realized gains or
losses on the sale of investments on a specific identification
method, and record such gains or losses as other (expense) income,
in our consolidated statements of operations. We did
not record a credit loss
reserve for short-term investments during the years ended
December 31, 2021 and 2020.
Share-Based
Compensation
The Company follows the fair value recognition provisions issued by
the FASB in ASC Topic 718, Stock
Compensation (“ASC 718”) and
has adopted Accounting Standards Update (“ASU”) 2018-07 for
share-based transactions with non-employees. Share-based
compensation expense recognized during 2021 and 2020
includes stock option and restricted stock unit compensation
expense. The grant date fair value of stock options is determined
using the Black-Scholes option-pricing model. The grant date is the
date at which an employer and employee or non-employee reach a
mutual understanding of the key terms and conditions of a
share-based payment award. The Black-Scholes option-pricing model
requires inputs including the market price of the Company’s Common
Stock on the date of grant, the term that the stock options are
expected to be outstanding, the implied stock volatilities of
several publicly-traded peers over the expected term of stock
options, risk-free interest rate and expected dividend. Each of
these inputs is subjective and generally requires significant
judgment to determine. The grant date fair value of restricted
stock units is based upon the market price of the Company’s Common
Stock on the date of the grant. We determine the amount of
share-based compensation expense based on awards that we ultimately
expect to vest and account for forfeitures as they occur. The
fair value of share-based compensation is amortized to compensation
expense over the vesting term.
Loss per Share
Basic loss per common share is computed by dividing net loss for
the period by the weighted-average number of shares of Common Stock
outstanding during the period. Diluted net loss per common share
reflects the potential dilution of securities that could share in
the earnings of an entity. The Company’s losses for the periods
presented cause the inclusion of potential Common Stock instruments
outstanding to be antidilutive. Stock options, restricted stock
units and warrants exercisable or issuable for a total of 5,596,853
and 7,566,502 shares of Common Stock were outstanding at December 31, 2021 and 2020, respectively. These securities are
not included in the computation of
diluted net loss per common share for the periods presented as
their inclusion would be antidilutive due to losses incurred by the
Company.
Accounts Receivable and
Allowance for Credit Losses
ASU No. 2016-13, Financial Instruments - Credit
Losses (Topic 326) requires
that financial assets measured at amortized cost be presented at
the net amount expected to be collected. The expected credit losses
are developed using an estimated loss rate method that considers
historical collection experience, current conditions, and
reasonable and supportable forecasts that affect the collectability
of the reported amount. The estimated loss rates are applied to
accounts receivables with similar risk characteristics such as the
length of time the balance has been outstanding and the location of
the customer. In certain instances, the Company may identify individual accounts receivable
assets that do not share risk
characteristics with other accounts receivables, in which case the
Company records its expected credit losses on an individual asset
basis. If an accounts receivable asset is evaluated on an
individual basis, the Company excludes those assets from the
portfolios of accounts receivables evaluated on a collective
basis.
At December 31, 2021 and 2020, the Company had an allowance for credit
losses related to accounts receivable of $134 and $10,
respectively. If a major customer’s creditworthiness deteriorates,
or actual defaults exceed our historical experience, such estimates
could change and impact our future reported financial results.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Inventories
Inventories are valued at the lower of cost or net realizable
value. The cost of substantially all the Company’s inventory is
determined by the FIFO cost method. Inventory is comprised of raw
materials, assemblies and finished products intended for sale to
customers. The Company evaluates the need for reserves for
excess and obsolete inventories determined primarily based upon
estimates of future demand for the Company’s products.
At December 31, 2021 and 2020 the Company had no reserve for obsolescence.
Property, Equipment and
Depreciation
Property and equipment is stated at cost. Depreciation on property
and equipment is computed over the estimated useful lives of
three years using the
straight-line method. On any retirement or disposition of property
and equipment, the related cost and accumulated depreciation or
amortization is removed and a gain or loss recorded.
Business
Combinations
Transactions in which the Company obtains control of a business are
accounted for according to the acquisition method as described in
ASC 805, Business
Combinations. The assets acquired and liabilities assumed are
recognized and measured at their fair values as of the date control
is obtained. The Company measures goodwill as the excess of
consideration transferred, which the Company also measures at fair
value, over the net of the acquisition date amounts of the
identifiable assets acquired and liabilities assumed. Acquisition
related costs in connection with a business combination are
expensed as incurred. Contingent consideration is recognized and
measured at fair value at the acquisition date and until paid is
re-measured on a recurring basis and classified as a liability.
Intangible
Assets
Intangible assets consisted of (a) capitalized legal fees and
filing costs related to obtaining patents and trademarks, (b)
customer agreements, tradenames, software, non-solicitation and
non-compete agreements acquired in business combinations and valued
at fair value at the acquisition date, (c) purchased software, and
(d) the purchase cost of indefinite-lived website domains. The
estimated useful lives of identifiable intangible assets with
definite useful lives have been estimated to be between
one and twenty years. Purchased website
domain costs with an indefinite useful life are not subject to amortization, but are subject
to an annual impairment test, by comparing their carrying amount
with their corresponding fair value. For any given intangible asset
with an indefinite useful life, if its fair value exceeds its
carrying amount no impairment loss
shall be recognized.
The carrying value of intangibles is periodically reviewed and
impairments, if any, are recognized when the future undiscounted
cash flows realized from the assets is less than its carrying
value.
Impairment of Long-Lived
Assets
Long-lived assets and identifiable intangibles held for use are
reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be
recoverable. If the sum of undiscounted expected future cash flows
is less than the carrying amount of the asset or if changes in
facts and circumstances indicate, an impairment loss is recognized
and measured using the asset’s fair value. An impairment charge of
$170 for purchased software was recorded in 2021. The Company did not recognize any other
impairment loss during the years ended December 31, 2021 and 2020.
Classification and
Valuation of Warrants
The Company accounts for warrants as either equity or liabilities
based upon the characteristics and provisions of each particular
instrument. Warrants valued and classified as equity are recorded
as additional paid-in capital based on the issue date fair value
and no further adjustment to
valuation is made. As of December 31,
2021, the Company has no
warrants or other derivative financial instruments that require
separate accounting as liabilities and periodic revaluation.
Advertising and Promotion
Costs
Advertising costs are charged to expense as incurred and were $145
and $287 for the years ended December 31, 2021 and
2020, respectively. The Company
also incurred product promotion costs for demonstration products
delivered to prospective customers of $924 and $747 for the years
ended December 31, 2021 and
2020, respectively. Advertising and
promotion costs are included in selling, general and administrative
expenses in the accompanying statements of operations.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Demonstration and
Training Costs
The Company maintains a demonstration and training department as a
part of its sales and marketing activities and does not charge for product demonstrations or
training. Training is not a
condition or requirement of sale as most sales are made through
distributors to their end customers. The Company conducts local and
regional in-person, webinar and on-line demonstrations and use of
force and escalation training to support law enforcement agencies
with no purchase requirement. Such
training, when provided, may occur
before or after initial or subsequent purchase or field deployment
of the Company’s products. The Company believes that law
enforcement trainers and officers that have seen demonstrations or
have been trained about its products are more supportive of their
departments purchase and deployment of product.
Research and Development
Costs
Research and development costs are expensed as incurred.
Contract
Manufacturers
The Company employs contract manufacturers for production of
certain components and sub-assemblies. The Company may provide parts and components to such
parties from time to time but recognizes no revenue or markup on such
transactions.
Leases
The Company adopted ASC Topic 842,
Leases (“Topic 842”) on January 1, 2019. In accordance with the
guidance in Topic 842, the Company
recognizes lease liabilities and corresponding right-of-use-assets
for all leases with terms of greater than 12 months. Leases with a term of 12 months or less will be accounted for in a
manner similar to the guidance for operating leases prior to the
adoption of Topic 842. Refer to
Note 9, Leases for more
information.
Revenue
Recognition
In May 2014, the FASB issued ASU
2014-09, Revenue from Contracts with Customers
(“ASU 2014-09”) and ASC Subtopic 340-40, Other
Assets and Deferred Costs - Contracts with Customers (“ASC
340-40”), (collectively, “Topic 606”). On January 1, 2018, the Company adopted Topic
606 and, as it had no prior revenue or contracts with customers,
there was no transition required
nor any impact on prior results. ASU 2014-09
requires entities to recognize revenue through the application of a
five-step model, which includes
identification of the contract, identification of the performance
obligations, determination of the transaction price, allocation of
the transaction price to the performance obligations and
recognition of revenue as the entity satisfies the performance
obligations. See Note 2 for
additional information.
Shipping and Handling
Costs
Shipping and handling costs are included in cost of revenues.
Shipping and handling costs invoiced to customers are included in
revenue. Actual shipping and handling costs were $167 and $75 for
the years ended December 31, 2021
and 2020, respectively. Actual
revenues from shipping and handling were $88 and $63 for the years
ended December 31, 2021 and
2020, respectively.
Exit Activity
Expense
During 2021 the Company recorded
$747 of product line exit costs related to the wind down and
closure of the BolaWrap 100 product
line related to a shift in production efforts to a new BolaWrap
150 generation product requiring
new tooling, new production equipment and processes and additional
licensing. These non-cash inventory costs included end of life raw
material write offs of $641 and tooling retirement costs of
$106.
The $747 of exit costs were recorded as a component of cost of
revenues. There was no such expense recorded during the prior year.
Development and start-up expense of new products are expensed as
incurred except for capitalized equipment and tooling.
Warranty
Reserves
The Company warrants its products and accessories to be free from
defects in materials and workmanship for a period of one year from the date of purchase. The
warranty is generally limited. The Company currently provides
direct warranty service. International market warranties are
generally similar to the U.S. market.
The Company establishes a warranty reserve based on anticipated
warranty claims at the time product revenues are recognized.
Factors affecting warranty reserve levels include the number of
units sold, anticipated cost of warranty repairs and anticipated
rates of warranty claims. The Company evaluates the adequacy of the
provision for warranty costs each reporting period. The warranty
reserve was $96 and $48 at December 31,
2021 and 2020. Actual warranty
costs could differ from estimates.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Segment
Information
ASC Topic 280, “Segment Reporting,”
requires use of the “management approach” model for segment
reporting. The management approach model is based on the way a
company’s management organizes segments within the company for
making operating decisions and assessing performance. The Company
operates as a single segment and will evaluate additional segment
disclosure requirements as it expands its operations.
Income Taxes
No income tax expense was recorded
for the periods ended December 31,
2021 and 2020 due to losses
incurred. Deferred tax assets and liabilities are determined based
on temporary differences between the bases of certain assets and
liabilities for income tax and financial reporting purposes.
The Company maintains a valuation allowance with respect to
deferred tax assets. The Company establishes a valuation allowance
based upon the potential likelihood of realizing the deferred tax
asset and taking into consideration the Company’s financial
position and results of operations for the current period. Future
realization of the deferred tax benefit depends on the existence of
sufficient taxable income within the carry-forward period under the
Federal tax laws. Changes in circumstances, such as the Company
generating taxable income, could cause a change in judgment about
the realizability of the related deferred tax asset. Any change in
the valuation allowance will be included in income in the year of
the change in estimates.
Recently Issued
Accounting Guidance
Adopted First Quarter of 2021:
In December 2019, the
FASB issued ASU 2019-12, Income
Taxes (Topic 740):
Simplifying the Accounting for Income
Taxes (“ASU 2019-12”), which is intended to simplify
various aspects related to accounting for income taxes.
ASU 2019-12 removes certain exceptions to the
general principles in Topic 740 and also clarifies and amends existing
guidance to improve consistent application. We adopted
ASU 2019-12 in the first quarter ended March 31, 2021 and it did not have a significant impact on our
financial statements.
Other Pronouncements:
In August 2020, the FASB issued ASU
2020-06, Debt—Debt with Conversion
and Other Options (“Subtopic 470-20”) and Derivatives and
Hedging—Contracts in Entity’s Own Equity
“(Subtopic 815-40”): Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity,
which simplifies accounting for convertible instruments by removing
major separation models required under current U.S. GAAP. The ASU
removes certain settlement conditions that are required for equity
contracts to qualify for the derivative scope exception and it also
simplifies the diluted earnings per share calculation in certain
areas. This guidance is effective for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2021, with early adoption
permitted. The Company is currently evaluating the impact of this
standard on its financial statements and related disclosures.
In May 2021, the FASB issued ASU
No. 2021-05, Leases (Topic 842), Lessors - Certain Leases with Variable
Lease Payments. This ASU addresses an issue related to a lessor's
accounting for certain leases with variable lease payments. The
amendments in this Update affect lessors with lease contracts that
(1) have variable lease payments
that do not depend on a reference
index or a rate and (2) would have
resulted in the recognition of a selling loss at lease commencement
if classified as a sales-type lease or a direct financing lease.
For public business entities, the amendments in this Update are
effective for fiscal years, and interim periods within those fiscal
years, beginning after December 15,
2021. The Company does not
expect that the adoption of this standard will have a material
effect on the Company’s consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-08 (“ASU No.
2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and
Contract Liabilities from Contracts with Customers, to require that
an acquirer recognize and measure contract assets and contract
liabilities acquired in a business combination in accordance with
Topic 606, Revenue from Contracts
with Customers. At the acquisition date, an acquirer should account
for the related revenue contracts in accordance with Topic
606 as if it had originated the
contracts. The amendments in this update should be applied
prospectively and are effective for fiscal years beginning after
December 15, 2022, including
interim periods within those fiscal years. We do not expect the adoption of this standard to
have a material impact on our consolidated financial statements and
related disclosures.
The Company has reviewed other recently issued, but not yet effective, accounting pronouncements
and does not believe the future
adoptions of any such pronouncements will be expected to cause a
material impact on its financial condition or the results of
operations.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
2. REVENUE AND PRODUCT
COSTS
On January 1, 2018, the Company
adopted FASB ASC Topic 606, Revenue
from contracts with customers (“Topic 606”) and, as it had no prior revenue or contracts with customers,
there was no transition required
nor any impact on prior results. Topic 606 requires entities to recognize revenue
through the application of a five-step model, which includes
identification of the contract, identification of the performance
obligations, determination of the transaction price, allocation of
the transaction price to the performance obligations and
recognition of revenue as the entity satisfies the performance
obligations.
The Company enters into contracts that include various combinations
of products, accessories, software and services, each of which are
generally distinct and are accounted for as separate performance
obligations.
A performance obligation is a promise in a contract to transfer a
distinct good or service to a customer, and is the unit of account
in Topic 606. For contracts with a
single performance obligation, the entire transaction price is
allocated to the single performance obligation. For contracts with
multiple performance obligations, the Company allocates the
contract transaction price to each performance obligation using the
Company’s estimate of the standalone selling price (“SSP” or
“SSPs”) of each distinct good or service in a contract. The
Company determines SSPs based on the relative SSP. If the SSP is
not observable through past
transactions, the Company estimates the SSP considering available
information such as market conditions and internally approved
pricing guidelines related to the performance obligations.
Most of the Company’s products and accessories are sold through
domestic and international distributors. Performance obligations to
deliver products and accessories are generally satisfied at the
point in time the Company ships the product, as this is when the
customer obtains control of the asset under our standard terms and
conditions. Periodically, certain customers request bill and
hold transactions for future delivery as scheduled and designated
by them. In such cases, revenue is not recognized until after control, title and
risk of ownership has transferred which is generally when the
customer has requested such transaction under normal billing and
payment terms and has been notified that the product (i) has been
completed according to customer specifications, (ii) has passed
quality control inspections, and (iii) has been tagged and packed
for shipment, separated from other inventory and ready for physical
transfer to the customer. The value associated with custodial
storage services is deemed immaterial in the context of such
contracts and in total, and accordingly, none of the transaction price is allocated to
such service.
The Company has elected to recognize shipping costs as an expense
in cost of revenue when control has transferred to the
customer.
Time-based virtual reality system contracts generally include
setup, training and the use of software and hardware for a fixed
term, generally one to five years and support and upgrade services
during the same period. The Company does not sell time-based arrangements without
setup, training and support services and therefore revenues for the
entire arrangement are recognized on a straight-line basis over the
term. When hardware is bundled and not sold separately the Company allocates the
contract transaction price to each performance obligation using the
SSP of each distinct good and service in the contract.
The timing of revenue recognition may differ from the timing of invoicing to
customers. The Company generally has an unconditional right to
consideration when customers are invoiced and a receivable is
recorded. A contract asset is recognized when revenue is recognized
prior to invoicing, or a contract liability (deferred revenue) when
revenue will be recognized subsequent to invoicing. At December 31, 2021 the Company’s deferred
revenue totaled $265 including $172 related to virtual reality
training and $67 related to extended warranties. At December 31, 2020 the Company’s deferred
revenue totaled $16, of which $14 related to virtual reality
training and $2 related to extended warranties.
The Company may also receive
consideration, per terms of a contract, from customers prior to
transferring goods to the customer. The Company records customer
deposits as a contract liability.
The Company recognizes an asset if there are incremental costs of
obtaining a contract with a customer such as commissions. These
costs are ascribed to or allocated to the underlying performance
obligations in the contract and amortized consistent with the
recognition timing of the revenue for any such underlying
performance obligations. The Company had no such assets at
December 31, 2021 and December 31, 2020. The Company will apply the
practical expedient to expense any sales commissions related to
performance obligations with an amortization of one year or less when incurred within
selling, general and administrative expense.
Estimated costs for the Company’s standard one-year warranty are charged to cost of
products sold when revenue is recorded for the related product.
Royalties are also charged to cost of products sold.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
On December 14, 2020, the Company,
through a new wholly-owned subsidiary, Wrap Reality, Inc., entered
into an Asset Purchase Agreement with NSENA Inc, a Delaware
corporation, to acquire all of NSENA’s tangible and intangible
assets, properties, and rights held for use in connection
with NSENA’s virtual reality training business. The
acquisition enhances the Company’s training services primarily
targeting law enforcement agencies.
The Company paid to NSENA cash consideration of $210 and recorded a
short-term business acquisition liability of $275. The liability
was paid $100 by March 15, 2021,
$100 by June 15, 2021 and $75 by
September 15, 2021. In addition,
the Company assumed a $15 liability for unearned revenues. As
additional earn-out consideration, the Company agreed to pay NSENA
contingent revenue-based consideration based on certain specific
prospects that became customers before September 30, 2021. The fair value of the
contingent consideration was determined as a $23 additional
business acquisition liability but was revalued to $0 in the
third quarter of 2021 resulting in a $23 gain included in
other income.
The acquisition was accounted for under the acquisition method of
accounting. Under acquisition accounting, the acquired tangible and
intangible assets and liabilities of NSENA were recorded at their
respective fair values. The following table summarizes the
estimates of fair value of the assets acquired and liabilities
assumed on December 14, 2020:
Equipment
|
|
$ |
10 |
|
Software
|
|
|
460 |
|
Customer contracts
|
|
|
40 |
|
Tradenames
|
|
|
2 |
|
Noncompete agreements
|
|
|
10 |
|
Deferred revenue
|
|
|
(15 |
) |
Total consideration
|
|
$ |
507 |
|
A portion of the fair value of the consideration transferred was
assigned to identifiable intangible assets as follows:
Description
|
|
Useful life in years
|
|
|
Fair Value
|
|
Software
|
|
|
5 |
|
|
$ |
460 |
|
Customer contracts
|
|
|
1 |
|
|
|
40 |
|
Tradenames
|
|
|
1 |
|
|
|
2 |
|
Noncompete agreements
|
|
|
2 |
|
|
|
10 |
|
Total acquired intangible assets
|
|
|
|
|
|
$ |
512 |
|
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
All assets acquired were determined to be finite-lived intangible
assets and are being amortized on a straight-line basis over their
estimated useful life with no residual value.
Assets and liabilities recorded at fair value on a recurring basis
in the Consolidated Balance Sheets and assets and liabilities
measured at fair value on a non-recurring basis or disclosed at
fair value, are categorized based upon the level of judgment
associated with inputs used to measure their fair values. The
accounting guidance for fair value provides a framework for
measuring fair value and requires certain disclosures about how
fair value is determined. Fair value is defined as the price that
would be received upon the sale of an asset or paid to transfer a
liability (an exit price) in an orderly transaction between market
participants at the measurement date. The accounting guidance also
establishes a three-level valuation
hierarchy that prioritizes the inputs to valuation techniques used
to measure fair value based upon whether such inputs are observable
or unobservable. Observable inputs reflect market data obtained
from independent sources, while unobservable inputs reflect market
assumptions made by the reporting entity. The three-level hierarchy for the inputs to
valuation techniques is briefly summarized as follows:
Level 1—Inputs are
unadjusted, quoted prices in active markets for identical assets or
liabilities at the measurement date;
Level 2—Inputs are
observable, unadjusted quoted prices in active markets for similar
assets or liabilities, unadjusted quoted prices for identical or
similar assets or liabilities in markets that are not active, or other inputs that are
observable or can be corroborated by observable market data for
substantially the full term of the related assets or liabilities;
and
Level 3—Unobservable inputs
that are significant to the measurement of the fair value of the
assets or liabilities that are supported by little or no market data.
The Company’s cash equivalent Money Market Funds and short-term
investments consisting of U.S. Treasury bill securities are
classified as Level 1 because
they are valued using quoted market prices.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
The following table shows the Company’s cash and cash equivalents,
Money Market Funds and short-term investments by significant
investment category as of December
31, 2021 and 2020.
|
|
As of December 31, 2021
|
|
|
|
Adjusted
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
Market
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds
|
|
$ |
1,670 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,670 |
|
U.S. Treasury securities considered cash equivalents
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
U.S. Treasury securities in short-term investments
|
|
|
29,989 |
|
|
|
- |
|
|
|
(6 |
) |
|
|
29,983 |
|
Total Financial Assets
|
|
$ |
31,659 |
|
|
$ |
- |
|
|
$ |
(6 |
) |
|
$ |
31,653 |
|
|
|
As of December 31,
2020
|
|
|
|
Adjusted
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
Market
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds
|
|
$ |
6,035 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
6,035 |
|
U.S. Treasury securities considered cash equivalents
|
|
|
9,998 |
|
|
|
- |
|
|
|
- |
|
|
|
9,998 |
|
U.S. Treasury securities in short-term investments
|
|
|
24,979 |
|
|
|
15 |
|
|
|
- |
|
|
|
24,994 |
|
Total Financial Assets
|
|
$ |
41,012 |
|
|
$ |
15 |
|
|
$ |
- |
|
|
$ |
41,027 |
|
Unrealized gains or losses resulting from our short-term
investments are recorded in accumulated other comprehensive gain or
loss. During the year ended December 31,
2021 and 2020, $(21) and $15
was recorded to accumulated other comprehensive loss and gain,
respectively.
Our financial instruments also include accounts receivable,
accounts payable, accrued liabilities and business acquisition
liabilities. Due to the short-term nature of these instruments,
their fair values approximate their carrying values on the balance
sheets.
Inventory is recorded at the lower of cost or net realizable value.
The cost of substantially all the Company’s inventory is determined
by the FIFO cost method. Inventories consisted of the
following:
|
|
December 31, |
|
|
|
2021
|
|
|
2020
|
|
Finished goods
|
|
$ |
1,027 |
|
|
$ |
1,249 |
|
Work in process
|
|
|
2 |
|
|
|
64 |
|
Raw materials
|
|
|
537 |
|
|
|
1,342 |
|
Inventories - net
|
|
$ |
1,566 |
|
|
$ |
2,655 |
|
As part of product line exit costs (see Note 1) end of life raw material costs aggregating
$621 were written off during the year ended December 31, 2021. During the year ended
December 31, 2020 the Company wrote
off $68 of raw
material and scrap parts primarily due to startup production, model
changes and improvements.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
6.
|
PROPERTY AND EQUIPMENT, NET
|
Property and equipment consisted of the following:
|
|
December 31, |
|
|
|
2021
|
|
|
2020
|
|
Production and lab equipment
|
|
$ |
500 |
|
|
$ |
148 |
|
Tooling
|
|
|
273 |
|
|
|
81 |
|
Computer equipment
|
|
|
467 |
|
|
|
180 |
|
Furniture, fixtures and improvements
|
|
|
176 |
|
|
|
165 |
|
|
|
|
1,416 |
|
|
|
574 |
|
Accumulated depreciation
|
|
|
(440 |
) |
|
|
(217 |
) |
Property and equipment, net
|
|
$ |
976 |
|
|
$ |
357 |
|
Depreciation expense was $297 and $144 for the years ended
December 31, 2021 and 2020, respectively. As part of product line
exit costs (see Note 1) unamortized
production tooling costs of $106 were written off in the second quarter of 2021.
7. INTANGIBLE ASSETS,
NET
Intangible assets consisted of the following:
|
|
December 31, |
|
|
|
2021
|
|
|
2020
|
|
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
Patents
|
|
$ |
416 |
|
|
$ |
280 |
|
Trademarks
|
|
|
134 |
|
|
|
84 |
|
Software
|
|
|
1,212 |
|
|
|
662 |
|
Other
|
|
|
50 |
|
|
|
50 |
|
|
|
|
1,812 |
|
|
|
1,076 |
|
Accumulated amortization
|
|
|
(174 |
) |
|
|
(23 |
) |
Total amortizable
|
|
|
1,638 |
|
|
|
1,053 |
|
Indefinite life assets (non-amortizable)
|
|
|
344 |
|
|
|
344 |
|
Total intangible assets, net
|
|
$ |
1,982 |
|
|
$ |
1,397 |
|
Amortization expense was $182 and $18 for the years ended
December 31, 2021 and 2020, respectively. An additional impairment
charge of $170 for purchased software was recorded in the
second quarter of 2021.
At December 31, 2021, annual
amortization of intangible assets, based upon the Company’s
existing intangible assets and current useful lives, is estimated
to be the following:
2022
|
|
$ |
261 |
|
2023
|
|
|
256 |
|
2024
|
|
|
256 |
|
2025
|
|
|
251 |
|
2026
|
|
|
164 |
|
Thereafter
|
|
|
450 |
|
Total estimated amortization expense
|
|
$ |
1,638 |
|
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
8. ACCOUNTS PAYABLE AND
ACCRUED LIABILITIES
Accounts payable includes $228 and $53 due to related party Syzygy
Licensing, LLC (“Syzygy”) as of December 31, 2021 and 2020, respectively. Accounts payable at
December 31, 2020 also included $10
due to related party V3 Capital
Partners, LLC.
Accrued liabilities consist of the following:
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Patent and legal costs
|
|
$ |
28 |
|
|
$ |
65 |
|
Accrued compensation
|
|
|
628 |
|
|
|
563 |
|
Warranty costs
|
|
|
96 |
|
|
|
48 |
|
Taxes and other
|
|
|
72 |
|
|
|
45 |
|
|
|
$ |
824 |
|
|
$ |
721 |
|
Accrued compensation includes $305 and $563 in employee bonuses and
commissions payable at December 31,
2021 and 2020,
respectively.
9. LEASES
The Company determines if an arrangement is a lease at inception.
The guidance in Topic 842 defines a
lease as a contract, or part of a contract, that conveys the right
to control the use of identified property, plant, or equipment (an
identified asset) for a period of time in exchange for
consideration. Operating lease ROU assets and lease liabilities are
recognized based on the present value of future minimum lease
payments over the lease term at commencement date. The Company’s
leases do not provide an implicit
rate. Due to a lack of financing history or ability, the Company
uses an estimate of low-grade debt rate published by the Federal
Reserve Bank as its incremental borrowing rate based on the
information available at the commencement date in determining the
present value of future payments. The ROU asset includes any lease
payments made and excludes lease incentives and initial direct
costs incurred.
For leases beginning on or after January
1, 2019, lease components are accounted for separately from
non-lease components for all asset classes. The Company’s leases
may contain renewal provisions and
escalating rental clauses and generally require the Company to pay
utilities, insurance, taxes and other operating expenses. The
renewal provisions of the existing lease agreement was not included in the determination of the
operating lease liabilities and the ROU assets.
At December 31, 2021 the Company
was party to one operating leases
for office and production facilities under an agreement that
expires in July 2022. The Company
has elected the short-term lease exemption such that the new lease
standard was applied to leases greater than one year in duration. Leases with an initial
term of twelve months or less are
not recorded on the balance sheet.
The Company recognizes lease expense for these leases on a
straight-line basis over the lease term.
Amortization of ROU operating lease assets was $88 and $122 for the
years ended December 31, 2021 and
2020, respectively.
Operating lease expense for capitalized operating leases included
in operating activities was $95 and $137 for the years ended
December 31, 2021 and 2020, respectively. Operating lease
obligations recorded on the balance sheet at December 31, 2021 are:
Operating lease liability- short term
|
|
$ |
56 |
|
Operating lease liability - long term
|
|
|
- |
|
Total Operating Lease Liability
|
|
$ |
56 |
|
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Future lease payments included in the measurement of lease
liabilities on the balance sheet at December 31, 2021 for future periods are as
follows:
2022
|
|
$ |
57 |
|
Total future minimum lease payments
|
|
|
57 |
|
Less imputed interest
|
|
|
(1 |
) |
Total
|
|
$ |
56 |
|
The weighted average remaining lease term is 0.6 years and the
weighted average discount rate is 7%. Variable lease payments
totaled $29 and are comprised of taxes and other miscellaneous
costs.
The Company did not have any short-term
lease expense during the years ended December 31, 2021 and December 31, 2020. The Company does
not have any finance leases.
The Company’s debt at December 31,
2021 and 2020 included
operating lease liabilities (see Note 9). The Company’s debt at December 31, 2020 also included business
acquisition liabilities (see Note 3).
On May 1, 2020, the Company
received loan proceeds of $414 from Bank of America, N.A. (the
“Lender”), as a potentially forgivable loan (the “PPP
Loan”) from the U.S. Small Business Administration pursuant to
the Paycheck Protection Program (the “PPP”) enacted by
Congress under Division A, Title 1
of the Coronavirus Aid, Relief, and Economic Security Act
(15 U.S.C. 636(a)(36))
(the “CARES Act”), which was enacted March 27, 2020. The PPP Loan was in the form
of a two-year
Promissory Note dated May 1, 2020
payable to the Lender (the “PPP Note”), bearing interest at
a rate of 1% per annum.
Under the terms of the CARES Act, the Company subsequently applied
for and in December 2020 was
granted forgiveness for the PPP Loan plus interest. The Company’s
PPP Loan in the amount of $414 and accrued interest was forgiven in
full by the Small Business Administration. The Company recognized
$417 in debt forgiveness income as a result of the forgiveness.
The Company’s authorized capital consists of 150,000,000 shares of
Common Stock, par value $0.0001 per share, and 5,000,000 shares of
preferred stock, par value $0.0001 per share (“Preferred
Stock”).
2020 Follow-On Public Offering
On June 2, 2020, the Company
consummated a follow-on public offering (the “Unit
Offering”) whereby the Company offered and sold certain
securities consisting of one share of Common Stock and one
detachable two-year
warrant to purchase one share of
Common Stock at an exercise price of $6.00 per share (a “Unit”) at
the public offering price of $6.00 per Unit. Pursuant to the Unit
Offering, the Company sold 2,066,667 Units, resulting in the
Company’s receipt of gross cash proceeds of $12.4 million and net
cash proceeds of $11.67 million after deduction of commissions and
offering costs.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Summary of Stock Purchase
Warrants
The following table summarizes warrant activity during the years
ended December 31, 2020 and
2021:
|
|
Number
|
|
|
Average Price Per Share
|
|
Shares purchasable under outstanding warrants at January 1,
2020
|
|
|
6,620,620 |
|
|
$ |
5.41 |
|
Stock purchase warrants issued
|
|
|
2,066,667 |
|
|
$ |
6.00 |
|
Stock purchase warrants exercised
|
|
|
(5,155,976 |
) |
|
$ |
5.08 |
|
Stock purchase warrants expired
|
|
|
(324,401 |
) |
|
$ |
5.00 |
|
Shares purchasable under outstanding warrants at December 31,
2020
|
|
|
3,206,910 |
|
|
$ |
6.36 |
|
Stock purchase warrants issued
|
|
|
- |
|
|
|
- |
|
Stock purchase warrants exercised
|
|
|
(1,815,012 |
) |
|
$ |
6.64 |
|
Stock purchase warrants expired
|
|
|
(231 |
) |
|
$ |
7.58 |
|
Shares purchasable under outstanding warrants at December 31,
2021
|
|
|
1,391,667 |
|
|
$ |
6.00 |
|
During the year ended December 31,
2020 the Company received gross proceeds of $26,190 from the
exercise of 5,155,976 warrants and paid $1,017 as an agent fee to
facilitate exercise of certain warrants resulting in net proceeds
of $25,174. Elwood Norris was a Company officer at the time he
exercised 333,334 of these warrants at $5.00 per share for cash of
$1,667.
During the year ended December 31,
2021 the Company received proceeds of $12,047 from the
exercise of 1,815,012 warrants.
The Company has outstanding Common Stock purchase warrants as of
December 31, 2021 as follows:
|
|
Number of
|
|
|
Exercise Price
|
|
|
Description
|
|
Common Shares
|
|
|
Per Share
|
|
Expiration Date
|
Purchase Warrants
|
|
|
1,391,667 |
|
|
$ |
6.00 |
|
June 1, 2022
|
12.
|
SHARE-BASED COMPENSATION
|
On March 31, 2017, the Company
adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”)
authorizing 2,000,000 shares of Company Common Stock for issuance
as stock options and restricted stock units to employees, directors
or consultants. In May 2019, the
stockholders ratified an increase in the Plan authorizing an
additional 2,100,000 shares of Common Stock and in June 2020 ratified a further authorization of
1,900,000 shares of Common Stock for a total of 6,000,000 shares
subject to the Plan. In June 2021,
the stockholders ratified an increase in the 2017 Stock Incentive Plan authorizing an
additional 1,500,000 shares of Common Stock to a total of 7,500,000
shares. At December 31, 2021 there
were 1,380,816 shares of Common Stock available for grant under the
Plan.
The Company generally recognizes share-based compensation expense
on the grant date and over the period of vesting or period that
services will be provided.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
Stock Options
The following table summarizes stock option activity for the years
ended December 31, 2020 and
2021:
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
|
Options on
|
|
|
|
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Common
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Shares
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
Outstanding January 1, 2020
|
|
|
2,928,750 |
|
|
$ |
2.96 |
|
|
|
3.71 |
|
|
|
|
|
Granted
|
|
|
1,423,836 |
|
|
$ |
6.66 |
|
|
|
- |
|
|
|
|
|
Exercised
|
|
|
(371,000 |
) |
|
$ |
1.90 |
|
|
|
- |
|
|
|
|
|
Forfeited, cancelled, expired
|
|
|
(50,000 |
) |
|
$ |
3.00 |
|
|
|
- |
|
|
|
|
|
Outstanding December 31, 2020
|
|
|
3,931,586 |
|
|
$ |
4.41 |
|
|
|
4.80 |
|
|
|
|
|
Granted
|
|
|
1,254,500 |
|
|
$ |
5.33 |
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(915,404 |
) |
|
$ |
1.83 |
|
|
|
|
|
|
|
|
|
Forfeited, cancelled, expired
|
|
|
(334,799 |
) |
|
$ |
5.14 |
|
|
|
|
|
|
|
|
|
Outstanding December 31, 2021
|
|
|
3,935,883 |
|
|
$ |
5.24 |
|
|
|
4.79 |
|
|
$ |
1,608 |
|
Exercisable December 31, 2021
|
|
|
2,415,063 |
|
|
$ |
5.19 |
|
|
|
2.44 |
|
|
$ |
1,608 |
|
All outstanding options at December 31,
2021 are service-based options.
The Company uses the Black-Scholes option pricing model to
determine the fair value of the options granted. The following
table summarizes the assumptions used to compute the fair value of
options granted to employees and non-employees:
|
|
For the Year Ended
|
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Expected stock price volatility
|
|
|
50 |
% |
|
|
47 |
% |
Risk-free interest rate
|
|
|
0.90 |
% |
|
|
0.38 |
% |
Expected dividend yield
|
|
|
0 |
% |
|
|
0 |
% |
Expected life of options - years
|
|
|
5.74 |
|
|
|
5.64 |
|
Weighted-average fair value of options granted
|
|
$ |
2.57 |
|
|
$ |
2.90 |
|
Estimated volatility is a measure of the amount by which the
Company’s stock price is expected to fluctuate each year during the
expected life of awards. The Company’s estimated volatility was
based on an average of the historical volatility of peer entities
whose stock prices were publicly available. The Company’s
calculation of estimated volatility is based on historical stock
prices of these peer entities over a period equal to the expected
life of the awards. The Company uses the historical volatility of
peer entities due to the lack of sufficient historical data of its
stock price.
The risk-free interest rate assumption is based upon observed
interest rates on zero coupon U.S.
Treasury bonds whose maturity period is appropriate for the term of
the options. The dividend yield of zero is based on the fact that
the Company has never paid cash dividends and has no present intention to pay cash dividends.
The Company calculates the expected life of the options using the
Simplified Method for the employee stock options as the Company
does not have sufficient historical
data.
Notes to Consolidated Financial Statements
(in thousands, except per share and share amounts)
The following table summarizes information about stock options
outstanding at December 31,
2021:
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
Average
|
|
|
|
|
|
|
Average
|
|
|